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ABSTRACT 
Yue Wang 
Neurofibromin, nerve growth factor and Ras: their roles in controlling the 
excitability of mouse sensory neurons
Neurofibromin, the product of the Nf1 gene, is a guanosine triphosphatase 
activating protein (GAP) for p21ras (Ras) that accelerates the conversion of 
active Ras-GTP to inactive Ras-GDP.  It is likely that sensory neurons with 
reduced levels of neurofibromin have augmented Ras-GTP activity.  In a mouse 
model with a heterozygous mutation of the Nf1 gene (Nf1+/-), the patch-clamp 
recording technique is used to investigate the role of neurofibromin in controlling 
the state of neuronal excitability.  Sensory neurons isolated from adult Nf1+/- 
mice generate more APs in response to a ramp of depolarizing current compared 
to Nf1+/+ mice.  In order to elucidate whether the activation of Ras underlies this 
augmented excitability, sensory neurons are exposed to nerve growth factor 
(NGF) that activates Ras.  In Nf1+/+ neurons, exposure to NGF increases the 
production of APs.  To examine whether activation of Ras contributes to the 
NGF-induced sensitization in Nf1+/+ neurons, an antibody that neutralizes Ras 
activity is internally perfused into neurons.  The NGF-mediated augmentation of 
excitability is suppressed by the Ras-blocking antibody in Nf1+/+ neurons, 
suggesting the NGF-induced sensitization in Nf1+/+ neurons depends on the 
activation of Ras.  Surprisingly, the excitability of Nf1+/- neurons is not altered by 
the blocking antibody, suggesting that this enhanced excitability may depend on 
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previous activation of downstream effectors of Ras.  To determine the 
mechanism giving rise to augmented excitability of Nf1+/- neurons, isolated 
membrane currents are examined.  Consistent with the enhanced excitability of 
Nf1+/- neurons, the peak current density of tetrodotoxin-resistant (TTX-R) and 
TTX-sensitive (TTX-S) sodium currents (INa) are significantly larger than in 
Nf1+/+ neurons.  Although the voltage for half-maximal activation (V0.5) is not 
different, there is a significant depolarizing shift in the V0.5 for steady-state 
inactivation of INa in Nf1+/- neurons.  In summary, these results demonstrate that 
the enhanced production of APs in Nf1+/- neurons results from a larger current 
amplitude and a depolarized voltage dependence of steady-state inactivation of 
INa that leads to more sodium channels being available for the subsequent firing 
of APs.  My investigation supports the idea that regulation of channels by the Ras 
cascade is an important determinant of neuronal excitability.  
 
Grant D. Nicol, Ph.D, Chair 
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I. INTRODUCTION 
Overview 
Neurofibromatosis type 1 (NF1) is a common genetic disorder 
characterized by formation of tumors (Lakkis and Tennekoon, 2000).  Many 
people with NF1 exhibit an exaggerated painful response to stimuli that elicit only 
slight discomfort in normal people (Creange et al., 1999; Wolkenstein et al., 
2001).  The origins of this painful sensation are not understood, and there is no 
effective treatment.  The perception of pain starts from the activation of the 
peripheral endings of special nerve cells, known as nociceptors (specific sensory 
neurons that initiate the signaling pathway that leads to the perception of pain).  
The peripheral activation of these nociceptors generates action potentials (APs) 
and the subsequent release of neurotransmitters, such as glutamate, substance 
P (SP) and calcitonin gene-related peptide (CGRP).  These released 
neurotransmitters generate excitatory post-synaptic potentials (EPSP) in the 
dorsal horn neurons by which the pain signals are relayed to the thalamus and 
cerebrum where the pain is localized and fully realized.  Under some pathological 
conditions, such as inflammation and neuropathic pain, there is an increase of 
pain perception (hyperalgesia) that is caused, at least in part, by a reduction of 
the threshold for activation of nociceptors (peripheral sensitization).  The 
abnormal painful sensation in people with NF1 may suggest an enhanced 
sensitivity of sensory neurons in the dorsal root ganglion (DRG).  The work 
presented in this thesis mainly focuses on sensory neurons and to examine the 
alterations in the firing of APs of neurons with a heterozygous mutation of the Nf1 
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gene (Nf1+/-) isolated from a mouse model of NF1.  NF1 results from a 
heterozygous mutation (NF1+/-) in the NF1 gene.  Because NF1+/- neurons have 
only one functional copy the NF1 gene, the protein product of the NF1 gene, 
neurofibromin, should be lower.  Neurofibromin increases the intrinsic GTPase 
activity of Ras (Ras-GTP, active form), thereby accelerates the hydrolysis of GTP 
from active Ras (Martin et al., 1990).  A decrease in the level of neurofibromin 
frequently results in an increase of Ras-GTP level (Guha et al., 1996; Ingram et 
al., 2001; Klesse and Parada, 1998).  Therefore, in Nf1+/- neurons, the level of 
Ras-GTP could be higher than in wild-type (Nf1+/+) neurons. 
One of the principle aims in this thesis is to determine whether Nf1+/- 
neurons have enhanced neuronal firing and support the idea that the 
augmentation of intracellular Ras-GTP level correlates with increased neuronal 
excitability (neurons have enhanced ability to generate APs, and transmits much 
stronger signals of pain to the brain).  The basic understanding of these 
mechanisms underlying the sensitization of nociceptors could lead to more 
effective treatment of the exaggerated painful condition associated with NF1 or 
other chronic painful conditions that arise from other ailments. 
A. Sensory neurons and ion channels  
Peripheral sensory neurons are nerve cells responsible for converting 
external stimuli, such as mechanical, thermal and chemical noxious information, 
into internal electrical signals like APs.  In complex organisms, when APs travel 
to the presynaptic membrane of DRG fibers in spinal cord, the rapid 
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depolarization of the membrane potential opens voltage-gated calcium channels 
and facilitates the influx of calcium ions that stimulate the release of 
neurotransmitters from the nerve terminal (Hawkins et al., 1983).  These 
released neurotransmitters generate EPSP in the dorsal horn neurons by which 
the pain signals are relayed to the thalamus and cerebrum where the pain is 
localized and fully realized.  These sensory neurons vary in size, specialization of 
endings, the degree of myelination around the axon, as well as the expression of 
different channels and receptors in the neuronal membrane.  These variations 
enable sensory neurons to propagate APs at various conduction velocities and 
detect multiple environmental stimuli.   
Neuronal sensitization is defined as a process of enhanced responses of a 
neuron to a given stimulation.  These responses include a decrease of the firing 
threshold for generating an AP, an increase of the numbers of APs in response 
to the same electrical stimuli and/or an increase in the release of neuronal 
transmitters, such as substance P (SP) and calcitonin gene-related peptide 
(CGRP) from sensory neurons.  A major focus of our laboratory has been to 
elucidate the electrical events and signaling pathways involved in neuronal 
sensitization, especially on the subset of sensory neurons thought to be involved 
in the transmission for signals of pain to the brain.  This subset of neurons is 
smaller in size, extends axons that are either lightly myelinated (Aδ) or 
unmyelinated (C), and has lower conduction velocities (the conduction velocity of 
Aδ fiber is 2.2-8.0 m/s, whereas the conduction velocity of C fiber is less than 1.4 
m/s) (Harper and Lawson, 1985).   
 3
The generation of APs by sensory neurons relies on the activity of ion 
channels, the pore-forming proteins, located across the neuronal membrane.  
Based on their properties of activation, ion channels can be classified as voltage-
gated, ligand-gated, or stretch-gated channels.  Channels can either open or 
close upon changing of the membrane voltage (voltage-gated channels), the 
binding of a specific ligand (ligand-gated channels), mechanical forces (stretch-
gated channels) as well as temperature (heat or cold responsive channels).  The 
opening of ion channels allows the passage of specific ions and thereby changes 
the transmembrane potential and underlies the generation of APs.  An AP can be 
roughly divided into three separate phases, the rising phase (depolarization), the 
falling phase (repolarization) and the recovery phase.  During the rising phase of 
the AP, the sodium channels open, which allows positively-charged sodium ions 
to enter cells and depolarize the membrane potential.  After the depolarization of 
membrane potential reaches its peak, sodium channels are inactivated and 
potassium channels are open.  Both the closing of the sodium channels and the 
opening of potassium channels lead to the repolarization of membrane potential 
back to the resting membrane potential (REM).  The propagation of APs along 
the cell membrane carries fast internal messages that trigger many downstream 
cellular activities, such as the secretion of hormones from glands and the release 
of neurotransmitters.  Since APs are such an essential feature in life, the 
regulation of channel activity that is critical in generating APs, such as potassium 
channels and sodium channels, has a significant influence on neuronal 
excitability and many other physiological functions of the cell. 
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1. Voltage-gated potassium channels in sensory neurons and their influence 
on neuronal excitability 
Voltage-gated potassium channels (Kv channels) are widely expressed in 
most cells.  They form potassium-selective pores that span cell membranes and 
play an essential role in controlling neuronal excitability (figure 1A).  In sensory 
neurons and many other types of excitable cells, potassium currents provide the 
outward currents that repolarize the membrane potential during the falling phase 
of APs.  Therefore, the properties of Kv channels, such as density, trafficking and 
the kinetics of activation and inactivation could all influence the firing patterns of 
sensory neurons.  Although more than 200 genes encoding a variety of 
potassium channels have been identified (Shieh et al., 2000), all potassium 
channels have common features: all potassium channels have: 1. a water-filled 
pore that allows potassium ions to flow across the cell membrane; 2. a highly 
selective filter to establish the ionic selectivity; 3. a sensor to control the opening 
and closing of the channel (Long et al., 2005; MacKinnon, 1991b).  Based on the 
primary amino acid sequence of the pore-containing subunit (α subunit), Kv 
channels can be divided into five subfamilies: Shaker (Kv1.1-1.7), Shab (Kv2.1-
2.2), Shaw (Kv3.1-3.4), Shal (Kv4.1-4.3) and ether-a-go-go (HERG) (Chandy and 
Gutman, 1993).  Kv channels are tetrameric assemblies of four identical or 
different pore-forming α-subunits containing six transmembrane regions (Christie 
et al., 1990; Isacoff et al., 1990; MacKinnon, 1991a).  Some Kv channels may 
have an auxiliary β subunit binding to the N-terminus of the -subunit (Shieh et 
al., 2000).  The pore-forming structure (the region between fifth and sixth 
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transmembrane domains, the p domain) forms the specific pathway for 
potassium ions to flow through (MacKinnon, 1991b), whereas the positively 
charged residues within the fourth putative transmembrane segments (S4) are 
thought to be the major component of the voltage sensor (Liman et al., 1991; 
Tytgat et al., 1993). 
The large diversity of the primary amino acid sequence of the pore-
containing subunits serves as an important mechanism for the heterogeneity of 
voltage-gated potassium channels, and underlies the variety of potassium 
currents (IK) with distinct kinetics and pharmacological properties (Stuhmer et al., 
1989; Wei et al., 1990).  Therefore, it is difficult to characterize the phenotypes of 
IK in DRG sensory neurons.  For example, Kostyuk et al., (1981) report that there 
are two major potassium currents on DRG sensory neurons.  In contrast, Gold et 
al., (1996b) demonstrate that there are six different voltage-gated potassium 
currents in adult rat DRG neurons.  It is highly possible that the large diversity of 
the phenotypes of potassium current observed in these published studies 
resulted from the expression of multiple Kv subtypes in sensory neurons.  In 
addition, the different conditions to culture these cells, such as the enzyme used 
to dissociate tissues, different percentage of CO2 in the incubator, different salt 
and nutrients in the culture media as well as the time of cells in culture may 
contribute to the differential expression of the potassium currents.   
It is well established that potassium currents are critical to determine 
neuronal excitability.  The outflow of potassium ions from inside to the outside of 
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the cell draws the membrane potential closer to the equilibrium potential of 
potassium (EK).  Under my experimental condition with 140 mM potassium ion 
([K]i) in the pipette solution, 5 mM potassium ion in the extracellular solution ([K]o) 
and at room temperature of 20 °C, Ek is calculated to be -84 mV based on the 
Nernst equation (EK=2.303
i
o
KF
RT
][
][
log10
K
where R is the gas constant, T is the 
absolute temperature and F is Faraday's constant.  At room temperature of 20 °C, 
RT/F=25.26 mV; Hille, 2001).  The opening of potassium channels 
hyperpolarizes the resting membrane potential (REM, around -50 to -70 mV in 
isolated sensory neurons in culture), decreases the frequency of neuronal firing 
and increases the rheobase currents (the minimum currents required to evoke an 
AP).  Although the roles of almost all potassium channels are to “stabilize” 
membrane potential, different potassium currents have a distinct function during 
the process of neuronal firing.  In sensory neurons, both the fast inactivating IA 
types (IA) and the slow inactivating delayed-rectifier types of IK (IKd) are 
identified by previous studies (Gold et al., 1996b; McFarlane and Cooper, 1991).  
The suppression of both types of current could result in augmentation of neuronal 
excitability.  Activation of IA modulates neuronal excitability by decreasing the 
frequency of neuronal firing (Connor and Stevens, 1971).  During the 
depolarization of membrane potential (the rising phase of an AP), most channels 
conducting IA are inactivated.  These channels can be reprimed (channels are 
recovered from inactivation and ready to open upon stimulation) during a period 
of hyperpolarization (most likely occurred during the phase for after-
hyperpolarization of the AP), IA can be activated again as the membrane 
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potential depolarizes.  The transient outward IA could cancel the inward INa 
during the depolarization of membrane potential.  Consequently, the membrane 
potential does not change.  The membrane potential will continue to approach 
the firing threshold as IA inactivates (Connor, 1978).  Therefore, IA is a key factor 
to determine the interspike interval, the time between the successive APs.  The 
suppression of IA results in a faster depolarization of membrane potential and 
shortens the interspike intervals.  IKd is another major type of potassium current 
that is critical to neuronal excitability by repolarizing membrane potentials and 
regulating the duration of the AP.  The high potassium permeability during 
repolarization decreases the duration of APs, thereby facilitates the quick 
recovery of neurons from a given stimuli.  A suppression of IKd produces a 
longer duration of the AP.  As a consequence, more calcium ions enter cells and 
facilitate the release of neurotransmitters from sensory neurons (Hawkins et al., 
1983). 
Since potassium channels have such significant roles in modulating firing 
patterns and other neuronal functions, such as the release of neurotransmitters, 
it is not surprising that potassium channels regulate neuronal excitability during 
inflammation and in neuropathic pain (Cherkas et al., 2004; Gold and Flake, 
2005; Katz and Gold, 2006; Liu et al., 2001).  Therefore, we asked whether 
potassium currents were suppressed in Nf1+/- neurons.  By using voltage-clamp 
technique, experiments were performed to determine the amplitude, the levels of 
steady-state inactivation as well as the voltage for half maximum activation and 
inactivation (V0.5) of potassium currents in both genotypes.  
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A  
B
Figure 1. Schematic picture of the structure of voltage-gated potassium 
channels (A) and sodium channels (B).  A is modified from Shieh et al., (2000).  
The voltage-gated potassium channels (Kv) are transmembrane proteins that 
consist of four α subunits containing six transmembrane regions (S1-S6), a pore 
forming structure (P) between S5 and S6 and a voltage sensor (S4).  Some of Kv 
channels may have auxiliary β subunits binding to the N-terminus of the -subunit.  
B is modified from Yu and Catterall, (2003).  The core of a voltage-gated sodium 
channel is composed of one α-subunit, which has 4 repeat domains, named from 
I to IV.  Each domain contains six transmembrane regions.  The structure 
between S5 and S6 is the pore-forming region, whereas the highly conserved S4 
segments act as the voltage sensor. The α subunits can assemble with one or 
more β subunits (β1-β4).   
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2. Voltage-gated sodium channels in sensory neurons and their influence on 
neuronal excitability   
Sodium channels are integral membrane proteins forming sodium-
selective pores that span the plasma membrane.  Like potassium channels, 
sodium channels play an essential role in controlling neuronal excitability.  In 
sensory neurons and many other types of excitable cells, upon changing of 
membrane potential, the opening of sodium channels allows sodium ions to flow 
rapidly down their electrochemical gradient and generate the upstroke of an AP 
(Hodgkin, 1949).  Thus, the properties of sodium channels, such as distribution, 
density, trafficking as well as the threshold of activation and inactivation could all 
influence the firing patterns of sensory neurons.   
Voltage-gated sodium channels have several known subunits: the α-
subunit that forms the sodium-selective aqueous pores and one or more smaller 
β subunits (β1-β4) which regulate the function of the α-subunit (Catterall, 2000; 
Isom, 2001; Yu and Catterall, 2003).  A functional sodium channel is composed 
of one α-subunit that can assemble with one or more β subunits (Yu and Catterall, 
2003).  The α-subunit has four repeat transmembrane domains, named from I to 
IV.  Each domain contains six transmembrane regions (S1-S6; Guy and 
Seetharamulu, 1986; Noda et al., 1984).  The S4 segments, which have 
positively charged arginines at every third residue and are thought to be the 
voltage sensor of voltage-gated sodium channels (Guy and Seetharamulu, 1986).  
When stimulated by a depolarization of the transmembrane potential, the 
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positively charged S4 segments within the pore move to the extracellular side, 
allowing the channel to become permeable to sodium ions (Leuchtag, 1994; 
Yang and Horn, 1995).  Without this movement, the positively charged S4 
segments block the entry of positive-charged sodium ions.   
Although voltage-gated sodium channels are less diverse than potassium 
channels, they clearly have functional diversifications (Neumcke, 1990).  Based 
on the primary amino acid sequence of the α-subunits, a family of nine isoforms 
of sodium channels has been identified: Nav1.1, Nav1.2, Nav1.3, Nav1.4, Nav1.5, 
Nav1.6, Nav1.7, Nav1.8 and Nav1.9 (Wood et al., 2004).  Based on the sensitivity 
to tetrodotoxin (TTX, a paralytic toxin isolated from puffer fish that blocks one 
type of sodium channels), two general classes of voltage-gated INa has been 
identified in sensory neurons: TTX-sensitive (TTX-S) INa and TTX-resistant 
(TTX-R) INa (Elliott and Elliott, 1993; Kostyuk et al., 1981; Roy and Narahashi, 
1992).  In contrast to TTX-S INa, which is blocked by TTX at nanomolar 
concentrations (IC50=0.3 nM), TTX-R INa can only be suppressed by micromolar 
TTX (IC50=100 µM) (Roy and Narahashi, 1992).  The Nav1.1-1.4 and Nav1.6-1.7 
are TTX-S sodium channels, whereas Nav1.5, Nav1.8 and Nav1.9 are recognized 
as TTX-R sodium channels.  TTX-S INa and TTX-R INa differ in their activation 
and inactivation kinetics.  The peak of the I-V relationship, the V0.5 for activation 
and steady-state inactivation of TTX-R INa are more depolarized in sensory 
neurons compared to TTX-S INa (Elliott and Elliott, 1993; Roy and Narahashi, 
1992).  As the membrane potential is held at -67 mV, TTX-R INa is recovered 
from inactivation within 5 ms, which is much faster when compared to TTX-S INa 
 11
(over 50 ms) (Elliott and Elliott, 1993).  This rapid recovery of TTX-R INa from 
inactivation could enable sensory neurons with a larger proportion of TTX-R INa 
to fire at a higher frequency than the neurons with more TTX-S INa (less sodium 
channels are available to generate the upstroke of an AP because of the slow 
recovery of TTX-S INa from inactivation).   
A number of studies indicate that the alteration of INa is an important 
underlying mechanism for a variety of painful disorders, such as inflammation 
(Black et al., 2004; Li et al., 2006; Tanaka et al., 1998), neuropathic pain (Dib-
Hajj et al., 1999; Lai et al., 2002), a painful inherited neuropathy called 
erythermalgia (Cummins et al., 2004), experimental ulcers (Bielefeldt et al., 2002) 
and nerve injury (Black et al., 1999; Dib-Hajj et al., 1996; Rizzo et al., 1995; 
Sleeper et al., 2000).  Both TTX-R and TTX-S INa are reported to have strong 
links with the development of inflammatory and neuropathic pain (in which the 
excitability of nociceptive neurons is enhanced) (Waxman et al., 1999).  For 
example, following peripheral inflammation, the TTX-R INa is enhanced in 
nociceptive neuronal cells in DRG (Tanaka et al., 1998).  In addition, 
inflammatory mediators like NGF, prostaglandin E2 (PGE2) and bradykinin 
enhance neuronal excitability in vitro, through an increase in the amplitude of 
TTX-R INa (England et al., 1996; Gold, 1999; Gold et al., 1996a; Gold et al., 
2002; Jeftinija, 1994; Rush and Waxman, 2004; Zhang et al., 2002).  As to TTX-
S sodium channels, it is reported that axotomy and other forms of nerve damage 
led to the reexpression of an embryonic form of TTX-S sodium channel, Nav1.3, 
in adult rat DRG neurons (Waxman et al., 1994).  The expression of another 
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TTX-S channel, Nav 1.7, was increased in DRG neurons after caraggeenan-
induced inflammation (Black et al., 2004).  A parallel increase of TTX-S INa is 
often observed as a consequence of the transcriptional change of TTX-S sodium 
channels.  All of these publications are consistent with the idea that the 
modulation of both TTX-R and TTX-S INa by multiple inflammatory mediators 
contributes to neuronal sensitization during inflammation or nerve injury. 
Evidence indicates that the sensory neurons with a heterozygous mutation 
of the Nf1 gene are sensitized because these cells release more CGRP upon the 
stimulation of capsaicin (Hingtgen et al., 2006).  Capsaicin is a compound found 
in hot peppers.  This compound selectively activates small-diameter sensory 
neurons involved in nociception (Holzer, 1991).  Hingtgen’s work indicates a 
significant neuronal sensitization in nociceptive sensory neurons with the 
heterozygous mutation.  Because INa is often regulated during neuronal 
sensitization, the next question to be examined in this work is whether INa in 
Nf1+/- neurons is altered, and could underlie the neuronal sensitization of Nf1+/- 
neurons. 
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B. Multiple inflammatory mediators sensitize DRG sensory neurons via 
modulating ion channel activity 
Multiple inflammatory mediators, such as prostaglandins, bradykinin and 
NGF are known to sensitize sensory neurons to given stimuli, resulting in a 
condition of enhanced neuronal sensitivity.  Prostaglandins, the metabolites of 
essential fatty acids, such as gamma-linolenic acid (GLA), arachidonic acid (AA) 
and eicosapentaenoic acid (EPA), are found in almost all tissues and organs.  
Once AA, GLA or EPA are oxidized by cyclooxygenases (COX), prostaglandins 
are produced (Bergstroem et al., 1964; Samuelsson, 1972).  Prostaglandins 
regulate a number of normal physiological functions, such as the constriction of 
smooth muscle or the aggregation/disaggregation of platelets.  In addition, 
prostaglandins closely correlate with inflammation.  The level of one form of 
prostaglandins most associated with inflammation, PGE2, is elevated 
significantly during inflammation and serves as an important mediator that 
causes redness, swelling and hyperalgesia (Ferreira et al., 1978; Willis and 
Cornelsen, 1973).  At the behavioral level, repeated injection of PGE2 in rat paws 
reduced the threshold for the withdrawal response to mechanical and thermal 
stimuli (Willis and Cornelsen, 1973).  PGE2 also directly sensitizes sensory 
neurons as demonstrated by the studies using electrophysiological methods.  
PGE2 was demonstrated to enhance the number of APs elicited by a ramp of 
depolarizing current in embryonic rat sensory neurons and suppressed a voltage-
gated potassium current (Nicol and Cui, 1994; Nicol et al., 1997).  The direct 
sensitizing effect of PGE2 is further confirmed by the studies using 
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radioimmunoassay, such as the observation that PGE2 augments the release of 
neuropeptides, SP and CGRP, from sensory neurons (Hingtgen and Vasko, 
1994).  These two neuronal peptides are widely expressed in the primary DRG 
sensory neurons (Lee et al., 1985; McCarthy and Lawson, 1990).  Evidence 
indicates that the release of these two neuropeptides participates in nociceptive 
transmission, such as the observation that the mechanical and thermal 
hyperalgesia (the enhanced sensitivity to a painful stimulus) induced by 
carrageenan was attenuated by an intrathecal administration of anti-CGRP 
antiserum (Kawamura et al., 1989).  In addition, the Intrathecal injection of SP 
produced a significant mechanical hyperalgesia (Kawamura et al., 1989).  The 
release of these two neuronal peptides from the central and peripheral terminal 
of Aσ or C type fibers is a critical event in modulating pain perception and in 
initiating neurogenic inflammation (Cuello, 1987).  The increase of the release of 
the two neuronal peptides, therefore, indicates a significant enhancement of the 
sensitivity of neurons to noxious stimuli and facilitates the onset of hyperalgesia. 
 Evidence suggests that the sensitizing effect of PGE2 may result from its 
capacity to modulate the activity of ion channels.  Linhart et al., (2003) reported 
that the enhancement of intracellular calcium concentration by PGE2 was 
abolished in calcium-free solution, suggesting that PGE2 activates ion channels 
permeable to calcium ions.  These channels could be vanilloid receptor type 1 
(TRPV1) or related ion channels because Lopshire and Nicol (1998) reported 
that PGE2 augmented the inward currents elicited by the vanilloid, capsaicin, in 
embryonic rat sensory neurons.  In addition, PGE2 was reported to enhance TTX-
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R INa in DRG neurons (England et al., 1996; Gold et al., 2002; Rush and 
Waxman, 2004).  Furthermore, Nicol et al., (1997) and Evans et al., (1999) 
demonstrated that PGE2 suppressed outward potassium currents.  These studies 
are consistent with the notion that PGE2 sensitizes sensory neurons via 
modulation of ion channels. 
NGF is another important inflammatory mediator that sensitizes sensory 
neurons.  NGF was discovered by Rita Levi-Montalcini in the 1950's (Levi-
Montalcini, 1952; Levi-Montalcini and Hamburger, 1951) and recognized to be an 
important factor in the survival, development and maintenance of sensory and 
sympathetic neurons (Eichler and Rich, 1989; Johnson et al., 1989; Kirstein and 
Farinas, 2002; Marzella and Gillespie, 2002).  However, it is clear that NGF also 
regulates the sensitivity of sensory neurons to noxious stimulation.  NGF was 
reported to be a potent causative agent in producing both thermal and 
mechanical hyperalgesia (Lewin et al., 1993).  In addition, approaches that 
blocked increased levels of NGF reduced the inflammatory pain.  By using an 
NGF neutralizing antibody, the elevated sensitivity to painful stimuli was 
attenuated in a rat model of inflammation induced by complete Freund’s adjuvant 
(Woolf et al., 1994).  Likewise, the hyperalgesia in carrageenan-induced 
inflammation was blocked by using a synthetic protein, TrkA-IgG, that abolished 
the biological effect of any free NGF (McMahon et al., 1995).  These studies 
suggest that an increase in NGF concentration is critical for the generation of 
inflammatory pain.  The effect of NGF in inflammatory hyperalgesia is on neurons 
because treatment of sensory neurons with NGF for two weeks increases the 
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basal and stimulus-evoked release of substance P (SP) and calcitonin gene-
related peptide (CGRP), from these neurons (Malcangio et al., 1997).  Similarly, 
NGF was shown to enhance neuronal excitability by increasing the frequency of 
AP firing elicited by a ramp of depolarizing current (Zhang et al., 2002).  
Interestingly, evidence also supports the idea that NGF or its downstream 
effectors sensitizes sensory neurons by modulating ion channels.  NGF was 
reported to enhance the inward currents elicited by capsaicin in small-diameter 
sensory neurons, indicating that NGF could be important in sensitizing 
nociceptive neurons to thermal stimuli (Lewin et al., 1993; Shu and Mendell, 
1999).  Moreover, NGF augmented the excitability of small diameter sensory 
neurons by increasing a TTX-resistant sodium current and suppressing a 
voltage-gated potassium current (Zhang et al., 2002).   
To date, investigators have recognized that NGF activates two kinds of 
receptors on the membrane of sensory neurons.  One is TrkA (p140trkA), the high 
affinity receptor (Kd = 10-11 M), and the other is p75, the low affinity receptor (Kd = 
10 -9 M) (Meakin and Shooter, 1992).  The stimulation of TrkA or p75 by NGF can 
lead to the activation of multiple intracellular cascades, such as the Ras cascade 
(Blochl et al., 2004; Corbett and Alber, 2001; Huang and Reichardt, 2003; Susen 
et al., 1999),  mitogen-activated protein kinase (MAPK) pathway (Ji et al., 2002), 
phosphatidylinositol 3-kinase (PI-3K) pathway (Salvarezza et al., 2003), 
phospholipase Cγ (PLC) pathway (Kim et al., 1991; Vetter et al., 1991) as well as 
sphingolipid pathway (see figure 2 for a summary).  However, which pathway 
modulates the sensitizing effect of NGF remains largely unclear.   
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C. Intracellular signaling pathways that may be involved in neuronal 
sensitization by NGF 
1. Ras-MEK-MAPK pathway  
Ras belongs to the superfamily of small GTP-binding proteins that function 
as “switches” in many intracellular signaling cascades.  Ras was the first member 
to be identified in this family of small GTP-binding proteins by analyzing the 
genome of cell lines transformed by Kirsten and Harvey sarcoma viruses (Chien 
et al., 1979).  Upon binding growth factors, such as NGF, epidermal growth factor 
and fibroblast growth factor, to their receptors on the cell membrane, the 
autophosphorylation of the receptors is initiated.  This autophosphorylation of 
specific tyrosine residues allows the subsequent binding of adaptor proteins, 
such as Shc, Grb2.  The activated Grb2 activates the guanine nucleotide 
exchange factor, Son of sevenless (SOS), which in turn stimulates the release of 
GDP from Ras and allows the subsequent binding of GTP.  This switches the 
complex to the active form, Ras-GTP (Schlessinger, 1993).  Active Ras-GTP will 
recruit the kinase, Raf, to the cell membrane.  The activated Raf stimulates a 
cascade of downstream effectors, such as mitogen-activated protein kinase 
kinase (MEK), which culminates in activation of a serine/threonine kinase, called 
mitogen-activated protein kinase (MAPK).  The MAPK family includes 
extracellular signal-regulated protein kinase (ERK1/2), p38, c-Jun N-terminal 
kinase/stress-activated protein kinase (JNK/SAPK), and ERK5 (Marshall, 1995).  
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The Ras-MEK-MAPK pathway has many functions in neurons, including synaptic 
plasticity, long-term potentiation, and survival (Grewal et al., 1999).   
Recently, several investigations have reported that the activation of MAPK 
is involved in the sensitization of nociceptors.  Zhuang et al., (2005) reported that 
phosphorylated ERK (P-ERK, the active form of ERK) was detected both in 
spinal cord and DRG after spinal nerve ligation (SNL).  Likewise, injecting NGF 
into the peripheral tissue increased P-ERK labeling in TrkA-containing neurons in 
DRG (Averill et al., 2001).  Moreover, p38 was activated in nociceptive sensory 
neurons located in the DRG after inflammation (Beloeil et al., 2006; Ji et al., 
2002).  All these observations indicate that the activation of MAPK may underlie 
the augmented painful sensation during inflammation or neuropathic pain.  In 
support of this idea, Zhuang et al., (2005) reported that the SNL-induced 
mechanical allodynia was suppressed by the Intrathecal injection of the MEK 
inhibitor, PD98059, which suggests that the activation of MAPK contributes to 
mechanical allodynia.  One possible mechanism for MAPK in hyperalgesia and 
allodynia could be the activation of phospholipase A2, the enzyme that liberates 
arachidonic acid, which then serves as the substrate for the generation of 
prostaglandins, leukotrienes and other proinflammatory agents.  These 
compounds could contribute to the abnormal painful sensation associated with 
inflammation (Higgs et al., 1984).  For example, leukotriene B4 was shown to 
directly activate TRPV1, the capsaicin receptor on isolated membrane patches of  
small-diameter sensory neurons (Hwang et al., 2000).  These observations are 
consistent with the idea that the activation of Ras-MEK-MAPK pathway serves as 
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an important component in numerous painful conditions, such as inflammation 
and nerve injury.
2. Phosphoinositide-3-kinase (PI-3K) pathway 
Phosphoinositide-3-kinase (PI-3K) pathway is the major survival-
promoting cascade in neurons (Philpott et al., 1997).  It can be activated by 
binding to the activated TrkA receptor, or by Ras-GTP (Rodriguez-Viciana et al., 
1996; Yuan and Yankner, 2000).  The activation of PI-3K stimulates 3'-
phosphoinositide-dependent kinase-1 (PDK-1) and 3'-phosphoinositide-
dependent kinase-2 (PDK-2), both of which can, in turn, activate a 
serine/threonine kinase, Akt.  Akt may suppress apoptosis by inhibiting the 
activities of Forkhead and Bad, proapoptotic members of the Bcl-2 family or 
attenuates apoptotic activities of GSK-3, thus increase the level of the anti-
apoptosis proteins, like IAP, Bcl-2 or Bcl-XL (Datta et al., 1997; Yuan and 
Yankner, 2000).  Akt might also promote neuronal survival by blocking the JUK-
p53-Bax pathway, the primary apoptotic cascade in neurons (Kaplan and 
Stephens, 1994).   
Evidence shows that PI-3K pathway is involved with neuronal sensitization 
induced by NGF.  By mutating the tyrosine residue Y760 on TrkA that is critical in 
activation of PI-3K, the NGF-induced phosphorylation of TRPV1 was completely 
abolished (Zhang et al., 2005).  Additionally, the potentiation of NGF for the 
capsaicin-evoked TRPV1 currents was completely blocked by PI-3K inhibitors 
(Zhuang et al., 2004),  indicating the activation of PI-3K could modulate TRPV1 
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channels, thereby enhancing the inward currents elicited by capsaicin or noxious 
heat and contributes to the heat hyperalgesia that occurs during inflammation.   
PI-3K can lead to the activation of other downstream protein kinases such 
as protein kinase A (PKA) and protein kinase C (PKC) via PDK-1 (Le Good et al., 
1998).  The activation of both kinases can initiate hyperalgesia (Aley and Levine, 
1999; Cesare et al., 1999; Souza et al., 2002; Zhou et al., 2001).  PI-3K was also 
reported to activate ERK (Zhuang et al., 2004), which is another possible factor 
that contributes to neuronal sensitization (Aley et al., 2001; Dai et al., 2002).  
These studies indicate that PI-3K is involved in neuronal sensitization either by 
directly modulating TRPV1 channels or by activating other intracellular cascades, 
whose activation leads to the sensitization of sensory neurons, and underlies the 
hypersensitivity of pain during inflammation.   
3. The Phospholipase C (PLC) Pathway  
The phosphoinositide-specific phospholipase C (PLC) is an enzyme that 
hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) to liberate inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol (DAG).  PLCs can be divided into three 
types: PLCβ, PLCγ and PLCδ (Lee and Rhee, 1995).  The activation of PLCγ by 
NGF has been demonstrated in previous studies (Rhee and Choi, 1992).  
Evidence indicates that NGF-induced sensitization of DRG cells is through PLC.  
Using an inhibitor of PLC, U73211, the effect of NGF to reverse the tachyphylaxis 
(the inward current in response to the second of two heat pulses is significantly 
smaller than the current elicited by the first heat pulses) was abolished in small-
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diameter DRG neurons (Galoyan et al., 2003).  Consistent with their findings, 
Chuang et al., (2001) demonstrated that the NGF-induced potentiation of the 
proton-evoked TRPV1 currents was abrogated in a heterologous system 
expressed mutant TrkA which is unable to interact with PLC.  Although these 
studies mainly focus on the potentiation of NGF on the TRPV1 currents, they do 
not rule out the possibility that the activation of PLC by NGF is an integral step of 
NGF-induced augmentation of neuronal firing in sensory neurons.   
4. The p75 pathway  
The p75 neurotrophin receptor (p75 NTR, p75) is a member of the tumor 
necrosis factor (TNF) receptor superfamily.  It is a pan-neurotrophin receptor that 
can be activated by NGF, brain-derived neurotrophic factor (BDNF), NT-3 and 
NT4/5 with equal affinities.  The intracellular domain of p75 is similar to the 
“death domain” found in the cytoplasmic regions of members in the tumor 
necrosis factor receptor family, whose activation is thought to induce apoptosis in 
certain cell types (Smith et al., 1994).  Although there is no inherent enzymatic 
activity in the cytoplasmic domain of the receptor, p75 has been shown to 
activate many intracellular signaling pathways.  The activation of p75 stimulates 
stress-activated protein kinase (JUNK) pathway in PC12 cells and activates 
NFκB in Schwann cells and oligodendrocytes (Becker et al., 2004; Carter et al., 
1996; Yoon et al., 1998).  The activation of JUNK and NFκB mainly leads to the 
apoptosis of non-neuronal cells.  However, in sensory neurons, evidence 
suggests that the activation of p75 leads to neuronal sensitization.  The activation 
of p75 by NGF stimulates sphingomyelinase (SMase), the enzyme that 
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hydrolyzes sphingomyelin (SM) to liberate ceramide (Dobrowsky et al., 1994), 
which is also a key player to modulate the excitability of nociceptive sensory 
neurons (Zhang et al., 2002; Zhang et al., 2006b).  Ceramide can be metabolized 
by ceramidase to sphingosine (Sph), which can be further converted to 
sphingosine-1-phospate (S1P).  Both Sph and S1P were shown to augment the 
excitability of sensory neurons isolated from adult rats.  Internal perfusion with 
Sph and S1P augments AP numbers evoked by a standard amount of current 
(Zhang et al., 2006b).  This augmented neuronal excitability may result from the 
direct modulation of ion channels by Sph/S1P or by the downstream signaling 
molecules activated by Sph/S1P.  Interestingly, external perfusion with S1P also 
augments neuronal excitability (Zhang et al., 2006a).  The external S1P may act 
via EDG receptors, the G-protein-coupled receptors, to augment neuronal 
excitability by activating various downstream signaling cascades, such as PLC, 
PKC and MAPK pathway.  S1P may modulate neuronal excitability in two ways: 
one is via a paracrine manner, in which S1P is released and bound to the EDG 
receptors of nearby neurons and thereby augments neuronal firing; second, via 
activation by NGF, S1P can act as internal second messenger to regulate 
membrane excitability.   
Interestingly, p75 also links to the activation of Ras-MEK-MAPK pathway, 
the possible contributor in the elevated sensitivity of sensory neurons to noxious 
stimuli during inflammation or nerve injury (Aley et al., 2001; Dai et al., 2002).  
Through activation of the p75 receptor, NGF stimulates the Ras and MAPK 
transduction cascade in expression systems and neuronal cells that do not 
 23
express TrkA (Blochl et al., 2004; Susen et al., 1999).  Additionally, Hida et al., 
(1998) demonstrated that ceramide activated Ras in cultured oligodendrocytes.  
Based on these observations, it is reasonable to speculate that the activation of 
p75 stimulates MAPK pathway and leads to neuronal sensitization. 
p75 was originally thought to cooperate with TrkA based on the 
observation that the activation of p75 enhances the number of high affinity 
binding sites for NGF in PC-12 cells.  Surprisingly, this effect of p75 does not 
require the extracellular domain, suggesting the transmembrane domain and 
cytoplasmic domain of p75 are responsible for the formation of high affinity 
binding sites for NGF (Esposito et al., 2001).  This enhancement of NGF binding 
with TrkA may result from the conformational change of TrkA by interacting with 
p75, and thereby generate the high affinity binding sites (Esposito et al., 2001).  
However, it is also possible that p75 enhances the potency of TrkA via the 
downstream effectors.  A recent study by Epa et al., (2004) showed that p75 
binds to and enhances the phosphorylation of Shc, a signaling molecule 
interacting with TrkA and leading to the activation of both MAPK and PI-3K 
pathway.  In addition, the phosphorylation of Akt is diminished by using an 
antisense molecule to reduce the expression of p75, suggesting the activation of 
Akt, the downstream effectors of TrkA, depends on the activation of p75 (Epa et 
al., 2004).  Based on these studies, it is reasonable to speculate that there could 
be a redundancy or synergy of the signaling cascades activated by TrkA and p75.   
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However, the pathways downstream of TrkA may also inhibit the pathways 
activated by p75, or the pathway activated by p75 may be suppressed by 
stimulating of TrkA.  Indeed, the stimulation of TrkA attenuates the “death signal”, 
i.e., the activation of JUNK and NFκB following the activation of p75 in cultured 
oligodendrocytes (Yoon et al., 1998).  In addition, in PC12 cells expressing both 
TrkA and p75, the activation of TrkA inhibits p75-dependent sphingomyelin (SM) 
hydrolysis (Bilderback et al., 2001).  The different ratio for the expression of NGF 
receptors in distinct systems could also contribute to the complexity of NGF 
signaling (Twiss et al., 1998). 
We are just beginning to understand the complex system of NGF signaling.  
The intricate aspect in investigating these pathways lies in the heterologous 
expression systems used to perform those studies.  The events happening in 
native cells may not actually occur in those artificial systems.  For example, in 
PC12 cells, the inhibition of PIP2 by using a monoclonal antibody augments 
TRPV1 currents (Chuang et al., 2001).  Such inhibition has not been observed in 
sensory neurons.  Another disadvantage of using heterologous expression 
systems is that, after growing for a period in different culture environments, the 
characteristics of these cells may become quite different compared to those 
found in their ascendant population, probably because the adaptation for different 
culture environments, such as temperature, pH, nutrients as well as 
concentration of salt.  Thus, the results from those studies using cell lines must 
be interpreted with great caution.   
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D. The intracellular transduction pathways activated by NGF modulate 
ion channels  
Numerous reports demonstrated that the downstream effectors following 
the activation of TrkA and p75 regulated channel activity.  For example, 
Fitzgerald and Dolphin (1997) demonstrated that the microinjection of K-Ras (an 
isoform of Ras) enhanced a voltage-gated calcium current in DRG neurons 
isolated from neonatal rats.  In addition, the overexpression of dominant active 
Ras mimicked the effect of NGF to augment the expression of the noxious heat-
sensing protein, TRPV1 in rat DRG neurons (Bron et al., 2003).  Moreover, 
activation of Ras decreased inward rectifier types of potassium currents in the 
heterologous expression of HEK 293 cells (Giovannardi et al., 2002).  MEK and 
MAPK, the downstream effectors of Ras, also regulate membrane currents like 
TTX-R INa (Jin and Gereau, 2006), A-type potassium currents (Karim et al., 2006) 
and voltage-gated calcium currents (Fitzgerald, 2000).  As to the signaling 
cascades activated by p75, SMase pathway, modulates membrane currents such 
as TTX-R INa and delayed-rectifier types of IK (Zhang et al., 2006a; Zhang et al., 
2002; Zhang et al., 2006b).  Taken together, these observations suggest that the 
binding of NGF to its receptors, TrkA and p75, leads to the activation of multiple 
intracellular signaling cascades that may sensitize sensory neurons by 
modulating membrane currents.  However, it remains to be clarified which 
cellular mechanism(s) underlies the augmented neuronal firing by NGF.  In this 
thesis work, two approaches are used to determine whether Ras is an important 
step in this NGF-induced augmentation of neuronal firing.  The first is to examine 
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whether the NGF-induced sensitization in Nf1+/+ mouse sensory neurons can be 
attenuated by using a neutralizing antibody to block the intracellular Ras activity.  
Second, to investigate whether NGF can sensitize Nf1+/- sensory neurons that 
supposedly have augmented intracellular level of Ras-GTP (see next section for 
detailed description; Guha et al., 1996).  If the stimulation of Ras is important in 
NGF-induced augmentation of neuronal firing, then it is not surprising that NGF 
loses its effect on neurons with previous activation of this cascade.  These works 
indicate whether Ras contributes to the augmented neuronal firing induced by 
NGF.   
E. Neurofibromatosis and sensory neurons with Nf1 heterozygous 
mutation   
Neurofibromatosis type 1 (NF1) is a common genetic disease in humans.  
It is an autosomal dominant disease with an incidence of 1 in 3,500 people 
(Lakkis and Tennekoon, 2000).  It is characterized by numerous abnormalities 
including neurofibromas (complex tumors composed of axonal processes, 
Schwann cells, and mast cells), as well as malignant tumors such as 
neurofibrosarcomas, malignant astrocytomas and myeloid leukemias.  In addition 
to the tumor formation, some people with NF1 also experience much more 
intense painful sensations to stimuli, such as minor injuries, that elicit only slight 
discomfort in normal people (Creange et al., 1999; Wolkenstein et al., 2001).  
Although the mechanism by which the NF1 causes the enhanced painful 
sensation has not been elucidated, it is likely that these abnormal painful states 
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involve the sensitization of small diameter nociceptive sensory neurons, cells that 
are known mediate the transmission of pain and itch.   
NF1 results from a heterozygous mutation of the NF1 gene (NF1+/-). 
Currently, investigators have developed two mouse models for NF1.  One is a 
mouse with a heterozygous mutation of the Nf1 gene (Nf1+/-; developed by 
Jacks et al., 1994).  Another is a mouse with a homozygous mutation of the Nf1 
gene (Nf1-/- ; developed by Largaespada et al., 1996).  Because Nf1-/- mice die 
at embryonic day 14, I use adult Nf1+/- mice in my study.  Although the disrupted 
Nf1 gene in these Nf1+/- mice can still be transcribed into mRNA containing an 
open reading frame, the protein product of the mutant mRNA is unstable and 
does not accumulate in cells (Jacks et al., 1994).  Therefore, the protein products 
of the Nf1 gene, neurofibromin, could be lower in cells with only one functional 
copy of the Nf1 gene.  Neurofibromin is expressed most abundantly in the 
nervous system, such as neurons, Schwann cells and oligodendrocytes in adult 
animals (Daston et al., 1992).  The high incidence of developmental retardation, 
learning difficulties as well as exaggerated painful response of those people with 
NF1 (Creange et al., 1999; Trovo-Marqui et al., 2005) indicates that the single 
active NF1 allele does not generate enough neurofibromin to fulfill the normal 
biological function in the nervous system.  Neurofibromin helps to switch the 
active form of Ras (Ras-GTP) to its inactive form (Ras-GDP) by serving as a 
GTPase activating protein (GAP).  The decrease of neurofibromin levels 
frequently results in both basal and cytokine-stimulated Ras activity in many cell 
types.  Investigators have shown that the level of Ras-GTP is elevated in NF1 
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neurofibrosarcomas and neurofibromas (Guha et al., 1996), in Nf1+/- mast cells 
(Ingram et al., 2001), in Nf1-/-Schwann cells (Sherman et al., 2000) and in Nf1-/- 
sensory neurons (Klesse and Parada, 1998; Vogel et al., 2000).  Based on the 
published studies, it is reasonable to speculate that the level of Ras-GTP is 
higher in adult sensory neurons with a heterozygous mutation of the NF1 gene 
(NF1+/- or Nf1+/-) than that of wild-type cells.  The augmentation of Ras-GTP 
alters the function of many cell types.  It is reported that neurons, mast cells, 
fibroblasts and Schwann cells from Nf1+/- and Nf1-/- mice exhibit abnormal 
characteristics compared to wild types.  The Nf1 mutation increased mast cell 
proliferation, survival and colony formation in response to the steel factor, which 
is a ligand for c-kit (the receptor for stem cell factors; Ingram et al., 2001).  In 
addition, embryonic sensory neurons with the Nf1 mutation do not require NGF 
for survival (Vogel et al., 1995; Vogel et al., 2000), indicating the importance of 
the Ras transduction cascade in the survival of embryonic sensory neurons, and 
the Nf1 mutation eliminated their dependency for NGF.   
Ras can be activated by many growth factors.  Among the growth factors 
that activate the Ras cascade, NGF has been explored extensively by 
researchers who study neuronal sensitization in inflammation or nerve injury.  It 
is clear that NGF regulates the sensitivity of sensory neurons to noxious 
stimulation because NGF in culture media for over 2 weeks increases the basal 
and stimulus-evoked release of SP and CGRP from these neurons (Malcangio et 
al., 1997).  NGF also enhances neuronal excitability by increasing the frequency 
of firing APs elicited by a ramp of depolarizing current (Zhang et al., 2002).  It is 
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possible that the enhanced Ras-GTP levels in nociceptive sensory neurons 
serves as a common mechanism either in the painful sensations experienced by 
people with NF1 or in the NGF-induced neuronal sensitization. 
Given the information that Ras modulates membrane currents that 
underlie the generation of APs (Bron et al., 2003; Fitzgerald, 2000; Fitzgerald 
and Dolphin, 1997; Giovannardi et al., 2002), it is logical to infer that enhanced 
Ras-GTP levels in sensory neurons confers a change in channel activity that 
leads to increased neuronal excitability and underlies the onset of enhanced 
painful sensation in people with NF1 as well as NGF-induced neuronal 
sensitization.  
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Figure 2. Intracellular signaling cascades that may contribute to the 
sensitization of DRG neurons.  
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F. Hypothesis and specific aims  
Specific Aims   
Based on the above introduction, my hypothesis is: enhanced Ras-GTP levels 
in sensory neurons changes the activity of ion channels that leads to an 
increased neuronal excitability.  In the studies outlined in this thesis, sensory 
neurons isolated from Nf1+/- mice, a mouse model for neurofibromatosis, are 
used to investigate the actions of the Ras transduction cascade on the neuronal 
excitability.  The electrophysiological properties of these neurons are examined 
with the patch-clamp recording technique.  This technique allows measurement 
of membrane voltage or currents arising from a single neuron.  Since the 
recording pipette has direct access to the cytoplasmic space, the intracellular 
signal transduction pathways can be manipulated in a physiologically 
characterized neuron.  To those ends, the specific aims are as follows:  
 
Specific aim 1 determines whether the excitability of sensory neurons is 
enhanced in Nf1+/- mice compared to wild types.  Since Nf1+/- neurons have 
augmented Ras activity, these studies investigate whether the activation of Ras 
enhances the excitability of sensory neurons.   
 
Specific aim 2 examines the sensitizing effect of NGF on wild-type neurons and 
Nf1+/- neurons.  Because Nf1+/- neurons have augmented Ras activity, the 
studies that compared the NGF-induced sensitization on wild-type and Nf1+/- 
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neurons determine whether Ras had a significant role in neuronal sensitization 
induced by NGF. 
 
Specific aim 3 by using an antibody that neutralizes intracellular Ras activity, 
this aim will investigate whether the suppression of Ras activity in Nf1+/- neurons 
decreases the excitability to the levels observed in Nf1+/+ neurons.  
 
Specific aim 4 examines which membrane currents are altered in Nf1+/- 
neurons and may contribute to the augmented neuronal excitability of Nf1+/- 
neurons. 
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II. MATERIALS AND METHODS 
A. Animals  
Adult mice heterozygous for the Nf1 mutation on a background of 
C57BL/6J were originally developed by Tyler Jacks (MIT).  Animals were housed 
and bred in the Laboratory Animal Care Resource Center (LARC) in accordance 
with protocols approved by the Indiana University Animal Care and Use 
Committee.  The mice used in this study served as a model for humans with NF1.  
The experiments used both Nf1+/+ and Nf1+/- mice as a source for acutely 
dissociated sensory neurons. 
The Laboratory Animal Resource Center, Indiana University School of 
Medicine, is in compliance with State and Federal regulations and is operated 
according to the “Guide for Care and Use of Laboratory Animals”.  The Director 
and Assistant Director are both veterinarians.  The animal care technicians are at 
various stages of AALAS certification.  A letter of assurance is on file with the 
Office of Protection from Research Risks.  Animals were housed in individual or 
group cages in the LARC facility until used for experiments.  In all experiments, 
animals were sacrificed by CO2 prior to tissue harvesting.  Those procedures are 
approved by the Indiana University Animal Care and Use committee.   
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B. Materials  
Horse serum, F-12 medium, L-glutamine, and penicillin/streptomycin were 
purchased from Invitrogen (Carlsbad, CA).  NGF was purchased from Harlan 
Bioproducts for Science (Indianapolis, IN).  Papain was purchased from 
Worthington Biochemical, and dispase was obtained from Roche (Indianapolis, 
IN).  Collagenase, poly-D-lysine, laminin, 5'-fluoro-2'-deoxyuridine, uridine, and 
standard laboratory chemicals were from Sigma-Aldrich (St Louis, MO).  
Capsaicin was first dissolved in 1-methyl-2-pyrrolidinone (MPL) to obtain a 1 
mg/ml stock solution.  The stock solution was diluted with normal Ringer’s 
solution to yield final concentration, 100 ng/ml capsaicin.  Anti-v-H-Ras, a 
monoclonal antibody that neutralizes the biological and biochemical activities of 
H-, K-, and N-Ras of vertebrates by binding to residues Glu-63, Ser-65, Ala-66, 
Met-67, Gln-70, and Arg-73 (Sigal et al., 1986), was obtained from Calbiochem 
(San Diego, CA).  Lyophilized solid antibody was reconstituted in normal pipette 
solution (see below for composition), then stored in aliquots at -20°C for long 
term storage.  
C. Isolation and culture of adult mouse sensory neurons 
Isolation of sensory neurons from adult mice used the procedure 
developed by Lindsay (1988) with slight modification.  Briefly, male adult animals 
were killed by placing them in CO2 chamber.  The isolated spinal column was 
dissected, the spinal cord was removed, and the dorsal root ganglia were 
collected in a culture dish filled with sterilized Pucks solution composed of (in 
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mM): 171 NaCl, 6.7 KCl, 1.6 Na2HPO4, 0.5 KH2PO4, 6 D-glucose, and 0.01% 
phenol red, pH 7.3.  The ganglia were transferred to a conical tube with Pucks 
solution containing 10 ng/ml papain.  After 10-15 min incubation at 37°C, the 
ganglia were transferred to another conical tube with F-12 medium containing 
1mg/ml collagenase 1A and 2.5 mg/ml dispase.  After 10-15 min incubation at 37 
°C, the tube was centrifuged for 30 s at 3000 rpm before the enzyme-containing 
supernatant was removed.  The pellet was resuspended in F-12 medium either 
without NGF or with various concentrations of NGF (1, 30, 100 ng/ml) and 
mechanically dissociated with fire-polished pipettes until all obvious chunks of 
tissue were gone.  Isolated cells were plated onto plastic cover slips that were 
previously coated with poly-D-lysine and laminin.  The cells were maintained in 
F-12 medium that was supplemented with 10% horse serum, 2 mM glutamine, 
100 µg/ml normocin, 50 µg/ml penicillin and streptomycin, 50 µM 5-fluoro-2'-
deoxyuridine, 150 µM uridine at 37 °C and 3% CO2 and used within 4-12 hour for 
electrophysiological recordings.  All procedures had been approved by the 
Animal Use and Care Committee of the Indiana University School of Medicine.   
D. Whole-cell patch-clamp recording 
Recordings were made using the whole-cell patch-clamp technique. This 
technique was originally developed by Erwin Neher and Bert Sakmann in the 
1970s.  Detailed description of this technique can be found in many sources, 
such as the Axon Guide (Axon instruments, Foster City, CA, USA) and other 
highly cited papers (Hamill et al., 1981; Neher and Sakmann, 1976). 
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1.  Instruments  
The patch-clamp recording system can be divided in three parts: 
electronics, optical system and mechanical components. The accessories, such 
as perfusion system, Agar bridge, recording pipette puller and polisher are 
outlined below. 
1). Electronics 
 Two different patch-clamp systems were utilized in this study.  One was 
composed of an EPC-7 amplifier (List Electronics, Darmstadt, Germany); a 
customized amplifier built by Dr. Grant Nicol; an analog to digital (A-D) converter 
(Model TL-1, Axon instruments, Foster City, CA, USA), an oscilloscope (Model 
5113, Tektronix Inc., Beaverton, Oregon) and a personal computer (Dell, Round 
Rock, TX).  The other was composed of an Axopatch 200B amplifier (Axon 
Instruments, Foster City, CA, USA); an A-D converter (DigiData 1322A, Axon 
Instruments, Foster City, CA, USA); an oscilloscope (Model 5113, Tektronix Inc., 
Beaverton, Oregon) and a personal computer (Dell, Round Rock, TX).   
 Briefly, command signals, either holding voltages or stimulating currents, 
were designed by using pCLAMP 6.0.3 or pClamp 9 software to evoke APs or 
activate/inactivate certain types of ion channels.  The digital signals generated by 
the computer were converted to analog signals by a digital to analogue (D-A) 
converter.  The analog signals then were sent to sensory neurons via the 
amplifier and headstage, to evoke a response from the sensory neurons.  The 
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electrical response of the sensory neuron, either membrane voltage or currents, 
were recorded by the headstage.  After amplification and filtration, the signals 
were sent to an oscilloscope for monitoring and to an A-D converter to be 
digitized.  The digitized signals were stored and analyzed in the computer by 
utilizing pCLAMP 6.0.3 or pCLAMP9 software (Axon Instruments, Foster City, CA, 
USA).  A schematic of the configuration for patch-clamp recording is provided in 
Fig 3.  
2). Optics and mechanical components 
During experiments, the sensory neurons were visualized by using an 
inverted microscope (Model IMT-2, Olympus Corp. Tokyo, Japan) with 200× 
magnification.  One hydraulic micromanipulator was mounted on the microscope 
and held the amplifier headstage.  For all electrophysiological experiments, the 
microscope was placed on an anti-vibration table (Technical Manufacturing 
Corporation, Peabody, MA) with 50-60 psi maintained air pressure.  A Faraday 
cage was placed on the air table in order to shield the experimental signal from 
other noises.  A central ground point that connected to the water pipe located in 
the ceiling of the laboratory was built on the wall of the Faraday cage.  The 
microscope and all the cables in the cage were connected to the central ground 
point.   
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 Figure 3. Schematic draft of the Patch-clamp device. 
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3). Superfusion system and recording chamber  
During all electrophysiological experiments, a VC-8 Eight Channel 
Perfusion Valve Control Systems (Warner Instruments, Hamden, CT,USA) was 
used.  The VC-8 Valve Controller was configured to control up to eight valves.  
Each valve was individually accessed by a manual switch for selecting perfusion 
solutions.  During experiments, eight (or less) 60 ml reservoirs were filled with 
different solutions.  The eight reservoirs fed into one polyethylene inflow tube 
connected to the recording chamber.  The superfusate was aspirated from the 
recording chamber by a polyethylene tube connected to a collection flask.  In 
most experiments, the solution flow was terminated during recording in order to 
reduce noise levels.  
The recording chamber was built on a 3” × 1” glass microscope slide.  The 
walls of the chamber were made of silicone epoxy sealant.  A 1-2 mm dam, 
made of fast drying epoxy glue, divided the chamber into two parts, the inflow 
chamber and the outflow chamber.  The inflow and outflow polyethylene tubing 
were connected to the inflow and the outflow chamber, respectively.  During 
perfusion, the solution passed over the epoxy dam and was drawn from the 
recording chamber to a connected flask.  The diameter of the inflow and outflow 
polyethylene tubing, the height of the silicone sealant wall and the epoxy dam 
were carefully adjusted to prevent the inflow chamber from drying.  In all 
experiments, the recording chamber was placed in a grooved opening of an 
aluminum platform and stabilized with tape.   
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4). Agar bridge, recording pipette, pipette puller and polisher.  
For all experiments, an agar bridge which served as reference electrode 
was placed in the recording chamber.  The agar bridge was constructed from 
#205 polyethylene tubing filed with 2% agar dissolved in normal Ringer’s solution 
(see below for composition).  The agar bridge was connected to a Ag-AgCl 
electrode that was contained in an electrode holder.  During experiments, the 
electrode holder was filled with normal Ringer’s solution, and was connected to 
the reference input of the amplifier headstage.  This electrode holder was 
permanently fixed to the aluminum platform that held the recording chamber.  
The recording pipette for whole-cell recordings was prepared from custom 
8520 glass micropipette (Warner Instruments, Hamden, CT) using a micropipette 
puller (Model P-87, Sutter Instruments, San Rafael, CA).  The tips of the 
recording pipette were polished using a microforge (MF-830, Narishige, Japan).  
Once filled with normal pipette solution (see below for composition), the 
recording pipette typically had a resistance between 1-2 MΩ.   
2. Solutions  
1). Normal Ringer’s solution 
Normal Ringer’s solution was the standard bath solution.  During all 
current and voltage clamp experiments, the whole-cell configuration was 
established in normal Ringer’s solution.  The composition of the normal Ringer’s 
solution was as follows (in mM): 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES 
 41
and 10 glucose, pH adjusted to 7.4 with NaOH.  To test for the sensitivity to 
capsaicin, 10 µl of capsaicin stock solution (1 mM, in methyl-2-pyrrolidinone, 
MPL) was dissolved in 100 ml of normal Ringer’s solution to yield a final 
concentration of 100 nM.  
2). N-methyl-glucamine (NMG) Ringer’s solution 
In order to isolate the potassium currents, the INa was eliminated by 
replacing NaCl in normal Ringer’s solution with an equimolar impermeant cation, 
NMG chloride.  The composition of NMG Ringer’s solution was as follows (in 
mM): 140 NMG chloride, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES and 10 glucose, pH 
adjusted to 7.4 with KOH.  
3). Ringer’s solution for INa recording (INa Ringer’s solution) 
Two INa Ringer’s solutions were used in this study.  The sodium 
concentration of one INa Ringer’s solution (low sodium INa Ringer’s solution) 
was reduced in order to decrease the size of INa and thereby improve the space 
clamp (some neurons generate large INa responsive to the holding potential in 
the presents of 110 mM sodium ion in Ringer’s solution, sometimes these 
currents saturate the amplifier).  The composition of low sodium INa Ringer’s 
solution is as follows (in mM): 30 NaCl, 65 NMG-Cl, 30 TEACl 
(tetraethylammonium chloride), 0.1 CaCl2, 5 MgCl2, 10 HEPES, pH adjusted to 
7.4 with HCl and TEAOH.  The osmolality was adjusted to 300-310 mOsM/l using 
glucose and sucrose.  In order to improve the condition for obtaining TTX-S INa, 
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full sodium INa Ringer’s solution was used.  The composition of full sodium INa 
Ringer’s solution is as follows (in mM): 110 NaCl, 30 TEACl, 0.1 CaCl2, 5 MgCl2, 
10 HEPES, pH adjusted to 7.4 with HCl and TEAOH.  The osmolality was 
adjusted to 300-310 mOsM/l using glucose.  TEA was used in both solutions to 
block potassium currents.  After establishing the whole-cell configuration, 
neurons were superfused with either low sodium or full sodium INa Ringer’s 
solution, and stimulated with a series voltage steps (see Figure 8 for details) to 
record the total INa.  The TTX-S INa was obtained by digital subtraction of the 
current traces before and after applying 500 nM TTX, a potent neurotoxin that 
blocks the TTX-S component of the total INa.   
4). Normal pipette solution 
The normal pipette solution was used in all experiments except for 
recording of the INa.  The normal pipette solution had the following composition 
(in mM): 140 KCl, 5 MgCl2, 4 ATP, 0.3 GTP, 2.5 CaCl2, 5 EGTA (calculated free 
Ca2+ concentration of ~100 nM) and 10 HEPES, adjusted pH at 7.3 with KOH.  In 
the experiments using the Ras blocking antibody, 30 µg/ml antibody was 
included in pipette solution.  
5). Pipette solution for INa recording  
For recording INa, the recording pipettes contained (mM): 80 aspartic acid, 
80 CsOH, 55 CsCl, 10 NaCl, 5 MgCl2, 4 ATP, 0.3 GTP, 1 CaCl2, 10 EGTA, 10 
glucose, and 10 HEPES, at pH 7.3 (adjusted with CsOH).  For obtaining TTX-S 
 43
components, the recording pipettes were filled with solution with following 
components:  110 CsF, 25 CsCl, 10 NaCl, 5 MgCl2, 4 ATP, 0.3 GTP, 1 CaCl2, 10 
EGTA, 10 glucose, and 10 HEPES, at pH 7.3 (adjusted with CsOH).   
3. Recording procedures 
All patch-clamp recordings were performed on small diameter (15-25 µm) 
sensory neurons that were maintained in culture for 4-12 hours after isolation. 
Prior to experiments, all solutions were brought to room temperature.  Sensory 
neurons grown on plastic coverslip were removed from the culture dish in a 
laminar-flow hood and placed in the recording chamber filled with normal 
Ringer’s solution.  The plastic coverslip was secured to the recording chamber 
with a small drop of vaseline.   
The recording chamber was brought to the Faraday cage and grounded 
with an agar bridge to the ground input of the amplifier headstage.  The inflow 
and outflow polyethylene tubes were connected to the output of the perfusion 
system and the vacuum aspirator, respectively.  The recording chamber was 
washed clean by superfusing normal Ringer’s solution for several minutes.  The 
small diameter neurons with minimum processes were selected for 
electrophysiology recordings.  The liquid junction potential for all solutions was 
less than 8 mV; data were not corrected for this offset.  At the end of the 
recordings, neurons were exposed to 100 nM capsaicin.  Neurons sensitive to 
capsaicin (depolarized by capsaicin) are believed to be nociceptive sensory 
neurons (Holzer, 1991).  The results using the patch-clamp technique reported in 
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this thesis were obtained from small diameter, capsaicin-sensitive neurons.  All 
experiments were performed at room temperature (~23 °C).  
A detailed description of patch-clamp recording process can be found in 
many sources, such as the Axon Guide (Axon instruments, Foster City, CA, USA) 
and other highly cited papers (Hamill et al., 1981; Neher and Sakmann, 1976).  
Briefly, under visual control, the recording pipette was lowered to touch the 
membrane of selected sensory neurons.  After gentle suction, the cell membrane 
formed a tight seal with the pipette tip (giga seal, the resistance reaches more 
than 1 GΩ).  During formation of the seal, a train of voltage pulses (5 mV) were 
applied to the stimulus input of the amplifier.  By observing the shape of the 
resulting current pulses, the progress of the seal formation was monitored.  After 
forming the seal (at least 1 GΩ), brief suction was applied to the pipette in order 
to rupture the attached cell membrane yielding the whole-cell configuration.  The 
establishment of the whole-cell configuration was identified by the sudden 
widening of the current transients due to the inclusion of the capacitance of cell.  
After establishing the whole-cell configuration, the pipette has direct access to 
the intracellular compartment of cell, thereby delivering currents or voltage stimuli 
to neurons.  In patch-clamp experiments, there is a potential drop across the 
pipette and other resistors in series with the pipette (series resistance).  In order 
to keep the fidelity of the command potential, series resistance compensation 
was performed.  Typically, 60-80% compensation of the series resistance could 
be achieved.  Another factor that influenced the time resolution of changing the 
voltage across the cell membrane was the capacitance of the cell.  When the 
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membrane potential was altered, there was a significant current transient in order 
to charge the capacitance.  Since it is impossible to record any meaningful data 
during this transient, this transient was compensated as well in most voltage 
clamp recordings.  By carefully manipulating the capacitance compensation 
provided by the patch-clamp amplifier, most transient currents were removed 
from the recording traces.  By performing the compensation, the values of the 
membrane capacitance and series resistance were read directly from the 
amplifier.  The value of cell capacitance was used to estimate the size of the 
recording neurons, whereas the value of the series resistance was used to 
estimate the accessibility of a recording pipette to internal milieu of the cell.  In all 
voltage clamp recordings, series resistance and capacitance were monitored and 
compensated through entire time of the recording.   
4.  Electrophysiological protocols 
1). Current clamp protocol  
Current clamp protocols were designed to examine the neuronal 
excitability and other factors that regulated the firing properties of sensory 
neurons.  The following parameters were measured from neurons.   
A) AP variables.  
 The parameters of the AP that were measured from DRG neurons are 
shown in Figure 4 (Modified from Djouhri et al., 2001).  These measurements 
indicate the properties of different ion channels in sensory neurons.  For example, 
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the rise time of an AP (APRT) indicated the activation properties of sodium 
channels, whereas AP duration at 50% recovery (APD50) and the falling time of 
an AP (APFT) represented the properties of some potassium channel subtypes, 
such as delayed rectifier potassium channels and calcium-dependent potassium 
channels.  The alterations of channel properties could be inferred by examining 
these parameters measured from sensory neurons of different groups. 
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 Figure 4. The measurements of AP parameters in the electrophysiology 
experiment (modified from Djouhri et al., 2001).  The variables measured on an 
AP invoked by a single stimulation of the sensory neuron from DRG (dorsal root 
Ganglion).  1, Membrane potential; 2, APDB (AP at base); 3, APRT (AP rising 
time); 4, APFT (AP falling time); 5, AP height; 6, AP overshoot; 7, AHP duration 
to 80% recovery; 8, AHP depth measured from Em, 9, AHP depth measured from 
0 mV; 10, APD50. 
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B) AP numbers, firing threshold and firing latency.   
Figure 5A shows a representative neuron held at its resting membrane 
potential and APs evoked by injecting a 1 s ramp of depolarizing current that had 
a final amplitude of 1000 pA.  AP number was the number of APs elicited by a 
standard amount of current.  Since the amplitude of the current ramp was fixed at 
a specific value, the more APs elicited by the ramp, the higher the excitability of 
the neuron.  The lower panel of Figure 5 is the dV/dt transformation of the APs 
shown in the upper panel.  The baseline dV/dt was calculated as the average of 
all the values between the onset of the current ramp and just prior to the initiation 
of the AP.  As described in Figure 5B, the firing threshold is the membrane 
voltage corresponding to the point at which dV/dt exceeded the baseline value by 
20-fold.  The lower the firing threshold, which means that the sensory neuron 
fires at a more negative membrane potential, the higher the excitability of 
sensory neurons.  The firing latency is taken as the time between the onset of the 
current ramp and the time at which the firing threshold is attained (Wang et al., 
2005).  The shorter the firing latency (the neuron had less charging time to reach 
the firing threshold), the higher the excitability.  
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A B  
 
 
Figure 5. The method used to determine AP numbers, firing threshold and 
firing latency of APs recorded from isolated sensory neurons in culture.  A: 
the neuron was held at its resting membrane potential and APs were evoked by 
injecting a 1 s ramp of depolarizing current that had a final amplitude of 1000 pA.  
Panel B is the enlarged version of the grey area of panel A.  Point A: the starting 
point of the injected ramp current.  Point B: the point whose value was 20 times 
above the base line value of the dV/dt trace.  Point C: the firing threshold.  The 
lower panel of A, B is the dV/dt transformation of the APs shown in the upper 
panel.  See text for details.   
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C) Rheobase, input resistance and resting membrane potential (REM).   
Rheobase is the minimum amount of current required to evoke an AP.  As 
shown in the upper panel of Figure 6, sensory neurons were held at their resting 
membrane potential and injected with current steps that were 200 ms in duration; 
the initial step began at -30 pA and increased by 10 pA increments until an AP 
was elicited.  The rheobase of this representative sensory neuron was 30 pA.  
The middle panel of Figure 6 shows the stimulation protocol used to generate the 
AP shown in the upper panel.  The lower panel of Figure 6 demonstrates the 
method to determine the resistance of the cell membrane.  A current-voltage plot 
was generated using the voltage values of points A, B, C, and D in the upper 
panel corresponding to the values of their stimulus currents.  These results were 
fit with a linear regression line using SigmaPlot 9 software (Jandel Scientific, San 
Rafael, CA, USA).  The slope of this regression line indicated the input resistance 
of the neuron.  Resting membrane potential (REM) was determined by averaging 
all the data points of the recording trace whose stimulating current was 0 pA.  
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 Figure 6. The method for determine rheobase, input resistance and resting 
membrane potential of sensory neurons.  Upper panel: the change of 
membrane potential of a sensory neuron in responsive to the stimulating currents.  
Middle panel: stimulation protocol for this particular neuron. Lower panel: the 
current-voltage plot to determine the input resistance of the representative 
sensory neuron.  Points A, B, C, D (upper panel): the four points whose values 
were plotted in the I-V trace of lower panel.  See text for details.   
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2). Voltage clamp protocol  
A) Voltage clamp protocol for recording potassium currents (IK)   
A series of voltage clamp protocols for activation and inactivation of 
potassium currents (IK) were designed using pClamp 9 software (Axon 
Instruments, Foster City, CA, USA).  As shown in Figure 7A, the membrane 
voltage was held at -60 mV; activation of the currents was determined by voltage 
steps of 300 ms, which were applied at 5 s intervals in +10 mV increments from -
80 mV to +60 mV.  Steady-state inactivation of IK was measured by applying a 
15 s conditioning prepulse (-100 to +20 mV in 20 mV increments) after which the 
voltage was stepped to +60 mV for 200 ms; a 20 s interval separated each 
prepulse sweep (Figure 7B).  The protocols described in Figure 7C and 7D were 
designed to isolate the fast inactivating potassium currents known as IA type.  In 
Figure 7C, by utilizing the 4 s conditional prepulse to -100 mV, inactivation of the 
IA type of IK was removed based on previous characterization of IA performed in 
our laboratory (see results section for details).  Activation of the currents was 
determined by the subsequent voltage steps of 300 ms, which were applied at 15 
s intervals in +20 mV increments to +40mV.  In Figure 7D, the 4 s conditional 
prepulse (-40 mV) inactivated IA type of potassium channels.  The fast 
inactivating potassium currents (IA type) were obtained by digital subtraction of 
the current traces recorded using the protocols shown in Figure 7C and Figure 
7D.  The protocol in Figure 7E was designed to characterize the kinetics of 
potassium tail currents.  In all IK recordings, after obtaining IK of sensory 
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neurons in normal Ringer’s solution, the superfusate was changed to the NMG 
Ringer’s solution and cells were superfused for the appropriate times.  At the end 
of each recording, the neurons were exposed to 100 nM capsaicin.  These 
neurons sensitive to capsaicin (depolarized by capsaicin) are believed to be 
nociceptive sensory neurons (Holzer 1991).   
B) Voltage clamp protocol for sodium currents (INa) 
As show in Figure 8, a series of voltage clamp protocols for activation and 
inactivation of INa were designed using pClamp 9 software (Axon Instruments, 
Foster City, CA, USA).  For the recordings using aspartic acid and CsOH (to 
generate Cs-aspartate) based pipette solution, the membrane voltage was held 
at -60 mV after establishing the whole-cell configuration.  Activation of INa was 
determined by voltage steps of 30 ms, which were applied at 10 s intervals in +5 
mV increments from -80 to +40 mV.  A 500 ms prepulse at -90 mV was used 
before the activation protocol to reprime the sodium channels.  After obtaining 
the control INa in low sodium INa Ringer’s solution, the superfusate was changed 
to the low sodium INa Ringer’s solution containing 500 nM TTX and cells were 
superfused for the appropriate times.  TTX-sensitive (TTX-S) INa was obtained 
by digital subtraction of the current traces recorded before and after TTX 
treatment.  Steady-state inactivation of INa was achieved by applying a 200 ms 
conditioning prepulse (-100 to +10 mV in 10 mV increments) after which the 
voltage was stepped to +0 mV for 30 ms; a 5 s interval separated each prepulse 
sweep.  
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In order to maximize the condition for obtaining TTX-S INa, CsF based 
pipette solution was used.  The membrane voltage was held at -100 mV after 
establishing the whole-cell configuration.  Activation of INa was determined by 
voltage steps of 30 ms, which were applied at 10 s intervals in +5 mV increments 
from -80 to +40 mV.  A 5 s interval separated each prepulse sweep.  After 
obtaining the control INa in full sodium INa Ringer’s solution, the superfusate was 
changed to the full sodium INa Ringer’s solution containing 500 nM TTX and 
cells were superfused for the appropriate times.  TTX-S INa was obtained by 
digital subtraction of the current traces recorded before and after TTX treatment. 
5. Analysis and statistical procedures of electrophysiological recordings 
All values represent the mean ± standard error of the mean (SEM).  The 
voltage dependence for activation of IK was characterized by fitting the value of 
the peak currents responsive to their holding voltages with the Boltzmann relation 
G/Gmax = 1/[1+exp(V0.5-Vm)/k], where G is the conductance that was determined 
from the equation G = I/(Vm-VE).  I is the measured membrane current, Vm is the 
voltage step, and E is the equilibrium potential (calculated to be -84 mV for IK).  
Gmax is the maximum conductance, V0.5 is the voltage for half-maximal activation, 
Vm is the holding voltage, and k is a factor describing the steepness of the 
relation.  The Boltzmann parameters (Gmax, V0.5, k) were determined for each 
individual neuron from which the mean ± S.E.M. was calculated.  The peak IK 
responsive to their holding potentials was determined isochronally at a chosen 
time at which most of the currents were close to their peak value.  
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To fit the peak IK obtained after 15 s conditional prepulses from -100 mV 
to + 20 mV as described in Figure 7B, the Boltzmann relation  G/Gmax = c+{(1-c) 
/[1+exp(V0·5-Vm)/k]} was used.  C is the fraction of non-inactivating current 
(defined as the peak current obtained at +60 mV for the +20 mV prepulse) and 
the other parameters are as defined above.  Fits were performed using the curve 
fitting protocols in SigmaPlot 9.0 (Jandel Scientific, San Rafael, CA, USA).   
The voltage dependence for activation of INa was characterized by fitting 
the value of the peak currents responsive to their holding voltage with the 
Boltzmann relation as described above.  The peak INa was determined by 
choosing the data point that has the biggest value compared to other points 
responsive to the same holding potential.  The equilibrium potential for INa was 
determined individually for each neuron.  For example, for a neuron generated -
212 and 129 pA peak current responsive to 25 mV and 30 mV holding potential, 
a scatter plot describing the I-V relationship was created using SigmaPlot 9.0 soft 
ware.  A linear regression line that is the best fit the data was generated.  The 
reversal potential (equilibrium potential) was determined using the value of the 
point on the regression line (in mV) whose corresponding current was 0 pA.  In 
this particular example, the reversal potential was 28 mV.   
To fit the peak INa obtained after 200 ms conditional prepulses from -100 
mV to + 10 mV as described in Figure 8B, the Boltzmann relation  G/Gmax = c+ 
{(1-c)/[1+exp(V0·5-Vm)/k]} was used.  c is the fraction of non-inactivating current 
(defined as the peak current obtained at 0 mV for the +10 mV prepulse) and the 
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other parameters are as defined above.  Fits were performed using the curve 
fitting protocols in SigmaPlot 9.0 (Jandel Scientific, San Rafael, CA, USA).   
Statistical differences between the control recordings and those obtained 
under various treatment conditions were determined by using either a Student's t-
test, analysis of variance (ANOVA), or a repeated measure ANOVA (RM 
ANOVA).  When a significant difference was obtained with an ANOVA, post hoc 
analyses were performed using a Dunnett's analysis, as appropriate and is 
specified in the text.  Values of P < 0.05 were judged to be statistically significant.   
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 Figure 7. Protocols for the activation or inactivation of IK.   
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 Figure 8. Protocols for the activation or inactivation of INa.  
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III. RESULTS 
A. Sensory neurons from Nf1+/- mice have higher excitability than 
neurons from Nf1+/+ mice.  
Neurofibromatosis type 1 (NF1) is a common genetic disease that is 
characterized by multiple tumor formation.  In addition, some people with NF1 
also experience much more intense painful sensations to stimuli, such as minor 
injuries, that elicit only slight discomfort in normal people (Creange et al., 1999; 
Wolkenstein et al., 2001).  Although the mechanism by which the NF1 mutation 
causes these symptoms has not been elucidated, it is likely that these abnormal 
painful states involve the sensitization (an exaggerated response to stimuli that 
generates more APs, or releases more neuronal transmitters) of small diameter 
nociceptive sensory neurons, cells that are known mediate the transmission of 
pain and itch.   
Using isolated sensory neurons from a mouse model of neurofibromatosis 
(Nf1+/-), Hingtgen et al., (2006) found that the capsaicin or high potassium 
evoked release of SP and CGRP was increased in sensory neurons from Nf1+/- 
mice compared to wild-types.  The increase in the release of these two peptides 
indicates a significant enhancement of the sensitivity of Nf1+/- neurons to 
noxious stimuli.  Therefore, it is logical to infer the excitability of Nf1+/- neurons is 
enhanced.  In this section, we explored the idea whether Nf1+/- neurons had 
augmented excitability compared to wild-types by using the whole-cell patch-
clamp technique. 
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Several measures of excitability were used in this study.  First is the 
number of APs elicited by a given amount of current.  The neuron was held at its 
resting membrane potential and APs were evoked by injecting a 1 s ramp of 
depolarizing current that had a final amplitude of 1000 pA.  The AP numbers 
evoked by the depolarizing ramp current were counted.  Since the amplitude of 
the current ramp was fixed at a specific value (1000 pA), the more APs elicited 
by the ramp, the higher the excitability of the neuron.  Figure 9 shows recordings 
from representative neurons in response to the current ramp from Nf1+/+ (A) and 
Nf1+/- (B) mice.  As can be easily appreciated, identical ramps of current elicited 
5 APs from the Nf1+/+ neuron, but 14 APs from the Nf1+/- neuron.  Figure 10A 
summarizes the responses of 8 neurons in the Nf1+/+ group and 11 neurons in 
the Nf1+/- group.  For identical stimuli, sensory neurons from Nf1+/- mice 
generated significantly more APs compared with Nf1+/+ neurons (6.0 ± 1.6 
versus 14.8 ± 2.2 APs for Nf1+/+ and Nf1+/- neurons, respectively, P < 0.05 
using a t-test).  At the end of each recording, the neurons were exposed to 100 
nM capsaicin.  Figure 9C shows a typical neuronal response to capsaicin (100 
nM).  These neurons sensitive to capsaicin (depolarized by capsaicin) are 
believed to be nociceptive sensory neurons.  The data reported in this work were 
obtained from capsaicin-sensitive neurons only.  
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Figure 9.  (Legend see next page).   
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Figure 9. Nf1+/- sensory neurons generate more APs in response to a given 
stimulus than Nf1+/+ neurons.  Voltage recordings from representative sensory 
neurons isolated from either a Nf1+/+ (A) or a Nf1+/- mouse (B) illustrate the 
number of APs evoked by the ramp of current.  The neurons were held at their 
resting membrane potential and APs were evoked by injecting a 1s ramp of 
depolarizing current that had a final amplitude of 1000 pA.  The dV/dt trace 
represents the differentiation of the membrane voltage.  The baseline dV/dt is 
calculated as the average of all the values between the injection of the ramp 
current and just prior to the initiation of the AP.  The firing threshold is the 
membrane voltage corresponding to the point at which dV/dt exceeds the 
baseline value by 20-fold.  The firing latency is calculated as the time between 
the onset of the current ramp and the time at which the firing threshold is attained.  
C. a typical neuronal response to capsaicin.   
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Two additional parameters indicative of the level of neuronal excitability 
are the firing threshold and firing latency.  These measurements were determined 
in the same neurons for which the number of APs evoked by the current ramp 
was assessed in the preceding text.  The firing threshold is the membrane 
voltage at which the AP is generated and was determined as described in the 
Methods.  A lower firing threshold means that the sensory neuron fires at a more 
negative membrane potential, therefore, the neuron has higher excitability.  As 
summarized in Figure 10B, neurons isolated from Nf1+/- mice had a significantly 
lower firing threshold compared with that of Nf1+/+ neurons (-31.7 ± 1.6 vs. -25.7 
± 1.3 mV for 11 Nf1+/- and 8 Nf1+/+ neurons, respectively, t-test).  A lower firing 
threshold suggests that the Nf1+/- neurons are capable of generating APs at 
more hyperpolarized membrane potentials.  Similar to the firing threshold, the 
firing latency, or the time from the onset of the current injection to the initiation of 
the first AP, was significantly shorter in the Nf1+/- sensory neurons (Figure 10C; 
230 ± 55 versus 85 ± 14 ms, for 8 Nf1+/+ and 11 Nf1+/- neurons, respectively, t-
test).  The shorter the firing latency, the higher the excitability of sensory neurons 
as this would suggest that the neuron had less charging time to reach the firing 
threshold.  However, there was no difference in the average values for the 
resting membrane potentials between these genotypes (see Figure 10D, -62.7 ± 
1.8 versus -60 ± 2.0 mV for 8 Nf1+/+ and 11 Nf1+/- neurons, respectively).  
These results demonstrate that the firing threshold was reduced in neurons 
isolated from the Nf1+/- mice.   
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Consistent with this observation was the finding that the rheobase (the 
minimum amount of current required to evoke an AP) also was reduced in Nf1+/- 
neurons.  Representative recordings to determine the rheobase from a Nf1+/+ 
and Nf1+/- neuron are shown in Figures 11A and B, respectively.  As summarized 
in Figure 11C, Nf1+/- neurons had a significantly lower rheobase value compared 
with Nf1+/+ neurons (56 ± 9 versus 154 ± 36 pA for 11 Nf1+/- and 8 Nf1+/+ 
neurons, respectively, using a t-test).  However, the input resistance was not 
significantly different between the two genotypes (712 ± 191 MΩ for Nf1+/+ 
neurons and 795 ± 79 MΩ for Nf1+/- neurons, Figure 11D).  In addition, the AP 
variables, such as APD50 and the amplitude of AHP measured from REM, were 
not significantly different (APD50 was 5.3 ± 0.2 ms, n=8 and 3.86 ± 0.4, n=11 for 
Nf1+/+ and Nf1+/- neurons, respectively.  The amplitude of AHP was 10.7 ± 1.1 
mV, n=8 and 13.7 ± 1.76 mV, n=11 for Nf1+/+ and Nf1+/- neurons, respectively.  
Data for other AP variables were not shown).  Taken together, these data clearly 
demonstrate that capsaicin-sensitive sensory neurons isolated from mice that are 
heterozygous for the Nf1 mutation exhibit enhanced excitability compared with 
capsaicin-sensitive sensory neurons from Nf1+/+ mice.  
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 Figure 10. Nf1+/- sensory neurons exhibit increased excitability compared 
with Nf1+/+ neurons.  To the right of each series of individual values is the 
mean ± SEM for each genotype (The error for the firing latency of Nf1+/- neurons 
in C is smaller than the symbol). The values in each panel are from the same 8 
Nf1+/+ and 11 Nf1+/- neurons. The asterisks represent a statistically significant 
difference between genotypes using a t-test (P < 0.05). 
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Figure 11. Sensory neurons from Nf1+/- mice show a lower rheobase 
compared with Nf1+/+ neurons.  Sensory neurons were held at their resting 
membrane potential and injected with current steps 200 ms in duration that 
began with a -20 pA step and increased by 20 pA increments until an AP was 
elicited. The rheobase is taken as the minimum current required to elicit an AP.  
Panels C and D summarize the rheobase and input resistance values, 
respectively, for 8 Nf1+/+ and 11 Nf1+/- neurons.  The mean ± SE is given to the 
right of each group.  The asterisks represent a statistically significant difference 
between genotypes using a t-test (P < 0.05).  
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B. Treatment with NGF enhances the excitability of Nf1+/+ sensory 
neurons and mimics the effects of the Nf1 mutation 
NGF is a growth factor known to increase the excitability of small diameter, 
capsaicin-sensitive sensory neurons (Zhang et al., 2002) and is known to 
activate the Ras transduction cascade (Blochl et al., 2004; Huang and Reichardt 
2003; Kaplan and Stephens 1994; Susen et al., 1999).  Few investigations 
examined whether NGF augmented neuronal firing by activating Ras signaling 
pathway.  Since Nf1+/- neurons supposedly have augmented Ras-GTP, whether 
NGF sensitizes Nf1+/- neurons in the same manner as in Nf1+/+ neurons could 
indicate the importance of Ras in NGF-induced sensitization.  Therefore, the 
actions of NGF on excitability in Nf1+/+ and Nf1+/- sensory neurons were 
examined.  The sensory neurons were maintained in culture media containing 
either no added NGF (to examine the excitability of cells without exogenous 
stimulation of Ras activity) or different concentrations of NGF (1, 30, and 100 
ng/ml), to examine the excitability of cells with exogenous stimulation of Ras at 
different concentrations of NGF.  The resting membrane potential, AP number, 
firing threshold, firing latency and rheobase were measured under conditions with 
different concentrations of NGF in culture media.  
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1. The presence of NGF in the culture media enhances the excitability of 
Nf1+/+ sensory neurons.  
As shown in Figure 12A, incubation with NGF for 5-12 hours caused a 
significant increase in the number of APs elicited by a standard ramp of 
depolarizing current in capsaicin-sensitive sensory neurons isolated from Nf1+/+ 
mice.  The number of evoked APs was significantly higher after treatment with 
NGF at 30 and 100 ng/ml (there were no significant difference between the 
values obtained from neurons with 1 ng/ml NGF and without NGF).  For example, 
the number of evoked APs increased from 5.9 ± 1.5 (n=8) in the absence of NGF 
to 14.8 ± 2.8 (n=6) after exposure to 100 ng/ml NGF for Nf1+/+ neurons.  NGF 
also decreased the firing latency and rheobase of Nf1+/+ sensory neurons 
(Figure 12C and D).  Firing latency was significantly shortened from 229.7 ± 55.0 
ms (n=8, no added NGF in media) to 58.2 ± 2.8 ms (n=10, 30 ng/ml NGF in 
media) or 63.8 ± 14.1ms (n=6, 100 ng/ml NGF in media).  Similar to the firing 
latency, the rheobase of Nf1+/+ neurons was decreased by NGF.  The rheobase 
of Nf1+/+ neurons in media containing no added NGF was 153.8 ± 35.5 pA (n=8) 
and was significantly higher compared to Nf1+/+ neurons treated with 30 ng/ml 
NGF (37.0 ± 4.2 pA, n=10) or 100 ng/ml NGF (35 ± 5.6 pA, n=6).  The change in 
firing threshold measured in Nf1+/+ neurons treated with the higher 
concentrations of NGF (30 ng/ml and 100 ng/ml) was not statistically different 
from neurons not treated with NGF (Figure 12B).  These data demonstrated that 
NGF dramatically altered the excitability of capsaicin-sensitive sensory neurons 
isolated from Nf1+/+ mice.  Interestingly, NGF did not depolarize the resting 
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membrane potential of Nf1+/+ neurons from adult mice.  The resting membrane 
potential of Nf1+/+ neurons was -63.0 ± 2.0 mV (n=8) in media containing no 
added NGF, which was not significantly different from the value obtained from 
neurons treated with NGF at various concentrations (-58.7 ± 1.6 mV, n=15; -56.5 
± 2.7 mV, n=10; -56.4 ± 2.8 mV, n=6 for the neurons treated by 1, 30, 100 ng/ml, 
respectively). 
2. The presence of NGF in the culture media has little effect on the 
excitability of Nf1+/- sensory neurons. 
To determine whether NGF alters the excitability of Nf1+/- neurons, the 
cells were maintained in culture media with NGF at various concentrations.  
Surprisingly, the presence of NGF in the culture media did not alter the 
excitability of Nf1+/- neurons.  As shown in Figure 12A, NGF did not enhance the 
number of APs elicited by a standard ramp of depolarizing current (1000 pA) in 
capsaicin-sensitive sensory neurons isolated from Nf1+/- mice.  The number of 
evoked APs from sensory neurons maintained in the absence of NGF was 14.8 ± 
2.2 APs (n=11), which was not significantly different from the value obtained in 
neurons with 1 ng/ml, 30 ng/ml or 100 ng/ml NGF in culture media (17.8 ± 2.8, 
15.5 ± 3.6, 11.8 ± 2.7 APs, respectively, n=5-12).  A similar lack of effect of NGF 
on firing latency and rheobase was observed in Nf1+/- sensory neurons.  The 
firing latency of Nf1+/- neurons without added NGF was 85 ± 14.2 ms, which was 
not significantly different from the value measured from Nf1+/+ neurons 
maintained in media containing 1ng/ml, 30 ng/ml, and 100 ng/ml NGF (43.7 ± 4.0 
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ms, 58.2 ± 2.8 ms and 77.4 ± 10 ms, respectively, n=5-12).  NGF did not alter the 
input resistance of sensory neurons isolated from either genotype.  The input 
resistance of Nf1+/+ neurons was 712.4 ± 190.8 MΩ, 794.6 ± 73.4 MΩ, 455.3 ± 
52.0 MΩ and  807.3 ± 255.4 MΩ for neurons treated with 1 ng/ml, 30 ng/ml or 
100 ng/ml NGF in the culture media, respectively.  The input resistance for Nf1+/- 
sensory neurons was 876.3 ± 191 MΩ, 835.2 ± 172.2 MΩ, 645.2 ± 100 MΩ and 
687 ± 165 MΩ for neurons treated with 1 ng/ml, 30 ng/ml or 100 ng/ml NGF in 
culture media, respectively.  
In summary, treatment with NGF enhanced the excitability of Nf1+/+ 
neurons, but had no effect on the excitability of Nf1+/- sensory neurons.  As a 
consequence, the difference in excitability observed between the genotypes in 
the absence of NGF was abolished after high doses of NGF (30 ng/ml and 100 
ng/ml).   
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Figure 12. NGF enhances the excitability of Nf1+/+ neurons, but has little 
effect on Nf1+/- neurons.  Sensory neurons isolated from adult mice were 
maintained in growth media for 5-12 hours in the absence or presence of NGF 
prior to recordings.  The columns represent the means ± SEM (5-12 neurons per 
group).  A depolarizing current ramp (1000 pA) was used to elicit APs. *, 
statistically significant difference between genotypes at a given concentration of 
NGF using a t-test (P < 0.05).  @, statistically significant difference between NGF 
treatments within a given genotype using a one way ANOVA followed by using a 
Dunnet's post hoc analysis (P < 0.05). 
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C. Y13-259, a neutralizing antibody for Ras, abolishes the NGF-induced 
sensitization of Nf1+/+ sensory neurons, but does not reduce the 
enhanced excitability of Nf1+/- neurons.  
Since Nf1+/- neurons have only one functional copy of the Nf1 gene, the 
protein product of this gene, neurofibromin, should be lower in Nf1+/- neurons. 
Neurofibromin helps to switch the active form of Ras (Ras-GTP) to its inactive 
form (Ras-GDP) by serving as a GTPase activating protein (GAPs).  The 
decrease of neurofibromin levels frequently results in both basal and cytokine-
stimulated Ras activity in many cell types, including sensory neurons (Guha et al., 
1996; Ingram et al., 2001; Klesse and Parada, 1998; Largaespada et al., 1996; 
Sherman et al., 2000).  To determine whether the enhanced excitability of Nf1+/- 
neurons was dependent on the Ras signaling pathway, a specific Ras-blocking 
antibody, Y13-259 (Oncogene Science, Uniondale, NY), was used to neutralize 
intracellular Ras activity.  Y13-259 neutralizes Ras by directly binding to amino 
acid residues of the Ras protein and stimulates the intrinsic GTPase activity of 
Ras; this converts the active Ras back to its inactive form (Sigal et al., 1986).  
This antibody (30 µg/ml) was added to the solution filling the pipette and 
internally perfused into the neurons.  Although the capacity of this antibody to 
neutralize Ras activity is well established, only a few studies have used internal 
perfusion.  For example, Hida et al., (1998) showed that the inhibition of inwardly 
rectifying potassium currents (IKir) by ceramide, an important lipid second 
messenger, was abolished by inclusion of 0.2 µg/ml Y13-259 in the recording 
pipettes.  In addition, Fitzgerald and Dolphin (1997) reported that neutralization of 
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endogenous Ras by microinjection of Y13-259 solution (0.1 mg/ml, 20 femto liter 
reduced the peak calcium current recorded from DRG neurons isolated from 
neonatal rats.  As a rough calculation, if one injected 20 femto liter of a 0.1 mg/ml 
antibody solution into a spherical neuron that was 25 µm in diameter, then the 
intracellular concentration was approximately 0.25 µg/ml.  Because 30 µg/ml 
Y13-259 is more than 100 times the value appearing in the literature, I would 
expect this concentration to be sufficient to block intracellular Ras activity.   
Another factor that must be considered in the experiments delivering the 
antibody inside a cell by internal perfusion is the necessary length of time for the 
antibody to enter the cell.  Pusch and Neher (1988) extensively studied the 
diffusional time course of small molecules up to 15 kD entering cells via diffusion 
from the recording pipette.  Based on the formulas provided in their paper, the 
time constant (τ, describing how fast a diffusing system reaches equilibrium) 
could be calculated by using the following equations: 
τ = (78.44 ± 6.6) * RA/D (1)  
τ= (0.6 ± 0.17)*RA*M1/3  (2) 
τ/τ0 = (CM/Co) 1.5 (3) 
where RA is the access resistance in MΩ, D is the diffusion coefficient in 10-
11m2s-1, molecular weight (M) is in Daltons, τo is the time constant for cells having 
a mean capacitance of 5.91 pF (Co), CM is the cell capacitance.  For mouse DRG 
neurons with 12.8 ± 1.1 pF capacitance (the series resistance was 5.3 ± 0.9 MΩ 
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in my patch-clamp experiments, n=23), τ was calculated to be between 5 and 9 
min.  Thus, 15 min should be sufficient for a considerable amount of antibody to 
enter the cells after establishing the whole-cell configuration. 
Therefore, in order to examine whether this antibody decreased the 
neuronal excitability of Nf1+/- neurons by neutralizing intracellular Ras activity, 
the antibody was delivered inside sensory neurons via diffusion from the 
recording pipette after establishing the whole-cell configuration.  As shown in 
Figure 13, the design of the experimental group was as follows: after establishing 
the whole-cell configuration, the control recording was obtained after 1-2 min to 
determine the basal excitability of either mouse genotype using the protocols 
described in the Materials and Methods section.  At 5, 10 and 15 min after 
establishing the whole-cell configuration, the current clamp protocols were used 
to examine the effect of internal perfusion of the Ras-blocking antibody on the 
excitability of sensory neurons.  Immediately after the 15 min recording, the 
neuron was exposed to NGF (100 ng/ml) via bath perfusion.  My data presented 
above demonstrated that NGF increased neuronal excitability of Nf1+/+ neurons.  
If NGF sensitizes neurons via Ras activation, the effect of NGF should be 
abolished by this antibody.  In addition, the efficacy and the length of time 
necessary for the antibody to diffuse into cells could be established if the 
antibody successfully abolished the NGF-induced sensitization (based on the 
assumption that most neurons could be sensitized by NGF).  The purified non-
specific rat IgG was used as negative control.  To eliminate the possibility that a 
high concentration of antibody in the pipette may alter the ability of neurons to be 
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sensitized, the obvious control experiment is to examine whether NGF can 
enhance the excitability of neurons in the presence of 30 µg/ml non-specific rat 
IgG in the pipette.  In addition, if activation of the Ras cascade contributed to the 
enhanced excitability of sensory neurons from Nf1+/- mice, I would expect the 
neurons treated with Y13-259 to have lower excitability compared to untreated 
neurons from the same Nf1+/- harvest, and be similar to the excitability of those 
neurons isolated from Nf1+/+ mice.  However, if the Y13-259 fails to decrease 
the excitability of Nf1+/- neurons, it is possible the downstream effectors that are 
critical in modulating neuronal excitability are activated by Ras, and this 
activation lasts longer than my recording period.  The experimental design is 
summarized in Figure 13. 
1. Internal perfusion with the non-specific IgG does not affect the 
sensitization of Nf1+/+ neurons by NGF 
It is well established that NGF enhances the excitability of isolated 
sensory neurons in culture (Wang et al., 2005; Zhang et al., 2002).  The studies 
described below examined whether the presence of non-specific IgG (30 ng/ml) 
in the pipette altered this NGF-induced sensitization. 
As shown in Figure 14E, NGF (100 ng/ml) caused a significant increase in 
the number of APs elicited by a standard ramp of depolarizing current in a 
representative Nf1+/+ sensory neuron in the presence of IgG in the pipette.  As 
summarized in Figure 14F, in six Nf1+/+ sensory neurons, after exposure to NGF 
(100 ng/ml), the number of evoked APs increased to 5.0 ± 1.0 compared with 3.2 
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± 0.7 in the absence of NGF.  In the first 15 min period of recording (before 
treatment with NGF), the evoked APs remained constant (the evoked APs were 
3.0 ± 0.5, 3.0 ± 0.9, 2.8 ± 0.9 for 5 min, 10 min, 15 min, respectively, n=6).  This 
finding suggests that the control antibody does not alter the basal neuronal 
excitability of Nf1+/+ neurons in this 15 min recording. 
Consistent with the increased production of APs, NGF also significantly 
decreased the rheobase in the Nf1+/+ neurons in the presence of IgG in pipette.  
The rheobase of Nf1+/+ neurons was decreased from 110.0 ± 19.8 to 33.3 ± 7.1 
pA after applying 100 ng/ml NGF (the rheobase of Nf1+/+ neurons was 108 ± 
19.7, 98 ± 14.2, 91 ± 16.8 pA for 5 min, 10 min, 15 min, respectively, n=6).  NGF 
did not depolarize Nf1+/+ sensory neurons.  The REM of Nf1+/+ neurons was 
constant over the 20 min testing period, even after applying NGF (The REM was  
-56 ± 2, -57 ± 2, -56 ± 1, -55 ± 2, -53 ± 1.5 mV for control, 5 min, 10 min, 15 min, 
and after 5 min exposure to NGF, respectively, n=6).  Firing threshold is another 
parameter that was not altered by NGF.  The firing threshold of Nf1+/+ neurons 
was -28 ± 2 mV after applying NGF, and was not significantly different from the 
firing thresholds measured under the IgG control conditions, the firing threshold 
was -27 ± 2, -26 ± 3, -25 ± 3, -25 ± 2 mV for control, 5 min, 10 min and 15 min, 
respectively, n=6.  Similar to REM and firing threshold, the membrane resistance 
of Nf1+/+ neurons was not altered by NGF.  The membrane resistance of Nf1+/+ 
neurons remained constant over the 20 min recording period (the membrane 
resistance was 789 ± 171, 605 ± 99, 657 ± 116, 534 ± 112 MΩ and 539 ± 112 
MΩ at 1 min, 5 min, 10 min, 15 min and 20 min, n=6).  In summary, these data 
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demonstrated that NGF enhanced the excitability of Nf1+/+ sensory neurons 
from adult mice on a rapid time scale by enhancing the frequency of neuronal 
firing.  The firing threshold, REM and membrane resistance were not altered by 
NGF.  The presence of 30 µg/ml non-specific antibody did not eliminate this 
NGF-induced sensitization.  Therefore, a high concentration of IgG in the pipette 
did not alter the ability of neurons to be sensitized. 
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 Figure 13. The experimental design of using Ras-blocking antibodies. A: 
The schematic draft of experiments using antibody in pipette solution.  B: the 
time course of experiments.   
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Figure 14. NGF enhances the excitability of Nf1+/+ sensory neurons in the 
presence of 30 µg/ml IgG in the pipette.  A: Voltage recordings from a 
representative Nf1+/+ sensory neuron illustrate the number of APs evoked by a 
ramp of current after 1 min of establishing the whole-cell configuration.  The 
neuron was held at its resting membrane potential and APs were evoked by 
injecting a 1 s ramp of depolarizing current that had a final amplitude of 100 pA.  B, 
C, and D: Voltage recordings from the same neuron after 5 min, 10 min, and 15 
min of establishing the whole-cell configuration.  IgG did not change the number of 
evoked APs.  E:  In the presence of 30 µg/ml non-specific IgG antibody in pipette, 
the representative neuron generated more APs in response to the same 
stimulation protocol in A-D after exposure to NGF (100 ng/ml).  F: The summary of 
data obtained from 6 Nf1+/+ DRG neurons.  The asterisk represents a statistically 
significant difference in Nf1+/+ sensory neurons before and after NGF treatments 
using a one way ANOVA followed by a Dunnet's post hoc analysis (P < 0.05). 
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 Figure 15. NGF sensitizes Nf1+/+ sensory neurons in the presence of 30 
µg/ml non-specific IgG in the pipette.  Panels A, B, C and D summarize the 
rheobase, membrane resistance, firing threshold and REM for 6 Nf1+/+ neurons, 
respectively.  To monitor the changes in those parameters over the time as well 
as by NGF, the protocols to determine those parameters were repeated at 1 min, 
5 min, 10 min, 15 min and 20 min (NGF 5 min) after established the whole-cell 
configuration.  A:  The rheobase did not significantly change at the first 15 min 
recording period.  Exposure to NGF 5 min significantly decreased rheobase of 
Nf1+/+ sensory neurons.  B, C and D:  NGF did not significantly alter input 
resistance, firing threshold and REM of Nf1+/+ sensory neurons in the presence 
of 30 µg/ml control antibody in pipette.  The data in this Figure were collected 
from same 6 Nf1+/+ sensory neurons.  The asterisk represents a statistically 
significant difference in Nf1+/+ sensory neurons before and after NGF treatments 
using a 1-way ANOVA followed by a Dunnet's post hoc analysis (P < 0.05). 
 
 81
2. Internal perfusion with the Ras neutralizing antibody, Y13-259, blocks the 
sensitization induced by NGF. 
My results showed that the capacity of NGF to augment the excitability of 
small diameter, capsaicin-sensitive neurons was not affected in the presence of 
30 µg/ml non-specific IgG in pipette.  These experiments indicated that this NGF-
induced sensitization was not altered by a high concentration of IgG in the pipette 
and thereby provided a valid control for Y13-259.  The studies described below 
established whether the NGF-induced sensitization could be abolished by the 
Ras-blocking antibody, Y13-259.  Since considerable amount of antibody should 
diffuse into neurons during the 15 min recording period after establishing the 
whole-cell configuration, the neurons were exposed to NGF after the recording at 
15 min to examine whether NGF-induced sensitization was affected by internal 
perfusion with Y13-259.  With Y13-259 in the recording pipette, the number of 
evoked APs did not increase after NGF treatment.  Figures 16A-E show the 
results obtained from a representative neuron at 1 min, 5 min, 10 min, 15 min 
and 20 min (NGF 5 min) after establishing the whole-cell configuration.  
Treatment with NGF did not increase the number of evoked APs in the presence 
of Y13-259 in pipette.  As summarized in Figure 16F, after exposure to 100 ng/ml 
NGF for 5 min, the number of evoked APs from Nf1+/+ neurons was 1.6 ± 1.5, 
which was not significantly different from the value obtained in the control 
recording (3.6 ± 1.5, n=5).  Y13-259 alone does not seem to modulate the 
neuronal excitability because the numbers of evoked APs remained constant as 
this antibody diffused into the cells (the APs were 4.4 ± 1.5, 3.8 ± 1.1, 2.8 ± 1.1 at 
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5 min, 10 min, 15 min respectively, after establishing the whole-cell configuration).  
These values did not significantly change in the 20 min recording period.  Similar 
to number of APs, the effect of NGF on other parameters revealing neuronal 
excitability, such as rheobase, was abolished by internal perfusion with Y13-259.  
Neither NGF nor Y13-259 altered the firing threshold, membrane resistance and 
REM of Nf1+/+ cells.  As shown in Figure 17, at 1 min, 5 min, 15 min and after 
exposure to NGF for 5 min, the rheobase of Nf1+/+ neurons was 154 ± 67, 146 ± 
65, 148 ± 63, 170 ± 68 and 194 ± 77 pA, the input resistance was 735 ± 309, 822 
± 301, 858 ± 319, 733 ± 263 and 671 ± 262 MΩ, the firing threshold was -24 ± 5, 
-28 ± 3, -28 ± 2, -28 ± 3 and -25 ± 5 mV and the resting membrane potential was 
-54 ± 5, -51 ± 5, -52 ± 5, -52 ± 4 and -57 ± 3 mV (n=5).  The values of all these 
parameters were not significantly different during the 20 min recording period.  
Therefore, the NGF-induced sensitization was abolished by the Ras-blocking 
antibody, Y13-259. 
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Figure 16. NGF fails to enhance of the numbers of evoked APs as the Ras-
blocking antibody is internally perfused into Nf1+/+ sensory neurons.  A: 
Voltage recordings from a representative Nf1+/+ sensory neuron illustrate the 
number of APs evoked by a ramp current after 1 min of establishing the whole-cell 
configuration.  The neuron was held at its resting membrane potential and APs 
were evoked by injecting a 1s ramp of depolarizing current that had a final 
amplitude of 30 pA.  B, C, and D: By using the same stimulation protocol as in A, 
the evoked APs from the same neuron after 5 min, 10 min, and 15 min of 
establishing the whole-cell configuration.  E: in the presence of Y13-259, the 
number of APs evoked from this representative neuron was not increased by 100 
ng/ml NGF.  F: The summary of data obtained from 5 Nf1+/+ DRG neurons.  The 
evoked APs after neurons were exposed to NGF for 5 min were not significantly 
different from control values. 
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 Figure 17. NGF does not sensitize Nf1+/+ sensory neurons in the presence 
of 30 µg/ml Ras-blocking antibody in pipette.  Panels A, B, C and D 
summarize the rheobase, membrane resistance, firing threshold and resting 
membrane potential for 5 Nf1+/+ neurons, respectively.  To monitor the changes 
of those parameters by the Ras-blocking antibody as well as by NGF, the 
protocols to determine those parameters were repeated at 1 min, 5 min, 10 min, 
15 min and 20 min (NGF 5 min) after established the whole-cell configuration.  A: 
The rheobase did not significantly altered at the first 15 min holding period as the 
Ras-blocking antibody entering cells.  Exposure to NGF 5 min did not change the 
rheobase of Nf1+/+ sensory neurons.  B, C and D: Neither the Ras-blocking 
antibodies nor NGF did not significantly alter input resistance, firing threshold and 
REM of Nf1+/+ sensory neurons. 
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3. Internal perfusion with the Ras-blocking antibody, Y13-259 does not alter 
the basal excitability of Nf1+/+ neurons.  
The studies described below determined whether the Ras-blocking 
antibody, Y13-259 alone could alter neuronal excitability in Nf1+/+ sensory 
neurons and thereby provide valid control experiments for the studies using NGF 
as a stimulus for the Ras cascade.  Figures 18A-E describe the APs evoked from 
a representative neuron in the presence of Y13-259 in pipette.  In the 20 min 
recording period, Y13-259 did not significantly alter the number of APs elicited by 
a standard ramp of depolarizing current in a capsaicin-sensitive sensory neuron 
isolated from Nf1+/+ mouse.  The number of evoked APs remained constant as 
Y13-259 diffused into the cells.  As summarized in Figure 18F, in 5 Nf1+/+ 
sensory neurons, this Ras-blocking antibody did not alter the neuronal excitability 
of Nf1+/+ neurons because the number of evoked APs remained constant in the 
20 min recording period as the Ras-blocking antibody perfused into the cells (the 
evoked APs were 2.8 ± 1, 3.6 ± 0.9, 3.6 ± 0.9, 4.4 ± 1.2 and 4 ± 1, at 1 min, 5 min, 
10 min, 15 min, 20 min, respectively, n=5).   
Like AP numbers, the values of the other parameters used to examine 
neuronal excitability like rheobase, membrane resistance, firing threshold and 
REM were not altered by Y13-259.  As summarized in Figure 19, in the 20 min 
recording period, the rheobase of Nf1+/+ neurons was 136 ± 32, 124 ± 36, 126 ± 
37, 120 ± 36 and 114 ± 40 pA, the input resistance was 828 ± 177, 844 ± 274, 
797 ± 228, 742 ± 172 and 566 ± 88 MΩ, the firing threshold was -15 ± 3, -18 ± 3, 
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-19 ± 3, -20 ± 2 and -20 ± 3 mV and the resting membrane potential was -55 ± 3, 
-57 ± 3, -56 ± 3, -56 ± 2 and -57 ± 3 mV.  The values of all these parameters 
were not significantly different from their control values.  Therefore, the Ras-
blocking antibody alone did not modulate neuronal excitability of Nf1+/+ neurons 
in the 20 min holding period.   
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 Figure 18. Internal perfusion of Y13-259 alone does not alter the numbers of 
APs evoked from Nf1+/+ sensory neurons.  A: Voltage recordings from a 
representative Nf1+/+ sensory neuron illustrate the number of APs evoked by a 
ramp current after 1 min of establishing the whole-cell configuration.  The neuron 
was held at its resting membrane potential and APs were evoked by injecting a 1s 
ramp of depolarizing current that had a final amplitude of 500 pA.  B, C, D and E: 
By using the same stimulation protocol as in A, the evoked APs from the same 
neuron at 5 min, 10 min, 15 min and 20 min after established the whole-cell 
configuration. The evoked APs did not change significantly as the Ras-blocking 
antibody was internally perfused into cells in the 20 min recording period.  F: The 
summary of data obtained from 5 Nf1+/+ DRG neurons.  The APs evoked from 5 
Nf1+/+ neurons were not significantly different during the 20 min recording period.  
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Figure 19. Y13-259 alone did not alter excitability of Nf1+/+ sensory 
neurons.  Panels A, B, C and D summarize the rheobase, membrane resistance, 
firing threshold and REM, respectively, for 5 Nf1+/+ neurons.  To monitor the 
changes in those parameters by the Ras-blocking antibody, the protocols to 
determine those parameters were repeated at 1 min, 5 min, 10 min, 15 min and 
20 min (NGF 5 min) after established the whole-cell configuration.  A:  The 
rheobase did not significantly change at the 20 min recording period as the Ras-
blocking antibody was internally perfused into sensory neurons.  B, C and D:  
The input resistance, firing threshold and REM of Nf1+/+ sensory neurons did not 
significantly changed by Y13-259. 
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4. Internal perfusion with the Ras blocking antibody, Y13-259, fails to alter 
the basal excitability of Nf1+/- neurons.   
As established above, the Ras-blocking antibody, Y13-259 abolished the 
neuronal sensitization induced by NGF in Nf1+/+ neurons.  This suggests that 
the activation of Ras is a critical step in NGF-induced sensitization.  Because 
Nf1+/- neurons had enhanced excitably that was supposedly due to higher levels 
of Ras-GTP, the experiments described below focused on whether internal 
perfusion with the Ras-blocking antibody could alter the excitability of Nf1+/- 
neurons.  Surprisingly, Y13-259 did not suppress the number of APs elicited by a 
standard ramp of depolarizing current in Nf1+/- sensory neurons (see Figure 
20A-F).  The number of evoked APs remained elevated and constant as Y13-259 
was internally perfused into the cells over the 20 min recording period.  As 
summarized in Figure 20F, in 5 Nf1+/- sensory neurons, this Ras-blocking 
antibody did not alter the number of evoked APs by a standard ramp of current.  
The final level of the ramp was adjusted to evoke 5-7 APs in the control.  The 
amplitude then remained constant throughout the recording period for each 
individual neuron (small ramp, compared to the large ramp used in the 
experiments described below, the value of this ramp level is relatively small).  
The number of evoked APs at 1 min, 5 min, 10 min, 15 min, 20 min after 
establishing the whole-cell configuration  was 5 ± 1.3, 5.2 ± 1.4, 6 ± 1, 6.4 ± 1.2 
and 5.4 ± 1.2 (n=5), which do not change as the Ras-blocking antibody was 
perfused internally into sensory neurons.  To exclude the possibility that the 
value of the ramp was too small to detect subtle changes in neuronal excitability, 
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another ramp (large ramp) designed to evoke 10-15 APs under control conditions 
was used to increase the experimental resolution.  Consistent with the data 
described above using the small ramp, Y13-259 did not alter the number of APs 
elicited by the large ramp whose amplitude was adjusted to evoke 10-15 APs 
under control conditions.  As shown in Figure 21, the number of evoked APs did 
not change as the Ras-blocking antibody was internally perfused into sensory 
neurons.  Consistent with the evoked APs, the values of the other parameters 
assessing neuronal excitability were not altered by Y13-259.  As shown in Figure 
22, as Y13-259 was internally perfused into cells, the rheobase at 1 min, 5 min, 
10 min, 15 min, 20 min after establishing the whole-cell configuration was 78 ± 
21, 64 ± 24, 50 ± 15, 46 ± 13 and 48 ± 15 pA, the input resistance was 570 ± 179, 
882 ± 250, 896 ± 247, 676 ± 168 and 680 ± 185 MΩ, the firing threshold was -29 
± 5, -28 ± 4, -29 ± 3, -29 ± 2 and -29 ± 3 mV and the resting membrane potential 
was -54 ± 4, -51 ± 2, -52 ± 2, -51 ± 1 and -50 ± 3 mV.  The values of all these 
parameters collected at 5 min, 15 min and 20 min after establishing the whole-
cell configuration were not significantly different from their control values.  
Therefore, my data suggests that direct neutralization of Ras activity in Nf1+/- 
neurons did not suppress the enhanced neuronal excitability. 
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Figure 20. Internal perfusion of Y13-259 does not alter the numbers of APs 
evoked from Nf1+/- sensory neurons by using small ramps.  The final level of 
the ramp was adjusted to evoke 5-7 APs in the control, the amplitude then 
remained constant throughout the recording period for each individual neuron.  A: 
Voltage recordings from a representative Nf1+/- sensory neuron illustrate the 
number of APs evoked by a ramp current after 1 min of establishing the whole-
cell configuration.  The neuron was held at its resting membrane potential and 
APs were evoked by injecting a 1s ramp of depolarizing current that had a final 
amplitude of 100 pA.  The final value of the ramp was adjusted to evoke 5-7 APs 
in the control condition.  B, C, D and E: By using the same stimulation protocol as 
in A, the evoked APs from the same neuron at 5 min, 10 min, 15 min and 20 min 
after established the whole-cell configuration. The evoked APs did not change 
significantly as the Ras-blocking antibody was internally perfused into cells in the 
20 min recording period.  F: The summary of data obtained from 5 Nf1+/+ DRG 
neurons.  The APs evoked from 5 Nf1+/- neurons were not significantly different 
during the 20 min recording period.  
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 Figure 21. Y13-259 does not alter the evoked APs of Nf1+/- sensory neurons 
by using large ramps (The final value of the ramp was adjusted to evoke 10-15 
APs in the control condition).  A: Voltage recordings from a representative Nf1+/- 
sensory neuron illustrate the number of APs evoked by a ramp current after 1 
min of establishing the whole-cell configuration.  The neuron was held at its 
resting membrane potential and APs were evoked by injecting a 1s ramp of 
depolarizing current that had a final amplitude of 500 pA.  The final value of the 
ramp was adjusted to evoke 5-7 APs in the control condition.  B, C, D and E: By 
using the same stimulation protocol as in A, the evoked APs from the same 
neuron at 5 min, 10 min, 15 min and 20 min after established the whole-cell 
configuration. The evoked APs did not change significantly as the Ras-blocking 
antibody was internally perfused into cells in the 20 min recording period.  F: The 
summary of data obtained from 5 Nf1+/+ DRG neurons.  The APs evoked from 5 
Nf1+/- neurons were not significantly different during the 20 min recording period.  
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Figure 22. Y13-259 does not alter the excitability of Nf1+/- sensory neurons.  
Panels A, B, C and D summarize the rheobase, membrane resistance, firing 
threshold and REM for 5 Nf1+/- neurons.  To monitor the changes in those 
parameters by the Ras-blocking antibody, the protocols to determine those 
parameters were repeated at 1 min, 5 min, 10 min, 15 min and 20 min after 
established the whole-cell configuration.  A:  The rheobase did not significantly 
change during the 20 min recording period as the Ras-blocking antibody was 
internally perfused into sensory neurons.  B, C and D:  The input resistance, 
firing threshold and REM of Nf1+/- sensory neurons did not significantly changed 
by Y13-259. 
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5. NGF does not sensitize neurons isolated from Nf1+/- mice in recordings 
with IgG in pipette. 
Since NGF sensitized wild-type sensory neurons on a rapid time scale and 
the duration of this sensitization remains unclear, the studies described below 
determined whether NGF could sensitize Nf1+/- neurons acutely. Interestingly, 
Nf1+/- neurons did not show sensitization after treatment by NGF (100 ng/ml) via 
bath perfusion.  Although there was a slight increase in the number of evoked 
APs by the current ramp in 2 out of 6 neurons, 4 neurons remained unresponsive 
to NGF.  As shown in Figure 23A-D, the numbers of APs evoked by a 50 pA 
current ramp from a representative neuron were unchanged in the first 15 min 
recording period in the presence of 30 µg/ml non-specific IgG in the pipette.  
Immediately after the recording obtained at 15 min, the neurons were superfused 
by normal Ringer’s solution containing 100 ng/ml NGF (Figure 23E).  Under 
these conditions, NGF did not increase the number of APs evoked from the 
representative sensory neuron.  Figure 23F summarizes the data obtained from 6 
Nf1+/- sensory neurons.  Treatment with NGF did not enhance the numbers of 
APs in response to a standard ramp of current (4 ± 1 in control versus 6 ± 2 after 
NGF treatment).  The values of other parameters indicating neuronal excitability 
were not altered by NGF as the IgG was internally perfused into cells.  As shown 
in Figure 24, the rheobase of Nf1+/- neurons at 1 min, 5 min, 10 min, 15 min, 20 
min (NGF 5 min) after establishing the whole-cell configuration was 75 ± 12, 63 ± 
15, 65 ± 14, 65 ± 22 and 67 ± 14 pA, the input resistance was 928 ± 198, 980 ± 
230, 909 ± 232, 844 ± 210 and 690 ± 194 MΩ, the firing threshold was -29 ± 2, -
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29 ± 2, -27 ± 2, -27 ± 3 and -30 ± 1 mV and the resting membrane potential was -
54 ± 1, -53 ± 1, -55 ± 1, -53 ± 2 and -56 ± 1 mV.  The values of all these 
parameters did not change after establishing the whole-cell configuration.  
Therefore, NGF did not sensitize Nf1+/- neurons in the presence of IgG in pipette. 
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with IgG  
Figure 23. NGF does not enhance the excitability of Nf1+/- sensory neurons 
in the presence of IgG in pipette.  A: Voltage recordings from a representative 
Nf1+/- sensory neuron illustrate the number of APs evoked by a ramp current 
after 1 min of established the whole-cell configuration.  The neuron was held at 
its resting membrane potential and APs were evoked by injecting a 1s ramp of 
depolarizing current that had a final amplitude of 50 pA.  The final value of the 
ramp was adjusted to evoke 5-7 APs in the control condition.  Panel B, C, D and 
E: By using the same stimulation protocol as in A, the evoked APs from the same 
neuron at 5 min, 10 min, 15 min and 20 min (NGF 5 min) after established the 
whole-cell configuration.  As shown in E, sensory neuron generated similar 
number of APs when treated by 100 ng/ml NGF.  F: the summary of data 
obtained from 6 Nf1+/-DRG neurons.  NGF did not enhance the evoked APs from 
Nf1+/- sensory neurons. 
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Figure 24. NGF does not sensitize Nf1+/- sensory neurons in the presence 
of IgG in pipette.  Panels A, B, C and D summarize the rheobase, membrane 
resistance, firing threshold and REM for 6 Nf1+/- neurons.  To monitor the 
changes of these parameters indicating neuronal excitability by NGF as well as 
over the time, the protocols to examine those parameters were repeated at 1 min, 
5 min, 10 min, 15 min and 20 min (NGF 5 min) after established the whole-cell 
configuration.  A: The rheobase did not change significantly during the 20 min 
recording period, even after exposure to NGF for 5 min.  B, C and D:  The input 
resistance, firing threshold and REM of Nf1+/- sensory neurons did not 
significantly changed by NGF.   
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6. The Ras blocking antibody, Y13-259, does not alter the inability of NGF to 
sensitize Nf1+/- neurons 
Based on the assumption that the augmented Ras-GTP level in Nf1+/- 
neurons caused the insensitivity of these cells to NGF, I asked whether the 
neutralization of Ras can restore the sensitivity of Nf1+/- cells to NGF treatment. 
Therefore, Nf1+/- neurons were exposed to NGF as Y13-259 was internally 
perfused into the sensory neurons.  In the presence of the Ras-blocking antibody, 
none of the 6 Nf1+/- cells studied was sensitized by NGF.  As shown in Figure 25, 
in the presence of Ras-blocking antibody (30 µg/ml) in pipette, the number of 
APs evoked by a ramp of current (final amplitude of 1000 pA) remained constant 
over the 20 min recording period.  Immediately after the recording obtained at 15 
min, the neurons were exposed to 100 ng/ml NGF.  Figure 25 F summarizes the 
data obtained from 6 Nf1+/- sensory neurons wherein none of the 6 Nf1+/- cells 
was sensitized by NGF.  The numbers of APs evoked by the ramp of current did 
not change during the 20 min holding period (the evoked APs were  4.8 ± 0.9, 6 ± 
1, 7 ± 2, 6 ± 2, 4 ± 2 at control, 5 min, 10 min, 15 min and after NGF treatment, 
respectively).  Other parameters indicating neuronal excitability were not altered 
by NGF as Y13-259 was internally perfused into cells.  At control, 5 min, 10 min, 
15min and 20 min (NGF treatment for 5 min), the rheobase of Nf1+/- neurons 
was 68 ± 16, 68 ± 22, 67 ± 22, 75 ± 24 and 110 ± 35 pA, the input resistance was 
955 ± 225, 1066 ± 202, 1026 ± 207, 1062 ± 200 and 957 ± 189 MΩ, the firing 
threshold was -26 ± 2, -26 ± 2, -26 ± 2, -24 ± 3 and -24 ± 5 mV, and the resting 
membrane potential was -55 ± 2, -56 ± 2, -56 ± 4, -57 ± 4 and -58 ± 4 mV (n=6, 
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Figure 26).  The values of these parameters measured at 5 min, 10 min, 15 min 
and 20 min (NGF 5 min) were not significantly different from their control values 
obtained at 1 min after establishing the whole-cell configuration.  Therefore, none 
of the 6 Nf1+/- neurons enhanced its excitability in the presence of the Ras-
blocking antibody in pipette at the 20 min recording period.  
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With Y13-259 
 
 
 
Figure 25. NGF does not enhance the excitability of Nf1+/- sensory neurons 
in the presence of 30 µg/ml Y13-259 in pipette solution. A: Voltage recordings 
from a representative Nf1+/- sensory neuron illustrate the number of APs evoked 
by a ramp current after 1 min of established the whole-cell configuration.  The 
neuron was held at its resting membrane potential and APs were evoked by 
injecting a 1s ramp of depolarizing current that had a final amplitude of 1000 pA.  
The final value of the ramp was adjusted to evoke 5-7 APs in the control 
condition.  Panel B, C, D and E: By using the same stimulation protocol as in A, 
the evoked APs from the same neuron at 5 min, 10 min, 15 min and 20 min (NGF 
5 min) after established the whole-cell configuration.  As shown in E, sensory 
neuron generated similar number of APs when treated by 100 ng/ml NGF.  F: the 
summary of data obtained from 6 cells.  NGF did not enhance the evoked APs 
from Nf1+/- sensory neurons. 
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Figure 26. NGF does not sensitize neuronal excitability of Nf1+/- sensory 
neurons with 30 µg/ml Ras-blocking antibody in pipette. Panels A, B, C and 
D summarize the rheobase, membrane resistance, firing threshold and REM for 
6 Nf1+/- neurons.  To monitor the changes of these parameters indicating 
neuronal excitability by NGF as well as by the Ras-blocking antibody, the 
protocols to examine those parameters were repeated after 1 min, 5 min, 10 min, 
15 min and 20 min (NGF) of established the whole-cell configuration.  A:  NGF 
did not significantly change the rheobase as the Ras-blocking antibody was 
internally perfused into pipette. Panels B, C and D:  The input resistance, firing 
threshold and REM of Nf1+/- sensory neurons did not significantly change by 
NGF in the presence of the Ras-blocking antibody.   
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D. IK does not contribute to the augmented excitability observed of 
Nf1+/- neurons. 
It is well established that potassium channels regulate neuronal excitability.  
The outflow of potassium ions from the inside to the outside of the cell draws the 
membrane potential closer to the equilibrium potential of potassium (calculated to 
be -84 mV in sensory neurons) and decreases neuronal excitability.  When the 
potassium channels are blocked or inhibited by certain chemicals, sensory 
neurons enhance their excitability (Birinyi-Strachan et al., 2005; Nicol et al., 1997; 
Zhang et al., 2002).  Under pathological conditions, such as inflammation (Gold 
and Flake, 2005; Katz and Gold, 2006) and neuropathic pain (Cherkas et al., 
2004; Liu et al., 2001), IK was reduced.  Because we have established that 
capsaicin-sensitive, small diameter sensory neurons from Nf1+/- mice exhibit 
greater excitability than Nf1+/+ neurons, an important question that arises is 
whether this augmentation of neuronal excitability results from the suppression of 
IK in Nf1+/- sensory neurons.  Therefore, isolated IK that is critical in controlling 
neuronal firing were examined by using the whole-cell patch-clamp technique.  
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1. The total potassium currents (IK) and the delayed-rectifier potassium 
currents (IKd) of Nf1+/+ and Nf1+/- mice are not different.   
The suppression of IK enhances the excitability of sensory neurons 
(Evans et al., 1999; Nicol et al., 1997; Zhang et al., 2002).  Therefore, a series of 
experiments were performed to determine whether IK was decreased in the 
Nf1+/- neurons compared to wild-types.  As illustrated in Figure 27, IK was 
elicited from Nf1+/+ neurons and Nf1+/- neurons by voltage steps from -80 mV to 
+60 mV in 10 mV increments.  Figure 27A shows a representative trace of IK 
recorded from a Nf1+/+ sensory neuron.  The trace of IK from Nf1+/- neurons 
looked exactly the same as the wild-types.  The peak currents of IK (measured 
close to the point indicated by the arrow in Figure 27A) reflect the current 
amplitude of both the fast-inactivating IA types and the slow inactivating delayed-
rectifier types of IK (IKd), therefore, the peak IK (total IK) was measured in 
Nf1+/+ and Nf1+/- sensory neurons.  The current-voltage relation (Figure 27B) 
demonstrates that the total IK from either genotype was not significantly different 
as determined by using a t-test (the average peak value of IK in Nf1+/+ and 
Nf1+/- neurons was 7638.6 ± 1538.6 and 6724.7 ± 1105.9 pA for the step to +60 
mV, n=7-11).  To minimize the variance of currents recorded from different sizes 
of cells, currents were normalized to the cell surface area and expressed as 
current density (pA/pF).  The membrane capacitance was read directly from the 
patch-clamp amplifier after performing the compensation for capacitance and 
series resistance.  The current density-voltage relation of Nf1+/+ and Nf1+/- 
neurons is illustrated in Figure 27C.  It is unlikely that the activation of IK was 
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altered in Nf1+/- neurons, because the two curves representing the current 
density-voltage relation of Nf1+/+ and Nf1+/- neurons are almost identical (the 
average peak current density of IK in Nf1+/+ and Nf1+/- neurons was 569.2 ± 
96.3 pA/pF and 559.9 ± 103.4 pA/pF, respectively, for the step to +60 mV, n=7-
11).  A similar result was observed for the conductance-voltage relation.  As 
summarized in the Figure 27D, the G/Gmax relation plotted as a function of 
voltage for Nf1+/- neurons was not different compared to Nf1+/- neurons.  The 
values of G/Gmax were fitted by the Boltzmann relation.  The Boltzmann 
parameters, such as half-activation voltage (V0.5) and k (slope factor), for the 
activation of IK in neurons of the two genotypes were not different (Table 1).  In 
summary, the total outward IK in Nf1+/- neurons is not different from Nf1+/+ 
neurons.  
Similar to IK, IKd in neurons of the two genotypes was not significantly 
different.  IKd was measured at the point indicated by the arrow and represents 
the steady-state IK (see Figure 28A).  In Figure 28B, the average value for the 
peak IKd of Nf1+/+ neurons was 6704.9 ± 1189.9 pA (for the step to +60 mV, 
n=11), and was not different from the peak IKd recorded from Nf1+/- neurons 
(6243.8 ± 921.3 pA, n=7).  In Figures 28C and D, the current density-voltage 
relation and the conductance-voltage relation of Nf1+/+ and Nf1+/- neurons were 
not significantly different (the peak current density of IKd was 497.8 ± 83.2 pA/pF 
and 511.8 ± 71.8 pA/pF for Nf1+/+ and Nf1+/- neurons, respectively.  N=7-11).  
The Boltzmann parameters, like V0.5 and k, for the activation of IKd in neurons of 
two genotypes were not significantly different (See Table 1). 
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Taken together, the activation of both total IK and IKd in neurons of the 
two genotypes was not significantly different.  It is unlikely that the activation of 
total IK and IKd contribute to the enhanced excitability of Nf1+/- neurons.  
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 Figure 27.  Total IK in Nf1+/+ and Nf1+/- sensory neurons are not different.  
Panel A shows the representative trace of IK recorded from a Nf1+/+ sensory 
neuron.  The arrow in A approximately points the location where the peak IK was 
measured.  The lower part of panel A shows the protocol to evoke IK.  The 
membrane voltage was held at -60 mV; activation of the currents was determined 
by voltage steps of 300 ms, which were applied at 5 s intervals in +10 mV 
increments from -80 mV to +60 mV.  Panel B summarizes the current-voltage 
relation of IK in both genotypes.  Panel C illustrates the current density-voltage 
relations of IK in both genotypes.  The conductance-voltage relation is illustrated 
in panel D.  The data points in D have been fitted by the Boltzmann relation and 
are shown as the continuous lines. The values in each panel are from the same 
11 Nf1+/+ and 7 Nf1+/- neurons. 
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 Figure 28. IKd in Nf1+/+ and Nf1+/- sensory neurons are not different.  Panel 
A shows the representative trace of IK recorded from a Nf1+/+ sensory neuron.  
The arrow in A approximately points the location where the data were measured.  
The membrane voltage was held at -60 mV; activation of the currents was 
determined by voltage steps of 300 ms, which were applied at 5 s intervals in +10 
mV increments from -80 mV to +60 mV.  Panel B summarizes the current-voltage 
relation of IK in both genotypes.  Panel C illustrates the current density-voltage 
relations of IK in both genotypes.  The conductance-voltage relation is illustrated 
in panel D.  The data points in D have been fitted by the Boltzmann relation and 
are shown as the continuous lines. The values in each panel are from the same 
11 Nf1+/+ and 7Nf1+/- neurons.  
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Table 1.  Boltzmann parameters for the activation of IK in Nf1+/+ and Nf1+/- 
sensory neurons.  
 
 
 V0.5 (mV)  k (mV)  
Nf1+/+ (n=11)   
IK  -2 ± 2 15 ± 1  
IKd  -3 ± 2  14 ± 1 
Nf1+/- (n=7)   
IK -1 ± 2 16 ± 1 
IKd 2 ± 2  16 ± 0  
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2.  There is no difference in the steady state inactivation of IK between the 
Nf1+/+ and Nf1+/- neurons.   
Inactivation is a process that blocks the conduction of potassium channels 
during a depolarization.  Once the potassium channels have been inactivated, 
the membrane must be hyperpolarized to reprime the channels.  The ratio of 
inactivated channels to total channels determines the amplitude of the total 
currents.  To further characterize the IK recorded from Nf1+/+ and Nf1+/- sensory 
neurons, the steady-state inactivation was examined.  Figure 29A illustrates the 
steady-state inactivation of IK obtained from a representative Nf1+/+ neuron.  
Figure 29B is the enlarged version of the circled area of A.  The inactivation 
properties of IK in neurons isolated from the two genotypes were not significantly 
different.  For example, after the conditioning prepulse to 20 mV, IK in Nf1+/+ 
cells was inactivated by 70 ± 5% (n=7), which was not different from Nf1+/- 
neurons (71 ± 7 %, n=5).  As illustrated in Figure 29C, the I/Imax-voltage relation 
in Nf1+/+ neurons was not different from Nf1+/- neurons.  The values of I/Imax as 
a function of the conditioning prepulse were fitted by the Boltzmann relation and 
the Boltzmann parameters for the inactivation of IK were provided in Figure 29C.  
Again, the V0.5 and k were similar in the two groups of neurons.  In summary, the 
inactivation of IK in Nf1+/- neurons was not different from Nf1+/+ neurons.  
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 Figure 29.  (Legend see next page).   
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Figure 29. Steady-state inactivation of IK in Nf1+/+ and Nf1+/- sensory 
neurons are not different.  A.  Upper panel shows the IK obtained by applying 
15 s conditioning prepulses (-100 to +20 mV in 20 mV increments) after which 
the voltage was stepped to +60 mV for 200 ms; a 20 s interval separated each 
prepulse sweep.  Lower panel shows the protocol to evoke the IK shown in upper 
panel.  B. The enlarged version of the circled area of panel A that represents the 
steady-state IK obtained at + 60 mV following the conditional prepulses.  C.  
Steady-state inactivation curves for IK.  Membrane currents were normalized to 
the maximal current obtained after -100 mV prepulse.  The data points in C have 
been fitted by the Boltzmann relation and are shown as the continuous lines.  
Boltzmann parameters for the inactivation of IK were provided in C.  The values 
in C are from 7 Nf1+/+ and 5 Nf1+/- neurons. 
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3. The A-types (IA) of IK do not contribute to the augmented excitability 
observed of Nf1+/- neurons.   
IA is another type of IK that modulates neuronal excitability by decreasing 
the frequency of neuronal firing (Connor and Stevens, 1971).  After firing an AP, 
most channels conducting IA are inactivated.  These channels can be reprimed 
during the repolarization of the membrane potential, especially during the phase 
of AHP.  IA can be activated when a cell is depolarized again to approach the 
firing threshold; the transient outward IA could oppose the depolarization.  The 
membrane potential can continue to approach the firing threshold as IA 
inactivates (Connor, 1978).  Therefore, IA is a key factor to determine the 
interspike interval, the time between the successive APs.  The suppression of IA 
results in a faster depolarization of the membrane potential and shortens the 
interspike intervals.  Since Nf1+/- neurons fire APs at a much higher frequency 
when stimulated by a depolarizing ramp of current, experiments were performed 
to determine whether Nf1+/- neurons had smaller IA currents than that of Nf1+/+ 
neurons.  As shown in Figure 30, IA was obtained by manipulating the holding 
potential.  A hyperpolarized holding potential of -100 mV was used to remove the 
inactivation of IA, whereas, in a different protocol, a depolarized holding potential 
(-40 mV) was used to inactivate IA.  After a 4 s prepulse at a holding potential of -
100 mV, the total IK was recorded in response to voltage steps from -80 mV to 
+60 mV in +20 mV increments (Figure 30A).  The sustained IK was obtained 
when the membrane potential was held at -40 mV for 4 s, followed by the same 
activating voltage steps above (Figure 30B).  Isolated IA was then obtained by 
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digital subtraction of sustained IK from total IK.  Since all isolated IA traces have 
a peak that decayed with time and then reached a stable plateau (Figure 30C), 
the isolated IA was speculated to be contaminated by a slowly inactivating, 
delayed-rectifier IK.  Based on the assumption that the steady-state currents of 
isolated IA were the contamination of delayed-rectifier types of IK, the final 
amplitude of IA was calculated as the peak value of IA minus the steady-state 
value measured at the ending point of 500 ms voltage steps (Figure 30C). 
To minimize the variance of the currents recorded from different sizes of 
the cells, currents were normalized for cell surface area and expressed as 
current density (pA/pF).  In Nf1+/+ neurons, the average peak IA was 5092.5 ± 
1680.4 pA and yielded a value of 369 ± 110.3 pA/pF (for the step to + 60 mV), 
the steady-state current was 2596.3 ± 1007.6 pA and yielded a value of 177.8 ± 
67.8 pA/pF (n=5).  These values were not significantly different from the values 
measured in Nf1+/- neurons (peak IA was 7388.2 ± 1018.9 pA, 587.7 ± 83.0 
pA/pF; steady-state current was 3542.3 ± 681.0 pA, 280.7 ± 54.9 pA/pF, n=3).  
Although the amplitude of IA in Nf1+/+ and Nf1+/- neurons was not statistically 
different, Nf1+/- neurons exhibited a trend for having bigger IA currents.  
Because the augmentation of IA could suppress neuronal excitability and my 
interest is how those Nf1+/- neurons enhanced their excitability, further 
investigation was not performed.  Figure 30F summarizes the conductance-
voltage relation of IA in either genotype.  The G/Gmax of IA as a function of 
voltage for Nf1+/- neurons was not different compared to Nf1+/- neurons.  The 
values of G/Gmax were fitted by the Boltzmann relation.  The Boltzmann 
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parameters, V0.5 and k for the activation of IA in neurons of the two genotypes 
were not different (Figure 30F).  To determine whether the kinetics of IA in Nf1+/- 
neurons was altered, the decay of the currents was fitted with an exponential 
function by using the pClamp 9 software.  In Nf1+/+ neurons, the decay phase of 
the currents was well fitted with a double exponential, this indicates that two 
kinetically distinct components are present in the IA currents of Nf1+/+ neurons: 
one is a slow component with a time constant (τ) of 155.9 ± 36.8 ms at a step of 
+60 mV, the other is a fast component with a τ of 15 ± 4.2 ms at the same 
activating voltage step (n=5).  The correlation coefficient of the fit was 0.992 ± 
0.002 (n=5; the sum of squared errors was much smaller than those fitted by one 
or three exponentials).  In the three Nf1+/- neurons having obvious IA 
components, the decay phase for two neurons was well fitted with a double 
exponential (the slow τ is 209.3 ms and 98.4 ms, the fast τ is 57.3 and 23.1 ms 
for two neurons at a voltage step of 60 mV, respectively).  In contrast to these 
two cells, the decay phase for one Nf1+/- neuron was fitted with a single 
exponential (τ is 199.6 ms at a voltage step of 60 mV).  Since there is no clear 
trend revealing a significant alteration of IA kinetics between genotypes, further 
investigation was not performed.   
Based on the experimental results, the IA currents in Nf1+/- and Nf1+/+ 
neurons were not different in amplitude, kinetics and profiles of activation.  It is 
unlikely that IA contributes the augmented neuronal excitability of Nf1+/- neurons.   
 115
  
 
Figure 30.  (Legend see next page).   
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Figure 30. The A-types of IK in Nf1+/- neurons are not suppressed in Nf1+/- 
neurons.  Currents were measured at different holding potentials.  A: For total IK, 
the membrane potential was held at -100 mV for 4 s and voltage steps were from 
-80 mV to +60 mV with 10 mV increments and 500 ms in duration.  B: For 
sustained IK, the membrane potential was held at -40 mV for 4 s and the voltage 
steps were the same as above.  C: The currents generated by the two protocols 
in A and B were subtracted to obtain the A-types of IK.  The peak currents (PK) 
of IA were measured at the peak of the fast inactivating component and the 
steady-state (SS) currents were measured at the ending point of 500 ms voltage 
steps (the two arrows in C point to the approximate locations where the PK and 
SS value of IA were measured).  The amplitude of IA was determined as the 
value of the peak subtracted by steady-state value.  The value of IA and the IA 
density (pA/pF) versus holding potential (I-V) was plotted in D and E, respectively.  
The current density (pA/pF) was calculated by dividing the current amplitude by 
the capacitance of cell membrane.  The conductance-voltage relation is 
illustrated in panel F.  The data points in F have been fitted by the Boltzmann 
relation and are shown as the continuous lines.  The values in D, E and F are 
from same 5 Nf1+/+ neurons and 3 Nf1+/- neurons. 
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4. The voltage-dependency of steady-state deactivation of tail currents is not 
different in Nf1+/+ and Nf1+/- neurons 
My results have shown that the activation and inactivation of total IK and 
IA were not significantly altered in Nf1+/- neurons.  In the following experiments, 
a different protocol was used to investigate the I-V relationships and the voltage-
dependency of deactivation of the potassium tail currents.  Under normal 
physiological conditions, channels are sitting at different states: open, closed, or 
inactivated.  In order to study the gating properties of potassium channels, two 
voltage steps were used to synchronize the channels.  The membrane potential 
was hyperpolarized to -100 mV for 3 s to reprime the potassium channels, then 
membrane potential was depolarized to +60 mV for 100 ms (almost all channels 
are opened by the depolarization).  After the two steps, the membrane potential 
was repolarized to a series of potentials ranging from -100 mV to + 40 mV for 
300 ms in 20 mV increments.  The peak currents/current densities versus voltage 
(I-V) curves are plotted in Figures 31C and D.  In Nf1+/+ neurons, the average 
peak value for the tail currents was 4504.0 ± 1636.4 pA (n=5; for the step to + 40 
mV, 347.2 ± 120.0 pA/pF),  which was not significantly different from the value in 
Nf1+/- neurons (n=4; peak tail currents were 6513.0 ± 1224.9 pA, 515.0 ± 57.7 
pA/pF).  To determine whether the kinetics of the tail current in Nf1+/- neurons 
was different from that in wild-types, the decay of the currents was fitted with an 
exponential function by using the pClamp 9 software.  The potassium tail 
currents in Nf1+/+ and Nf1+/- neurons were well fitted by a single exponential, 
indicating that there is only one major current component in the tail.  As shown in 
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Figure 31E, the deactivation kinetics (τ) of tail currents is voltage-dependent, 
being faster at more negative potentials and slower at more positive potentials.  
Surprisingly, the deactivation kinetics of Nf1+/- neurons were significantly slower 
compared to Nf1+/+ neurons.  This may indicate that one component of IK with 
slow kinetics becomes the dominant currents in Nf1+/- neurons.   
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Figure 31.  (Legend see next page).   
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Figure 31. The potassium tail currents in Nf1+/+ and Nf1+/- neurons are not 
significantly different.  A. The membrane potential was depolarized to + 60 mV 
for 100 ms after a 3 s, -100 mV prepulse and then repolarized to a series of 
potentials ranging from -100 mV to + 40 mV for 300 ms in 20 mV increments.  
The upper panel shows a representative trace recorded from a Nf1+/+ sensory 
neuron.  The lower panel shows the protocol to evoke the IK shown in upper 
panel.  B: the enlarged version of the circled area in A.  The amplitudes of the tail 
current were measured at the peak (the arrow in B approximately points the 
location from where data were collected).  The value of tail currents and current 
densities versus holding potentials was plotted in C and D, respectively.  The 
current density (pA/pF) was calculated by dividing the amplitude of tail currents 
by the capacitance of cell membrane.  E: the relationship of the deactivation 
kinetics (τ) of tail currents versus different holding potentials.  The asterisk 
represents a statistically significant difference in Nf1+/+ and Nf1+/- sensory 
neurons using a t-test (P < 0.05). 
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E. Augmented INa could underlie the enhanced excitability of Nf1+/- 
neurons 
INa plays an essential role in controlling neuronal excitability.  In sensory 
neurons and many other types of excitable cells, INa generates the rapid 
upstroke of the AP.  Therefore, the properties of sodium channels, such as 
distribution, density, trafficking as well as the threshold of activation and 
repriming characteristics could all influence the firing patterns of sensory neurons.  
Based on the sensitivity to TTX, two general classes of voltage-gated INa have 
been identified in small-diameter, nociceptive-like sensory neurons: TTX-S INa 
and TTX-R INa (Elliott and Elliott, 1993; Roy and Narahashi, 1992).  It is well 
documented that the alteration of INa is an important underlying mechanism for a 
variety painful disorders, such as inflammation (Black et al., 2004; Li et al., 2006; 
Tanaka et al., 1998), neuropathic pain (Dib-Hajj et al., 1999; Lai et al., 2002), a 
painful inherited neuropathy called erythermalgia (Cummins et al., 2004), 
experimental ulcers (Bielefeldt et al., 2002) and nerve injury (Black et al., 1999; 
Dib-Hajj et al., 1996; Rizzo et al., 1995; Sleeper et al., 2000).  Since people with 
neurofibromatosis experience enhanced painful sensation and the sensory 
neurons isolated from Nf1+/- mice have augmented excitability, the experiments 
described below were designed to study the INa in both Nf1+/+ and Nf1+/- 
sensory neurons to determine whether the enhanced firing of Nf1+/- neurons 
results from an alteration of INa. 
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1. The total INa is larger in Nf1+/- neurons with reduced extracellular sodium 
(30 mM) and a Cs-aspartate based pipette solution.  
Activation of INa was determined by voltage steps 30 ms in duration, 
which were applied at 10 s intervals in +5 mV increments from -80 to +40 mV 
following a 500 ms prepulse to -90 mV (see Figure 32A).  INa is usually studied 
using a fluoride-based pipette solution.  However, Coste et al., (2004) showed 
that fluoride caused a significant leftward shift in the I-V curve for both the 
activation and inactivation of INa (fluoride may generate a strong “bias” for 
sodium channels towards the open state, thus producing the leftward shift in the 
I-V curve).  Therefore, a Cs-aspartate based pipette solution was used in the 
studies described below.  Low sodium extracellular solution (30 mM) was used in 
the experiments to decrease the amplitude of INa and thereby minimize the 
errors in controlling membrane voltage (voltage error = current amplitude * 
uncompensated series resistance).  In Figure 32, the total INa recorded from 
Nf1+/- neurons were significantly larger compared to the INa measured from 
wild-type neurons.  The average peak value of INa in Nf1+/- neurons was -1437 
± 237 pA for the step to +0 mV (n=10).  This value was significantly larger 
compared to the INa measured in Nf1+/+ neurons (-676.0 ± 81.9 pA, n=9, for the 
step to +0 mV, t-test).  To minimize the variance of currents resulting from 
different sizes of the cells, currents were normalized to the cell surface area and 
expressed as current density (pA/pF).  The capacitance of the cells was read 
directly from the patch-clamp amplifier after performing the capacitance and 
series resistance compensation.  The reversal potential for INa was calculated to 
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be +28 mV.  The current density-voltage relation of INa in Nf1+/+ and Nf1+/- 
neurons is illustrated in Figure 32D.  Again, the peak current density of INa in 
Nf1+/- neurons was significant larger than that in Nf1+/+ neurons (-48.3 ± 6.6 
pA/pF, n=9 versus -103.5 ± 20.7 pA/pF, n=10 for Nf1+/+ and Nf1+/- neurons, 
respectively, for the step to +0 mV).  Figure 33C shows the conductance-voltage 
relation of Nf1+/+ and Nf1+/- sensory neurons.  Activation of total INa in Nf1+/- 
neurons appeared to be unaltered because V0.5 was -3.1 ± 1.8 mV (n=10), which 
was not different from the -2.7 ± 1.7 mV (n=9) determined in Nf1+/+ neurons.  
Therefore, it is clear that Nf1+/- neurons have augmented INa that could 
contribute to the enhanced excitability observed in Nf1+/- neurons.  
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Figure 32.  (Legend see next page).   
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Figure 32. The total INa is larger in Nf1+/- neurons with reduced 
extracellular sodium (30 mM) and a Cs-aspartate based pipette solution. 
The recordings of total INa from representative sensory neurons isolated from 
either a Nf1+/+ (panel A) or a Nf1+/- mouse (panel B). The lower part of panel A 
shows the protocol to evoke INa.  The membrane potential was held at -90 mV 
for 4 s and voltage steps were from -80 mV to +40 mV with +5 mV increments 
and 30 ms in duration.  The traces in A and B show only the recordings from 500 
ms to 550 ms.  Panel C summarizes the current-voltage relation of INa in both 
genotypes.  The values of the currents were determined at the peak of each 
recorded trace.  Panel D illustrates the current density-voltage relations of INa in 
both genotypes.  The values in each panel are from the same 9 Nf1+/+ and 11 
Nf1+/- neurons.  The asterisk represents a statistically significant difference 
between Nf1+/+ and Nf1+/- sensory neurons using a t-test (P < 0.05). 
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2. There is a significant depolarizing shift in the V0.5 for steady-state 
inactivation of total INa in Nf1+/- neurons with reduced extracellular 
sodium (30 mM) and a Cs-aspartate based pipette solution.   
Inactivation is a process that closes sodium channels and prevents 
channels from reopening until the membrane is repolarized to reprime the 
channels.  The property of inactivation could influence the numbers of channels 
that are capable to open during a given stimulus.  Given the importance of 
inactivation in regulating the availability of sodium channels, I asked whether the 
inactivation of INa was altered in the Nf1+/- sensory neurons.  The level of 
inactivation of INa was established by using a 400 ms conditioning prepulse (-
100 to +10 mV in 10 mV increments), after which the voltage was stepped to +0 
mV for 30 ms, a 5 s interval separated each sweep (the lower panel of Figure 
33A).  The upper panel of figure 33A demonstrates the steady-state inactivation 
of total INa from a representative Nf1+/+ neuron.  Figure 33B is the enlarged 
version of the circled area of A.  Interestingly, as illustrated in Figure 33C 
(dashed lines), the I/Imax-voltage relation in Nf1+/- neurons was significantly 
shifted to the right compared to that obtained from Nf1+/+ neurons.  The values 
of I/Imax were fitted by the Boltzmann relation and the Boltzmann parameters for 
the inactivation of INa in both genotypes are provided in Table 2.  There was a 
significant depolarizing shift in V0.5 of the inactivation of INa in Nf1+/- neurons (-
18 ± 1 mV vs. -25 ± 1 mV for Nf1+/+ neurons, n=7, p<0.05, t-test).  As a 
consequence, the total INa was inactivated by 74 ± 9% (n=7) in Nf1+/+ neurons 
after the conditioning prepulse to -20 mV (a value close to the V0.5 for the 
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inactivation of INa in both genotypes), which is significantly higher compared to 
Nf1+/- neurons (39 ± 7%, n=7).  Therefore, the inactivation of total INa in Nf1+/- 
neurons was altered, which can lead to more sodium channels capable to open 
in response to a given stimulus, thereby augment INa.  In addition, the 
depolarizing shift in the inactivation of INa resulted in a bigger window current.  
The window current is represented by the area created by the overlap of the 
activation and inactivation functions of the sodium channel (the shadowed and 
pointed area in Figure 33C).  The window current can result from the opening of 
the non-inactivated sodium channels (known as persistent INa).  Therefore, it is 
possible that the Nf1 mutation somehow increases the expression of more 
persistent INa, or shifts the inactivation of more sodium channels to a 
depolarized potential.   
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Figure 33.  (Legend see next page). 
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Figure 33. There is a significant depolarizing shift in the V  for steady-
state inactivation of total INa in Nf1+/- neurons with reduced extracellular 
sodium (30 mM) and a Cs-aspartate based pipette solution.
0.5
  A.  Upper panel 
shows the representative traces of steady-state inactivation of INa obtained by 
applying 4 s conditional prepulses (-100 to +10 mV in 10 mV increments).  After 
the conditional prepulse, the voltage was stepped to 0 mV for 30 ms, a 5 s 
interval separated each prepulse sweep.  Lower panel shows the protocol to 
evoke the INa shown in upper panel.  B. The enlarged version of the circled area 
of panel A that represents the INa obtained at + 0 mV following the conditional 
prepulses.  C. The G/Gmax-voltage relationship (the activation of INa) and the 
I/Imax-voltage relationship (the inactivation of INa) of Nf1+/+ and Nf1+/- sensory 
neurons.  The activation of INa is shown as the continuous lines (n=9-10), 
whereas the inactivation of INa is represented as dashed lines (n=7).  For the 
steady-state activation, the conductance was normalized with Gmax, which were 
determined by fitting conductance-voltage curves of data obtained from each 
neuron using the Boltzmann relation (G/Gmax).  For the steady-state inactivation, 
membrane currents were normalized to the maximal current obtained after -100 
mV prepulse (I/Imax).  Boltzmann parameters for the activation and inactivation 
of INa in Nf1+/+ and Nf1+/- sensory neurons were determined by fitting the 
conductance-voltage or current-voltage curves by Boltzmann equation.  Means ± 
SEM values for V0.5 and k (slope) are collected in Table 2. 
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Table 2.  Boltzmann parameters for the activation and inactivation of total 
INa in Nf1+/+ and Nf1+/- sensory neurons.  
 
 
 
 V0.5 (mV)  k (mV) 
INa activation    
Nf1+/+ (n=10) -2.7 ± 1.7 7.5 ± 1.0  
Nf1+/-  (n=10) -3.1 ± 1.8  7.7 ± 0.9 
INa inactivation   
Nf1+/+ -25.3 ± 1.9 4.3 ± 0.3 
Nf1+/- -17.9 ± 1.4 * 4.2 ± 0.2  
*: represents a statistically significant difference between Nf1+/+ and Nf1+/- 
sensory neurons using a t-test (P < 0.05). 
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3. The Nf1+/- neurons have augmented TTX-R INa with reduced 
extracellular sodium (30 mM) and a Cs-aspartate based pipette solution.   
The augmentation of TTX-R INa has been proposed to be an important 
underlying mechanism in neuronal sensitization (England et al., 1996; Gold et al., 
1996a; Gold et al., 2002; Jeftinija, 1994; Rush and Waxman, 2004; Tanaka et al., 
1998; Waxman et al., 1994; Zhang et al., 2002).  Based on the observation that 
Nf1+/- neurons had much higher excitability, I determined whether TTX-R INa in 
Nf1+/- neurons was augmented.  The TTX-R INa was obtained by using the 
same voltage protocol to evoke total INa in the presence of 500 nM TTX in the 
bath solution.  Figure 34A and B show representative traces for TTX-R INa in 
Nf1+/+ neurons and Nf1+/- neurons.  The peak currents of TTX-R INa in Nf1+/- 
neurons were significantly larger than that in Nf1+/+ neurons.  The current-
voltage relation for the maximum average peak value of TTX-R INa in Nf1+/- 
neurons was -1073.7 ± 230.1 pA (n=6, for the step to 0 mV), which was 
significantly larger than that in Nf1+/+ neurons (-404.1 ± 60.7 pA, n=5, for the 
step to 0 mV, t-test, Figure 34C).  To minimize the variance of currents resulting 
from different sizes of the cells, currents were normalized for cell surface area 
and expressed as current density (pA/pF).  The current density-voltage relation of 
TTX-R INa in Nf1+/+ and Nf1+/- neurons is illustrated in Figure 34D.  The peak 
current density of TTX-R INa in Nf1+/- neurons was significantly larger than that 
in Nf1+/+ neurons (-22.5 ± 3.7 pA/pF, n=5 versus -65.8 ± 16.9 pA/pF, n=6 for 
Nf1+/+ and Nf1+/- neurons, respectively, for the step to +5 mV).  The voltage 
dependence for activation of TTX-R INa was determined by fitting the 
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conductance-voltage curve by Boltzmann relation (Figure 35C) and their 
corresponding Boltzmann fits are shown in Table 3.  The activation of TTX-R INa 
seems to be unaltered because the V0.5 in Nf1+/+ neurons was -5.7 ± 1.5 mV 
(n=6), which was not different from that in Nf1+/+ neurons (-6.8 ± 2.5 mV, n=5).  
Both the slope factor (k) and the reversal potential for TTX-R INa were not 
different between neurons of the two genotypes.  Based on these results, the 
TTX-R INa in Nf1+/- neurons was significantly enlarged, which can contribute to 
the enhanced excitability in Nf1+/- neurons.  
4. There is a significant depolarizing shift in the V0.5 for steady-state 
inactivation of TTX-R INa in Nf1+/- neurons with reduced extracellular 
sodium (30 mM) and a Cs-aspartate based pipette solution.   
In order to study the inactivation of TTX-R INa in Nf1+/- neurons, the same 
protocol as described in Figure 32A was used while the neurons were in the 
recording chamber with 500 nM TTX in the bath solution.  Similar to total INa, the 
steady-state inactivation of TTX-R INa was shifted significantly to the right 
(Figure 35C).  The voltage dependence for inactivation of TTX-R INa was 
determined by fitting the I/Imax-voltage curve by the Boltzmann relation (Figure 
35C) and their corresponding Boltzmann fits are illustrated in Table 3.  A 
significant depolarizing shift in V0.5 of the inactivation of TTX-R INa in Nf1+/- 
neurons was observed (-20.8 ± 1.5 mV, n=5 for Nf1+/- neurons vs. -29.0 ± 2.4 
mV for Nf1+/+ neurons, n=4, p<0.05, t-test).  In Nf1+/- neurons, as a result of the 
leftward shift of I/Imax-voltage relationship, the TTX-R INa was inactivated by 
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55.0 ± 7.8% (n=5) after the conditioning prepulse to -20mV, which was 
significantly lower compared to that in the Nf1+/+ neurons (90 ± 2%, n=4).  This 
change in the inactivation of TTX-R INa of Nf1+/- neurons indicated that more 
sodium channels were available for a given stimulus, resulting in bigger INa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 134
Nf1+/+ Nf1+/- 
 
Figure 34. Nf1+/- neurons have augmented TTX-R INa with reduced 
extracellular sodium (30 mM) and a Cs-aspartate based pipette solution.  
The recordings of TTX-R INa from representative sensory neurons isolated from 
either a Nf1+/+ (A) or a Nf1+/- mouse (B) at the presence of 500 nM TTX.  The 
lower part of panel A shows the protocol to evoke INa.  the membrane potential 
was held at -90 mV for 4 s and voltage steps were from -80 mV to +40 mV with + 
5 mV increments and 30 ms in duration.  The traces in A and B only show the 
recordings from 500 ms to 550 ms.  Panel C summarizes the current-voltage 
relation of TTX-R INa in both genotypes.  The values of the currents were 
collected at the peak of each recorded trace.  Panel D illustrates the current 
density-voltage relations of TTX-R INa in both genotypes.  The values in each 
panel are from the same 5 Nf1+/+ and 9 Nf1+/- neurons.  The asterisk represents 
a statistically significant difference between Nf1+/+ and Nf1+/- sensory neurons 
using a t-test (P < 0.05). 
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Figure 35.  (Legend see next page).   
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Figure 35. There is a significant depolarizing shift in the V  for steady-
state inactivation of TTX-R INa in Nf1+/- neurons with reduced extracellular 
sodium (30 mM) and a Cs-aspartate based pipette solution. 
0.5
 A.  Upper panel 
shows the representative traces of steady-state inactivation of TTX-R INa by 
applying the same protocol described in the legend of Figure 32.  B. The 
enlarged version of the circled area of panel A that represents the TTX-R INa 
obtained at 0 mV following the conditional prepulses.  C. The G/Gmax-voltage 
relationship (the activation of INa) and the I/Imax-voltage relationship (the 
inactivation of INa) of TTX-R INa in Nf1+/+ and Nf1+/- sensory neurons.  The 
activation of INa is shown as the continuous lines (n=5-6), whereas the 
inactivation of INa is represented as dashed lines (n=4-5).  For the steady-state 
activation, the conductance was normalized to Gmax, which was determined by 
fitting the conductance-voltage curves of data obtained for each neuron using the 
Boltzmann relation (G/Gmax).  For the steady-state inactivation, membrane 
currents were normalized to the maximal current obtained after -100 mV prepulse 
(I/Imax).  The voltage dependence for activation and inactivation of TTX-R INa 
was determined by fitting the G/Gmax-voltage curve or I/Imax-voltage curve by 
Boltzmann relation and their corresponding Boltzmann fits are demonstrated in 
Table 3. D. shows the normalized average peak INa before and after TTX in 
Nf1+/+ and Nf1+/- neurons.  The peak currents were normalized to their 
respective control values (the peak values obtained before applying TTX).  N=6-7.   
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Table 3.  Boltzmann parameters for the activation and inactivation of INa in 
Nf1+/+ and Nf1+/- sensory neurons.  
 
 
 
 V0.5 (mV)  k (mV) 
TTX-R INa activation    
Nf1+/+ (n=5) -6.8 ± 2.5 6.8 ± 0.6  
Nf1+/-  (n=6) -5.7 ± 1.5  7.2 ± 0.7 
TTX-R INa inactivation   
Nf1+/+ -29.0 ± 2.4 5.0 ± 0.5 
Nf1+/- -20.8 ± 1.5 * 4.6 ± 0.3  
*: represents a statistically significant difference between Nf1+/+ and Nf1+/- 
sensory neurons using a t-test (P < 0.05). 
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5.  Few cells exhibit the characteristics of TTX-S INa in Nf1+/+ and Nf1+/- 
neurons with 30 mM extracellular sodium concentration and Cs-aspartate 
based intracellular solution.  
Given the information that TTX-S INa has a strong link with the neuronal 
sensitization during inflammation and nerve injury (Black et al., 1999; Black et al., 
2004; Dib-Hajj et al., 1996), I investigated whether the TTX-S INa in Nf1+/- and 
Nf1+/+ neurons was different under the condition with reduced extracellular 
sodium concentration (30 mM) and Cs-aspartate based intracellular solution.  
TTX-S INa was obtained by digital subtraction of the current traces recorded 
before and after treatment with TTX by using the same voltage protocol for total 
INa.  Surprisingly, under our experimental condition, few neurons exhibited the 
characteristics of TTX-S INa.  For example, in 6 Nf1+/+ neurons, only 3 cells had 
the TTX-S components.  The average peak TTX-S INa was -511.3 ± 149.2 pA (-
37.5 ± 11.2 pA/pF) for a step to -10 mV.  In contrast to Nf1+/+ cells, in 6 Nf1+/- 
neurons, only one cell exhibited TTX-S INa (peak INa was -289.9 pA for a step to 
-10 mV).  As illustrated in Figure 35D, in both genotypes, the peak INa before 
and after TTX were not significantly different.   
TTX-S INa with large amplitudes have been observed in small diameter 
sensory neurons (Cummins et al., 2001).  Under my experimental condition, few 
cells had TTX-S components.  This indicates that my experimental condition, i.e. 
30 mM extracellular sodium concentration and Cs-aspartate based intracellular 
solution, was not ideal for investigating TTX-S INa in mouse sensory neurons.  
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Therefore, in the sections described below, recordings for INa were performed 
using full extracellular sodium (110 mM) and a CsF based pipette solution.  
6. The total INa in neurons of either genotype exhibits two phenotypes with 
full extracellular sodium (110 mM) and a CsF based pipette solution. 
To optimize the recording conditions to measure TTX-S INa, a full 
extracellular sodium solution and CsF based pipette solution was used.  Because 
CsF caused a left-ward shift in the I-V relationship of INa (Coste et al., 2004), the 
protocols to record INa were modified in order to record total INa and TTX-R INa 
in the same neuron rapidly.  In my experiments, the recording for total INa and 
TTX-R INa were finished in 6 min.  In this short time-frame, the I-V curve was not 
significantly shifted by CsF, thus ensuring the successful isolation of TTX-S INa 
by digital subtraction of the currents recorded before and after applying TTX.  In 
addition, the time at which the recordings were obtained was consistent.  For 
example, the recordings for total INa were performed 2 min after establishing the 
whole-cell configuration, whereas all TTX-R currents were recorded 5 min after 
establishing the whole-cell configuration.  
The detailed description of the protocol used to record INa under full 
sodium extracellular solution and CsF based pipette solution can be found in the 
Materials and Methods.  Briefly, the membrane voltage was held at -100 mV after 
establishing the whole-cell configuration.  Activation of INa was determined by 
voltage steps that were 30 ms in duration, which were applied at 10 s intervals in 
+5 mV increments from -80 to +60 mV.  A 5 s interval separated each prepulse 
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sweep whose holding voltage was -100 mV.  Using the recording conditions with 
110 mM extracellular sodium and the CsF based pipette solution, the total INa 
clearly exhibited two phenotypes in both Nf1+/+ and Nf1+/- neurons: one was 
dominated by the fast activating and inactivating, TTX-S-like currents (type I, 
Figure 36A), the other was dominated by slow activating and inactivating, TTX-R-
like currents (type II, Figure 36C).  After type I neurons were treated with TTX, 
there was a dramatic decrease in the peak current in (Figure 36B).  In contrast, in 
type II neurons, the peak current was not significantly altered by TTX (Figure 
36D).  In ten Nf1+/- neurons, four neurons belonged to the type I group and six 
neurons belonged to the type II group, whereas in the Nf1+/+ neurons, eight cells 
belonged to the type I group (Figure 36D).  Because Type I neurons typically had 
a large peak TTX-S-like INa, the larger proportion of type I neurons in Nf1+/+ 
cells results a larger total currents.  Consequently, the difference in total INa 
between genotypes was diminished when observed under the condition with 
reduced extracellular sodium (30 mM) and a Cs-aspartate based pipette solution. 
The average peak value of total INa in Nf1+/+ neurons was -10897.8 ± 1534.8 
pA (n=5, for the step to -15 mV), which was not different from Nf1+/- neurons (-
10390.3 ± 1346.3 pA, n=7, for the steps to -15 mV).  To minimize the variance of 
the currents obtained from cells of different sizes, currents were normalized to 
cell surface area and expressed as current density (pA/pF).  The current density-
voltage relation for the total INa in Nf1+/+ and Nf1+/- neurons is illustrated in 
Figure 37B.  Again, the peak current density of INa in Nf1+/+ neurons was not 
significantly different from the value in Nf1+/- neurons (-730.8 ± 148.0 pA/pF, n=5 
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versus -878.2 ± 145.5 pA/pF, n=7 for Nf1+/+ and Nf1+/- neurons, respectively, 
for the steps to -15 mV).  Figure 37C shows the conductance-voltage relation 
obtained from Nf1+/+ and Nf1+/- sensory neurons.  Activation of total INa in 
Nf1+/- neurons appeared to be unaltered from that in Nf1+/+ neurons.  The 
values of V0.5 and k in Nf1+/+ neurons were not different from those measured in 
Nf1+/- neurons.  The values for V0.5 and k are provided in Table 4.  This result is 
contradictory to my previous observation that the total INa was augmented in 
Nf1+/- neurons using the reduced extracellular sodium solution and Cs-aspartate 
based pipette solution.  Under the condition with 30 mM sodium in extracellular 
solution and with CsF based pipette solution, the total INa was dominated by 
TTX-R INa.  This raised the question as to whether TTX-R INa was augmented in 
Nf1+/- neurons.  Therefore, the TTX-R INa was isolated and compared in 
neurons isolated from the two genotypes. 
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 Figure 36.  (Legend see next page). 
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Figure 36. The total INa exhibits two phenotypes in small diameter, 
nociceptive-like sensory neurons.  The recordings of total INa evoked from 
either a type I neuron (A) or a type II neuron (C).  B:  The TTX-R INa in type I 
neuron.  The lower part of panel B shows the protocol to elicit INa.  The 
membrane potential was held at -100 mV, the voltage steps were from -80 mV to 
+60 mV with + 5 mV increments and 30 ms in duration.  D:  The TTX-R INa in 
type II neurons.  E: left part of the Figure shows the phenotypes of total INa in 10 
Nf1+/+ neurons, whereas the right shows that of 10 Nf1+/- neurons.  It is highly 
possible that the percentage of type I neurons whose total INa are dominated by 
TTX-S INa is decreased in Nf1+/- neurons.  For clarity purposes, the INa 
presented in A and B only show the traces whose holding potential was from -60 
mV to -15 mV, whereas the currents in C and D presents those whose holding 
potential was from -60 mV to -5 mV (the voltage-range from beginning to activate 
the current to maximum activate  INa). 
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 Figure 37. Total INa in Nf1+/+ and Nf1+/- neurons is not significantly 
different under full sodium extracellular solution and CsF based pipette 
solution.  Panel A summarizes the current-voltage relation of total INa in both 
genotypes.  The values of the currents were collected at the peak of each 
recorded trace. The currents were evoked by using the protocols described in 
Figure 35 legend.  Panel B illustrates the current density-voltage relations of total 
INa in both genotypes.  The values in each panel are from the same 5 Nf1+/+ 
and 7 Nf1+/- neurons.  C:  the conductance was normalized to Gmax, which was 
determined by fitting conductance-voltage curves obtained from each neuron 
using the Boltzmann relation.  The voltage dependence for activation of total INa 
was determined by fitting the G/Gmax-voltage curve by Boltzmann relation and 
their corresponding Boltzmann fits are demonstrated in Table 4.  
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Table 4.  Boltzmann parameters for the activation of total INa in Nf1+/+ and 
Nf1+/- sensory neurons.  
 
 
 V0.5 (mV)  k (mV) 
Total INa activation    
Nf1+/+ (n=5) -29.2 ± 2.5 5.4 ± 1.0 
Nf1+/-  (n=7) -21.6 ± 3.6  8.1 ± 1.5 
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7. The TTX-R INa is augmented in Nf1+/- neurons with full extracellular 
sodium (110 mM) and a CsF based pipette solution. 
The TTX-R INa was obtained by using the same voltage protocol to evoke 
total INa in the presence of 500 nM TTX in the bath solution.  The TTX-R INa in 
Nf1+/- neurons was significantly larger compared to Nf1+/+ neurons under the 
condition with full extracellular sodium and the CsF-based pipette solution.  As 
illustrated in Figure 38A, the average peak value of TTX-R INa in Nf1+/- neurons 
was -6788.0 ± 1627.5 pA (n=6, for the step to -10 mV), which was significantly 
larger than the TTX-R INa in the Nf1+/+ neurons (-3149.9 ± 846.7 pA, n=4, for 
the step to -10 mV, Mann-Whitney Rank Sum Test).  The current density-voltage 
relation of TTX-R INa in Nf1+/+ and Nf1+/- neurons is illustrated in Figure 38B.  
The peak current density of INa in Nf1+/- neurons was significantly larger than 
that in Nf1+/+ neurons.  For example, for the step to -10 mV, the average peak 
current density of TTX-R INa in Nf1+/- neurons was -503.0 ± 71.8 pA/pF (n=6), 
which was significantly larger than that in Nf1+/+ neurons (-227.2 ± 72.3 pA/pF, 
n=4).  Figure 38C represents the conductance-voltage relation of Nf1+/+ and 
Nf1+/- sensory neurons.  Similar to the results obtained using low extracellular 
sodium and Cs-aspartate based pipette solution, the activation of TTX-R INa in 
Nf1+/- neurons appears to be unaltered compared to wild-type neurons.  V0.5 and 
k are provided in Table 5.  Based on the experimental results using either full 
extracellular sodium and the CsF-based pipette solution or low extracellular 
sodium and Cs-aspartate-based pipette solution, it is clear that Nf1+/- neurons 
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have augmented TTX-R INa that could contribute to the enhanced excitability 
observed in Nf1+/- neurons.   
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Figure 38. TTX-R INa in Nf1+/- neurons is significantly larger compared to 
Nf1+/+ neurons under full sodium extracellular solution and CsF based 
pipette solution.  Panel A summarizes the current-voltage relation of TTX-R INa 
in both genotypes.  The values of the currents were collected at the peak of each 
recorded trace. The currents were evoked by using the protocols described in 
Figure 35 legend and with 500 nM TTX in extracellular solution.  Panel B 
illustrates the current density-voltage relations of TTX-R INa in both genotypes.  
The values in each panel are from the same 4 Nf1+/+ and 6 Nf1+/- neurons.  C:  
the conductance was normalized to Gmax, which were determined by fitting 
conductance-voltage curves obtained from each neuron using the Boltzmann 
relation.  The voltage dependence for activation of TTX-R INa was determined by 
fitting the G/Gmax-voltage curve using Boltzmann relation and their 
corresponding Boltzmann fits are demonstrated in Table 5. @: represent a 
statistically significant difference between genotypes using Mann-Whitney Rank 
Sum Test.  *: represent a statistically significant difference between genotypes 
using a t-test.   
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Table 5.  Boltzmann parameters for the activation of TTX-R INa in Nf1+/+ 
and Nf1+/- sensory neurons  
 
 V0.5 (mV)  k (mV) 
Total INa activation    
Nf1+/+ (n=5) -14.0 ± 2.5 13.4 ± 1.6 
Nf1+/-  (n=7) -18.4 ± 2.6  9.6 ± 2.1 
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8. The TTX-S INa is larger in Nf1+/- neurons with full extracellular sodium 
(110 mM) and a CsF based pipette solution. 
This series of experiments was designed to investigate the TTX-S INa in 
Nf1+/- and Nf1+/+ neurons under the condition of full extracellular sodium 
solution and CsF-based pipette solution.  After obtaining the total INa, the 
superfusate was changed to Ringer’s solution containing 500 nM TTX and cells 
were superfused for the appropriate times.  TTX-S INa (Figure 39C) was 
obtained by digital subtraction of the current traces recorded before (Figure 39A) 
and after TTX treatment (Figure 39B).  As illustrated in Figure 39D, the TTX-S 
INa in Nf1+/- neurons was not significantly larger compared to the current 
obtained from Nf1+/+ neurons (-11230 ± 1126 pA versus -8299 ± 1057 pA, n=3, 
for the steps to -20 mV).  However, the average peak current density in Nf1+/- 
neurons was -969 ± 72 pA/pF (n=3) and was significantly larger compared to 
Nf1+/+ neurons (-546 ± 92 pA/pF, n=3, for the steps to -20 mV) as demonstrated 
in Figure 39E.  Figure 39F represents the conductance-voltage relation of Nf1+/+ 
and Nf1+/- sensory neurons.  Similar to TTX-R INa, the activation of TTX-S INa 
in Nf1+/- neurons appears to be unaltered compared to that in Nf1+/+ neurons. 
V0.5 and k are provided in Table 6.   
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Figure 39.  (legend see next page). 
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Figure 39. The current density of TTX-S INa in Nf1+/- neurons is 
significantly larger compared to Nf1+/+ neurons under full sodium 
extracellular solution and CsF based pipette solution.  A: Total INa. B: TTX-
R INa. C: TTX-S INa obtained by digital subtraction (A-B).  A-C: the membrane 
potential was hold at -100 mV.  The INa was evoked by applying voltage steps of 
30ms at 10 s intervals in +5 mV increments from -80 to +40 mV.  The traces in A-
C only show the currents whose command potential was from -60 mV to -15 mV.  
Panel D summarizes the current-voltage relation of TTX-S INa in both genotypes.  
The values of the currents were collected at the peak of each recorded trace.  
Panel E illustrates the current density-voltage relations of TTX-S INa in both 
genotypes.  The values in each panel are from the same 3 Nf1+/+ and 3 Nf1+/- 
neurons.  F: the conductance was normalized with Gmax, which were 
determined by fitting conductance-voltage curves obtained from each neuron 
using the Boltzmann relation.  The voltage dependence for activation of TTX-S 
INa was determined by fitting the G/Gmax-voltage curve using Boltzmann 
relation and their corresponding Boltzmann fits are demonstrated in Table 6.  The 
asterisks represent a statistically significant difference between genotypes using 
a t-test.   
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Table 6.  Boltzmann parameters for the activation of TTX-S INa in Nf1+/+ 
and Nf1+/- sensory neurons  
 
 V0.5 (mV)  k (mV) 
Total INa activation    
Nf1+/+ (n=5) -30 ± 5 5 ± 1 
Nf1+/-  (n=7) -34 ± 5 5 ±1 
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IV. DISCUSSION 
A. The sensory neurons with a heterozygous mutation of the Nf1 gene 
have augmented neuronal excitability  
In this thesis, I have demonstrated that small-diameter, capsaicin-sensitive 
sensory neurons with a heterozygous mutation of the Nf1 gene have augmented 
excitability compared with wild-type neurons.  The protein product of Nf1 gene is 
neurofibromin, which is a GAP that catalyzes the hydrolysis of active Ras-GTP to 
inactive Ras-GDP and, thereby, reduces the activation of downstream cascades 
(Li et al., 1992; Martin et al., 1990; Wallace et al., 1990).  Because Nf1+/- 
neurons have only one functional copy of the Nf1 gene, the protein product of 
this gene should be expressed in a lower level in the cell.  Neurofibromin is 
expressed most abundantly in the nervous system, in such cell types as neurons, 
Schwann cells and oligodendrocytes (Daston et al., 1992).  The high incidence of 
developmental retardation, learning difficulties as well as exaggerated painful 
response of those people with NF1 (Creange et al., 1999; Trovo-Marqui et al., 
2005) indicates that the single active NF1 allele does not generate enough 
neurofibromin to fulfill its normal biological function in the nervous system.  The 
decrease of neurofibromin levels frequently results in both basal and cytokine-
stimulated Ras activity in many cell types, including sensory neurons (Guha et al., 
1996; Ingram et al., 2001; Klesse and Parada, 1998; Sherman et al., 2000; Vogel 
et al., 1995).  Therefore, it is reasonable to infer that the Nf1+/- neurons have 
augmented levels of Ras-GTP.  The enhanced neuronal excitability of Nf1+/- 
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neurons suggests that the activation of the Ras transduction cascade modulates 
the function of ion channels that regulate the capacity of sensory neurons to fire 
APs.  However, the idea that the augmentation of intracellular Ras-GTP activity 
in Nf1+/- neurons enhances neuronal excitability is complicated because there 
are several isoforms of Ras that may have distinct functions in a variety of cell 
types.  For example, H-Ras, another Ras isoform, was reported to suppress the 
expression of sodium and calcium channels in differentiated BC3H1 myocytes 
(Caffrey et al., 1987).  In addition, Estacion (1990) reported that voltage-
dependent INa was not observed in three cell lines containing activated H-Ras.  
Since INa is critical for the firing of an AP, the inhibition of the expression for 
sodium channels suggests that H-Ras may decrease neuronal excitability.  
Based on the augmented excitability of Nf1+/- neurons, it is less likely that the 
activity of H-Ras is enhanced by the Nf1 mutation.  Interestingly, evidence 
suggests that another Ras isoform, K-Ras, is the primary target of the GAP 
activity of neurofibromin.  For example, K-Ras, but not H-Ras, is activated in 
astrocytes isolated from Nf1+/- and Nf1-/- mice, and could account for the fast 
proliferation and the abnormal actin cytoskeleton in these cells (Dasgupta et al., 
2005).  Since DRG neurons may express different isoforms of Ras with distinct 
functions, it should be very informative to investigate the expression of different 
Ras isoforms as well as their role in modulating channel activity, and thereby 
controlling the state of excitability.   
 Once Ras-GTP recruits the kinase, Raf, to the cell membrane, a cascade 
of downstream effectors is activated, such as the MAPK and PI-3K pathway (The 
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assumption here is that the augmented Ras-GTP level correlates with enhanced 
Ras activity).  In many types of cells, the mutation of the Nf1 gene decreased the 
intracellular GAP activity and led to an increase in cellular levels of Ras-GTP and 
its downstream effectors, like pERK, and pAkt, both at rest and when cells were 
exposed to growth factors that activate Ras (Guha et al., 1996; Ingram et al., 
2001; Klesse and Parada, 1998; Sherman et al., 2000; Vogel et al., 2000).  The 
enhanced activation of Ras and its downstream effectors in sensory neurons 
frequently correlate with hyperalgesia and neuronal sensitization.  The 
hyperalgesia induced by TNFα and epinephrine was greatly attenuated by 
blockers of MEK, SB202190 and UO126 (Aley et al., 2001; Jin and Gereau, 
2006).  Likewise, blockade of MAPK activity by expressing a dominant negative 
MEK exclusively in sensory neurons of adult mice significantly reduced the pain 
behavior compared to wild-type controls in formalin-induced inflammation (Karim 
et al., 2006).  Furthermore, applying the MEK inhibitors, PD98059 and U0126 
significantly suppressed the firing of dorsal horn neurons elicited by electrical 
currents (Hu and Gereau, 2003).  Based on the evidence above, it is possible 
that the activation of MAPK, as a consequence of the decreased GAP activity in 
Nf1+/- neurons, leads to the augmentation of excitability of Nf1+/- sensory 
neurons.  
Few studies have investigated the role of the PI-3K pathway, another 
intracellular signaling cascades activated by Ras, in the modulation of neuronal 
excitability.  Recent evidence shows that the PI-3K pathway is involved with 
neuronal sensitization.  By mutating the tyrosine residue in TrkA (Y760) that is 
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involved in the activation of PI-3K, the sensitization produced by NGF was 
significantly attenuated (Zhang et al., 2005).  To support the notion that PI-3K led 
to neuronal sensitization, Zhuang et al., (2004) demonstrated that the PI-3K 
inhibitors, LY294002 and wortmannin, successfully blocked the activation of ERK 
in primary rat sensory neurons and attenuated the capsaicin- and NGF-induced 
heat hyperalgesia.  These findings suggest that PI-3K may lead to activation of 
ERK and could contribute to neuronal sensitization and inflammatory pain.  Since 
the activity of PI-3K could also be augmented in Nf1+/- neurons by elevated level 
of Ras-GTP, it would be important to examine whether the activity of PI-3K is 
augmented in Nf1+/- neurons and contributes to the enhanced excitability.   
Based on the current literature, it is poorly understood whether 
neurofibromin has other functions in addition to its capacity as a GAP for Ras.  
However, several investigations suggest that  neurofibromin may interact with 
PKA and PKC, whose activation leads to neuronal sensitization (Ahlgren and 
Levine, 1994; Evans et al., 1999).  It was reported that neurofibromin was 
phosphorylated constitutively by PKA (Izawa et al., 1996; Tokuo et al., 2001), 
indicating PKA might modulate the function of neurofibromin.  Likewise, The et al., 
(1997) demonstrated that the expression of PKA rescued the size defect of a 
Drosophila mutant (reduction in size of larvae, pupae, and adults) that results 
from homozygous mutation of an NF1 homolog, suggesting that NF1 and PKA 
interacted to control the growth of Drosophila.  The biological significance of the 
phosphorylation of neurofibromin or the interaction between PKA and 
neurofibromin is not clear at present, but I speculate that neurofibromin may 
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serve as a linker between two major intracellular pathways, the Ras and PKA 
signaling cascade, and the heterozygous mutation of the Nf1 gene may alter the 
activity of PKA, a well documented protein kinase whose activation leads to 
neuronal sensitization (Aley and Levine, 1999; England et al., 1996; Evans et al., 
1999; Lopshire and Nicol, 1998; Taiwo et al., 1989). 
Besides PKA, neurofibromin was also reported to interact with other 
signaling molecules, like PKC.  Mangoura et al., (2006) showed that PKC 
modulated the function of neurofibromin because the Ras-GAP activity of 
neurofibromin was diminished when PKCα (an isoform of PKC) was 
downregulated.  PKC is another protein kinase that leads to neuronal 
sensitization (Ahlgren and Levine, 1994; Baker, 2005; Hucho et al., 2005; Vellani 
et al., 2001).  Based on the close interaction between neurofibromin and 
PKC/PKA, it is possible that the heterozygous mutation of Nf1 gene alters the 
activity of PKA and PKC, and contributes to neuronal sensitization.  It will be 
interesting to study the activity of PKA or PKC in Nf1+/- neurons and determine 
whether there is an aberrant activity of PKA or PKC, whose activation could lead 
to the augmented excitability in Nf1+/- neurons.  
The augmented neuronal firing in Nf1+/- neurons involves the activity of 
ion channels in the cell membrane.  Previous evidence suggests that the Ras 
transduction cascade can modulate the activity of ion channels.  For example, 
Fitzgerald and Dolphin (1997) demonstrated that microinjection of activated K-
Ras enhanced the voltage-gated calcium current in DRG neurons isolated from 
 159
neonatal rats.  This augmentation of calcium currents by K-Ras was not 
associated with any significant changes in either activation or inactivation of the 
current.  In support of the notion that Ras modulates the activity of these calcium 
channels, the blockage of intracellular Ras activity decreased calcium currents.  
This was accomplished by two approaches, one used a Ras-neutralizing 
antibody, the other used a peptide that inhibited the interaction of Ras with the 
TrkA-Src complex (Fitzgerald and Dolphin, 1997).  Besides affecting calcium 
channels, the activation of Ras may modulate other types of ion channels.  The 
inward-rectifying potassium currents (IKir) in HEK cells coexpressed with 
constitutively active Ras are significantly smaller compared to the IKir in cells 
when IKir is expressed alone.  These results suggest that Ras inhibits IKir 
(Giovannardi et al., 2002).  Both the suppression of IK and the augmentation of 
calcium currents can lead to the augmentation of neuronal excitability.  Therefore, 
these data support the idea that increased Ras activation leads to enhanced 
neuronal excitability in isolated Nf1+/- sensory neurons by modulating the activity 
of ion channels. 
The downstream effectors of Ras were also shown to modulate channels.  
MAPK, a downstream effector of Ras-GTP, was reported to modulate multiple 
membrane currents.  Jin and Gereau (2006) reported that the TNFα-induced  
augmentation of TTX-R INa was dramatically reduced by the blocker of MAPK, 
SB 202190 in DRG neurons isolated from adult mice.   
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In mouse sensory neurons,  the ERK-dependent suppression of an A-type 
IK was significantly reduced when these neurons expressed a dominant negative 
MEK (Karim et al., 2006).  Also, Kv4.2, one type of potassium channel exhibiting 
IA properties, was shown to be the substrate of MAPK by direct phosphorylation 
of the pore-forming alpha subunit (Adams et al., 2000; Schrader et al., 2006).  
Furthermore, Fitzgerald (2000) reported that voltage-gated calcium currents were 
significantly enlarged by activating Ras-MEK-MAPK pathway.  Taken together, 
these investigations strongly suggest that the activation of MAPK leads to 
neuronal sensitization by modulating multiple membrane currents.   
The augmentation of INa and suppression of IK could lead to enhanced 
neuronal excitability (Evans et al., 1999; Leffler et al., 2002; Waxman et al., 1999; 
Zhang et al., 2002).  However, there was no difference in the resting membrane 
potential or the input resistance between Nf1+/+ and Nf1+/- neurons, suggesting 
that the potassium channels that maintain the resting membrane potential and 
resistance appear to be unaffected by the mutation in Nf1+/- cells.  Consistent 
with this observation, neither the delayed rectifier types of IK nor IA were 
suppressed in Nf1+/- neurons (see section F for detailed discussion).  Therefore, 
it is less likely that this mutation alters IK in mouse sensory neurons.  Based on 
the augmented excitability of Nf1+/- neurons, we hypothesized that INa in Nf1+/- 
neurons was somehow modified by the mutation and contribute to the enhanced 
excitability of Nf1+/- neurons.  To elucidate the specific channels that are 
modulated by the Nf1 mutation and contribute to the augmented excitability of 
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Nf1+/- neurons, we performed voltage-clamp studies for INa (see G about the 
detailed discussion about INa).   
B. NGF in the culture media for 4-12 hours causes neuronal 
sensitization in Nf1+/+ neurons.  
Much evidence suggests that NGF causes hyperalgesia and neuronal 
sensitization (Fjell et al., 1999a; Ji et al., 2002; Lewin and Mendell, 1993; Lewin 
et al., 1993; Woolf et al., 1994; Zhang et al., 2005; Zhang and Nicol, 2004; Zhang 
et al., 2002).  My investigation demonstrates that when NGF is added to the 
culture media for 4-12 hours the neuronal excitability of wild-type sensory 
neurons is significantly augmented.  The direct sensitizing effect of NGF on 
sensory neurons was also observed in other studies.  For example, NGF 
enhanced the neuronal firing of isolated sensory neurons in response to electrical 
stimuli (Zhang et al., 2002) as well as augmented the capsaicin-evoked inward 
current (Shu and Mendell, 1999).  Several investigations demonstrated that the 
Ras-MEK-MAPK pathway and the downstream effectors of this pathway could 
underlie the NGF-induced neuronal sensitization.  The injection of NGF into the 
rat hind paw produced a profound thermal hyperalgesia in these animals (Lewin 
et al., 1993; Woolf et al., 1994) as well as increased p-ERK labeling in TrkA-
containing neurons in the DRG (Averill et al., 2001), suggesting that NGF could 
directly act on the peripheral terminal of sensory neurons to enhance ERK 
activity and thereby contribute to the augmented neuronal firing.  In addition, 
during peripheral inflammation in which the local concentration of NGF was 
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enhanced, the level of phosphorylated p38 (another member of the mitogen-
activated kinase family) in nociceptive sensory neurons was elevated (Ji et al., 
2002).  This increase in phosphorylated p38 was correlated with an increase in 
expression of TRPV1 in DRG neurons and elevated thermal hyperalgesia.  All of 
these responses were blocked by treatment with antisera to NGF prior to the 
initiation of inflammation induced by CFA.  It is possible that NGF enhanced the 
expression of TRPV1 by activating p38 and thereby contributing to the thermal 
hyperalgesia and neuronal sensitization.  In addition, the expression of 
constitutively active Ras mimicked the action of NGF to increase TRPV1 
expression in isolated sensory neurons and increased neuronal levels of pERK 
and pAkt (Bron et al., 2003).  Moreover, treatment with the Mek inhibitor, 
PD98059, reduced the capsaicin sensitivity of neurons that were treated with 
NGF for 1 week (Ganju et al., 1998).  These studies suggest that Ras modulates 
TRPV1.  Although most of these investigations have focused on the role of the 
Ras transduction cascade in NGF-mediated changes of TRPV1 expression and 
capsaicin responses, they do not exclude the possibility of Ras-mediated 
changes in the excitability of nociceptive sensory neurons.  To address this 
question, it will be important to examine whether the increased excitability 
induced by NGF can be suppressed by the approaches to reduce intracellular 
Ras-GTP levels, e.g., Ras-neutralizing antibodies and dominant-negative 
isoforms of Ras in sensory neurons.   
In addition to stimulating intracellular signaling cascades, NGF can induce 
gene expression.  In my experiments, NGF remained in the culture media for 4-
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12 hours.  The NGF-induced sensitization (under our condition) could involve 
acute as well as chronic sensitization that resulted from NGF-induced changes in 
gene expression.  After treatment by NGF, a myriad of genes was induced in 
neurons and PC12 cells.  Mandelzys et al. (1990) described that NGF strongly 
increased the expression of nicotinic receptors in nodose neurons from neonatal 
rats.  Likewise, Toledo-Aral et al., (1995) found that exposure to NGF for 1 min 
was sufficient to increase the expression of functional sodium channels in PC12 
cells.  The induction of genes by NGF in PC12 cells was mimicked by expressing 
activated forms of Src, Ras or raf and was blocked by expression of a dominant-
negative form of Ras (D'Arcangelo and Halegoua, 1993).  These observations 
support the notion that NGF induces gene expression by activating downstream 
intracellular signaling molecules. Consistent with this idea, in sensory neurons, 
the mRNAs of several sodium channel subunits, such as Nav1.1, β1 and β2 were 
significantly upregulated in sensory neurons isolated from NGF-overexpressing 
transgenic mice (Fjell et al., 1999a).  Likewise, Zur et al., (1995) reported similar 
observations that NGF increased the mRNA levels of Nav1.2 and β1 in neurons 
isolated from E16 rat embryos.  The upregulation of sodium channel transcripts 
was often paralleled by the augmentation of INa in sensory neurons (Cummins 
and Waxman, 1997).  Based on these observations, under my experimental 
condition wherein NGF is present in media for 4-12 hours, it is possible that the 
NGF-induced augmentation of neuronal firing also depends on the upregulation 
of the mRNA of sodium channels and other functional proteins that may enhance 
neuronal excitability.   
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IK is another membrane current suppressed by acute exposure to NGF in 
rat sensory neurons (Zhang et al., 2002).  However, based on published studies, 
the idea that NGF regulates the expression levels of the mRNA for Kv channels 
is complicated by different results.  In PC12 cells, (Sharma et al., 1993) reported 
that the mRNA for Kv2.1 was increased about 4 fold after exposure to NGF for 
12 hours, and this elevation lasted for at least six days of continuous NGF 
treatment.  Conversely, Lei et al., (2001) demonstrated that the amplitude of IK in 
adult sympathetic neurons were unchanged by exposure to a high concentration 
of NGF (200 ng/ml) in the culture media for more than 10 days.  Likewise, Park et 
al. (2003) suggested that no significant change in the levels of mRNA for Kv1.1, 
1.4 and 4.2 after treatment with NGF for 12-24 hours in sensory neurons isolated 
from adult rats.  Based on my observation that neither the resting membrane 
potential nor the input resistance was significantly altered after exposure to NGF 
for 4-12 hours compared with neurons grown in the absence of NGF, it seems 
less likely that long-term exposure to NGF (4-12 hrs) alters the expression 
pattern of Kv channels.  As a consequence, IK in adult mice sensory neurons 
may not be changed by long-term NGF treatment.  In addition, my studies 
showed that neither the amplitude of total IK nor IA was suppressed in Nf1+/- 
neurons, suggesting that the activation of Ras-MEK-MAPK, either by long-term 
NGF treatment or by decreased Ras-GAP activity of neurofibromin, did not 
suppress IK in mouse sensory neurons.  In general, the observations described 
above are consistent with our findings that NGF increased the excitability of wild-
type mouse sensory neurons.  NGF could augment neuronal firing either by 
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activating intracellular second messengers that modulate the activity of ion 
channels, or by the upregulation of the mRNA for sodium channels and other 
functional proteins that could augment neuronal excitability.  It is important to 
establish the hierarchy of the signaling molecules following NGF stimulation, 
such as Ras, MAPK, ceramide and their role in modulating the activity of specific 
ion channels that contribute to the augmentation of neuronal firing.  Such 
information can lead to the identification of novel therapeutic targets for the 
hyperalgesia associated with inflammation or the chronic painful conditions that 
arise from other ailments.   
C.  Exposure to NGF has little effect of Nf1+/- sensory neurons.   
My results demonstrate that exposure of the Nf1+/- neurons to NGF has 
little effect on the neuronal excitability.  It is possible that NGF did not further 
enhance the excitability of Nf1+/- neurons because the mutated neurons have 
already attained their maximum ability to fire APs when stimulated by electrical 
currents.  Alternatively, it is possible that the pathway(s) activated by NGF may 
be chronically stimulated in the Nf1+/- neurons and not capable of further 
modulation.  Interestingly, applying NGF acutely via bath perfusion did augment 
the number of evoked APs by the current ramp in 2 out of 6 Nf1+/- neurons.  It is 
difficult to explain how NGF sensitized these 2 of 6 Nf1+/- neurons.  One 
possibility is that, in a group of Nf1+/- neurons, NGF still increases neuronal 
excitability by enhancing the Ras-GTP levels and thereby augments neuronal 
excitability.  However, it seems unlikely because NGF failed to sensitize other 
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Nf1+/- neurons (n=33) in my experiments.  Based on my observations, I 
speculate that the augmentation of excitability in these two Nf1+/- neurons may 
be due to some unknown reasons other than to be sensitized by NGF.  However, 
Hingtgen et al., (2006) reported that NGF increased the release of CGRP from 
Nf1+/- neurons in a concentration-responsive manner, indicating that these 
neurons can be further sensitized by NGF.  This discrepancy between my results 
and Hingtgen et al., (2006) raises the question that the signaling cascades 
stimulated by NGF that augment neuronal firing may be different from the 
cascades modulating the release of neurotransmitters in sensory neurons.  In 
addition, the different culture conditions could also contribute to the difference.  
Under my experimental condition, neurons were isolated from adult mice and 
stayed in culture for 4-12 hours, whereas the neurons in study by Hingtgen et al., 
(2006) remained in culture for 7 days before performing the release experiments.  
It is possible that the properties of these neurons may change after staying in 
culture for a long time and result in the different NGF-induced sensitization in 
these cells. 
My data suggested that the pathway(s), such as the Ras-dependent 
pathways activated by NGF, which augment neuronal firing may be chronically 
stimulated in the Nf1+/- neurons.  However, internal perfusion with the Ras-
blocking antibody failed to suppress the augmented excitability in the Nf1+/- 
neurons.  These results suggest that the effectors downstream of Ras have a key 
role in the NGF-induced augmentation of neuronal firing.   
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D. Y13-259 blocks the NGF-induced augmentation of neuronal firing in 
wild-type sensory neurons. 
My study demonstrates that the acute NGF-induced sensitization (NGF 100 
ng/ml via bath perfusion for five min) in wild-type neurons is suppressed by using 
a specific Ras-blocking antibody that binds directly to the amino acid residues of 
Ras that regulate its activity; this converts the active Ras back to its inactive form 
(Sigal et al., 1986).  This loss of NGF-induced sensitization is not due to the non-
specific effect of a high concentration of IgG inside the cell because these 
neurons can be sensitized by an acute 5 min exposure to NGF in the presence of 
30 µg/ml IgG in the recording pipette.  In addition, the non-specific actions of IgG 
do not alter basal neuronal excitability over the 20 min recording period.  My 
investigation demonstrates that the activation of Ras is a critical step in the acute 
NGF-induced augmentation of neuronal excitability in mouse sensory neurons.  
Since the NGF-induced sensitization occurs on a rapid time scale (less than 5 
min), the acute effect of NGF likely results from the activation of Ras and the 
downstream effectors of Ras that modulate channel activity (such as 
phosphorylation of channels), rather than the induction of gene expression.   
The Ras-MEK-MAPK pathway can modulate many  membrane currents 
such as TTX-R INa (Jin and Gereau, 2006), A-types of IK (Adams et al., 2000; 
Karim et al., 2006; Schrader et al., 2006) and voltage-gated calcium currents 
(Fitzgerald, 2000; Fitzgerald and Dolphin, 1997).  It is possible that the NGF-
mediated activation of Ras or its downstream effectors modulates the activity of 
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channels, and thereby enhances neuronal excitability. Based on my observation 
that NGF does not depolarize these Nf1+/- cells in the presence of IgG, Ras may 
not modulate IK that is a key player in setting the resting membrane potential.  
However, Zhang et al., (2002) demonstrated that NGF depolarized sensory 
neurons isolated from adult rats as well as suppressed IK.  This inconsistency 
between my observation and Zhang et al., (2002) leads to the speculation that 
NGF may modulate the activity of different ion channels in sensory neurons 
isolated from different species.  Consistent with this idea, Woodbury et al., (2004) 
reported that mouse and rat exhibit different colocalization of TRPV1 and 
isolectin B4 (IB4) binding in small diameter sensory neurons.  In this study, rat 
sensory neurons exhibited staining profiles where approximately 60% of the IB4 
positive cells stained for TRPV1, however, only 2% of the IB4 positive mouse 
sensory neurons were TRPV1 positive.  The TRPV1 positive and the majority of 
the IB4-positive neurons are highly likely to be heat-responsive nociceptors 
(Holzer, 1991; Molliver et al., 1997).  The distinct pattern of colocalization of 
TRPV1 and IB4 may indicate that the signaling cascades whose activation can 
lead to modulation of channels and thereby augment neuronal excitability could 
be different between mouse and rat sensory neurons.  Because neither the 
resting membrane potential nor the input resistance is changed by acute 
exposure to NGF in mouse sensory neurons, it is possible that the activation of 
Ras may not suppress IK in mouse neurons.   
In summary, my data demonstrate that the acute NGF-induced 
augmentation of neuronal excitability is blocked by the Ras-blocking antibody, 
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suggesting that NGF enhances neuronal excitability via activation of Ras in wild-
type neurons.  The validity of this conclusion depends on how specific this Ras-
blocking antibody is in its ability to neutralize Ras activity.  Although it is less 
likely that this Ras-blocking antibody binds to other intracellular proteins 
modulating neuronal excitability with the exact same amino acid residues like 
those in Ras, additional experiments, like those examining NGF-induced 
sensitization in primary sensory neurons expressing a dominant negative or 
constitutively active Ras are necessary to resolve this question.   
E. Y13-259 has little effect on the excitability of Nf1+/- neurons.   
As established above, the activation of Ras appears to be a critical step in 
NGF-induced sensitization of wild-type neurons.  Surprisingly, the Ras-blocking 
antibody has little effect on the parameters of excitability in Nf1+/- neurons.  
Several potential mechanisms could underlie the relative ineffectiveness of the 
Ras-blocking antibody in Nf1+/- neurons.  First, although the activation of Ras 
could contribute to neuronal sensitization, it is not a direct modulator of ion 
channel activity.  In this case, the downstream factors that directly phosphorylate 
channels have already been activated by the high level of Ras-GTP.  Therefore, 
blockade of upstream Ras activity will have little effect on the downstream 
effectors and likely can not suppress the excitability.  Second, since 
neurofibromin is a large protein that could interact with multiple signaling 
molecules, such as PKA and PKC (Izawa et al., 1996; Mangoura et al., 2006; 
The et al., 1997; Tokuo et al., 2001), the involvement of signaling cascades other 
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than Ras could produce the neuronal sensitization of Nf1+/- neurons.  In this 
case, neutralizing Ras activity would not suppress the excitability of Nf1+/- 
neurons.  Third, it is well documented that the activation of the Ras-MEK-MAPK 
pathway stimulates gene transcription.  After treatment of cells with mitogens and 
growth factors for 1-5 min, ERK translocates from cytoplasm to the nucleus and 
phosphorylates TCF, the transcription factor that mediates c-fos induction (Gille 
et al., 1992). c-fos belongs to the family of immediate early genes that are 
activated in response to a wide variety of cellular stimuli and has many functions, 
such as serving as transcription factors or DNA binding proteins.  The long term 
changes in gene transcription in Nf1+/- neurons can not be reversed by short-
term Ras neutralization.  Lastly, the compensatory mechanisms for the mutation 
of the Nf1 gene may also contribute to the neuronal sensitization of Nf1+/- 
neurons.  These compensatory mechanisms may change the expression of 
specific signaling molecules or functional channels, leading to the augmentation 
of neuronal excitability.  Therefore, other approaches, such as using gene chips 
to examine the changes in the global expression patterns of genes in Nf1+/- 
neurons, could be important to identify the exact targets whose activity leads to 
the elevated neuronal firing and help to develop better therapeutic strategies for 
the elevated pain sensitivity in people with NF1.   
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F.  IK does not contribute to the enhanced excitability of Nf1+/- neurons.  
It is well established that the inhibition of IK by multiple inflammatory 
mediators led to the augmentation of neuronal excitability (Nicol et al., 1997; 
Zhang et al., 2002; Zhang et al., 2006b).  However, my results indicate that 
neither the amplitude nor the activation kinetics of IK is altered in Nf1+/- neurons, 
suggesting the activation of Ras and its downstream effectors by the Nf1 
mutation does not modulate IK in mouse DRG neurons.  However, evidence 
indicates that MAPK modulated the IA type of IK in dorsal horn neurons and 
COS-7 cells (Adams et al., 2000; Hu et al., 2003; Karim et al., 2006).  The 
difference between my results and published studies could be explained by the 
variance of biological systems wherein these studies were conducted.  In my 
experiments, many small-diameter mouse sensory neurons do not have apparent 
IA currents (in eleven wild-type sensory neurons, only five cells had IA; whereas 
in seven Nf1+/- neurons, three had IA components), suggesting that IA may not a 
major IK in some subsets (e.g. capsaicin-sensitive) of mouse sensory neurons.  
Since the expression of IA in different types of cells could have large diversities, 
the signaling cascades modulating the activity of these potassium channels may 
also be different.  Based on my observations, it is less likely that the mutation of 
the Nf1 gene and its consequent activation of Ras and its downstream effectors 
suppress IK in mouse sensory neurons.   
To determine whether the kinetics of IK is changed in Nf1+/- neurons, the 
deactivation (the kinetic analysis of the current decay) of the potassium tail 
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currents is analyzed.  The time constant for the IK tail (τ tail) reflects how fast the 
channels are closing.  The longer the τ tail, the slower the channels are closed.  
Surprisingly, the τ tail in Nf1+/- neurons is much longer compared to Nf1+/+ 
neurons, indicating that the potassium channels are closing more slowly.  If this 
result truly reflects the character of potassium channels in Nf1+/- neurons, larger 
IK should be observed (more potassium channels should be open due to the 
slow closing of channels).  In addition, the opening of more potassium channels 
during the firing of an AP can lead to more effective repolarization in the falling 
phase, resulting in a narrower AP.  However, none of the above phenomena was 
observed in Nf1+/- neurons.  It is possible that the slower deactivation kinetics of 
potassium tail currents in Nf1+/- neurons results from biological variability of 
these sensory neurons.   
The suppression of IK can lead to increased neuronal excitability (Zhang 
et al., 2002).  However, based on my results, neither IK nor IA was suppressed in 
Nf1+/- neurons.  Thus, the augmented neuronal firing of Nf1+/- neurons did not 
result from the modulation of IK.  It is less likely those signaling cascades 
stimulated by the mutation of the Nf1 gene modulate the activity of potassium 
channels.   
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G. Augmented INa could contribute to the enhanced excitability in 
Nf1+/- neurons 
My investigation demonstrates that both TTX-R and TTX-S INa are 
significantly augmented in Nf1+/- neurons, suggesting the increased excitability 
of Nf1+/- neurons could result from larger INa.  Although the augmentation of INa 
during neuronal sensitization is well documented (England et al., 1996; Gold et 
al., 1996a; Gold et al., 2002; Jeftinija, 1994; Rush and Waxman, 2004; Waxman 
et al., 1994; Zhang et al., 2002), the cellular mechanisms that give rise to 
enlarged INa in sensory neurons are poorly understood.  Interestingly, multiple 
inflammatory mediators enhancing INa, like NGF and TNFα, were also reported 
to activate the MAPK pathway.  It is possible that the activation of MAPK 
modulates the activity of sodium channels.  Indeed, Jin and Gereau (2006) 
reported that the augmentation of TTX-R INa by acutely applying TNFα on 
mouse sensory neurons was dramatically suppressed by a blocker of MEK, SB 
202190.  Thus, it is logical to speculate that the activation of MAPK augments 
INa in Nf1+/- neurons or in wild-type sensory neurons upon stimulation with 
inflammatory mediators and this leads to neuronal sensitization.  It would be 
interesting to examine whether the augmented INa in Nf1+/- neurons could be 
suppressed by MEK inhibitors.   
In addition to augmented TTX-R INa, my results demonstrate that the 
TTX-S INa in Nf1+/- neurons is significantly larger than that in wild-type neurons.  
Interestingly, the TTX-S INa is much larger when a CsF-based pipette solution is 
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used compared to the currents obtained by using a Cs-aspartate-based pipette 
solution.  This obvious difference in the amplitude of TTX-S INa using different 
pipette solutions leads to the speculation whether CsF functions as an activator 
of TTX-S INa in small diameter, capsaicin-sensitive sensory neurons.  One 
possibility is that the F- binds to the Al+3 released from the glass of the pipette, 
forming a complex able to activate G proteins that may increase the amplitude of 
TTX-S INa (Saab et al., 2003).  However, Saab et al., (2003) reported that the 
peak INa was not altered by inclusion of an aluminum chelator in the pipette 
solution, suggesting that the fluoride-aluminum complex did not augment INa.  It 
is unlikely that the augmentation of TTX-S INa in Nf1+/- neurons results from 
including F- in pipette solution.  Consistent with this idea, Black et al., (2004) 
demonstrated that TTX-S INa in DRG neurons was augmented following 
carrageenan-induced inflammation when a CsF-based pipette solution was used.  
In addition, many reports demonstrated that multiple inflammatory mediators 
were able to augment TTX-R INa when CsF was in the pipette (Cardenas et al., 
1997; Cardenas et al., 2001; England et al., 1996; Gold et al., 1996a; Rush and 
Waxman, 2004; Tanaka et al., 1998; Zhang et al., 2006a; Zhang et al., 2002).  
These investigations suggest that CsF in the pipette is not a confounding variable 
in studying the manipulation of INa by multiple inflammatory mediators.  Based 
on my observation that the amplitudes of both TTX-R and TTX-S INa are 
increased in Nf1+/- neurons that exhibit augmented excitability, it is possible that 
the larger INa contributes to the augmented excitability in Nf1+/- neurons.  The 
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enlarged INa may have resulted from these pathways that are chronically 
activated in Nf1+/- neurons, like Ras and MAPK.   
In addition to a larger INa, the gating properties of INa in Nf1+/- neurons 
are different from that in Nf1+/+ neurons.  Voltage-dependent activation of INa in 
Nf1+/- neurons appears to be unaltered because the V0.5 was not different than 
that measured in wild-type neurons.  Interestingly, multiple inflammatory 
mediators, such as PGE2, NGF and endothelin, do cause a hyperpolarized shift 
in the voltage-dependent activation of INa in rat sensory neurons (England et al., 
1996; Gold et al., 1996a; Gold et al., 2002; Kwong and Lee, 2005; Zhang et al., 
2002; Zhou et al., 2002).  This inconsistency could result from species difference 
(mouse vs. rat).  Alternatively, the signaling cascades activated by these 
inflammatory mediators other than Ras and MAPK, such as cyclic AMP-PKA 
pathway, could cause the hyperpolarized shift in the voltage-dependent 
activation of INa.   
However, there is a significant depolarizing shift in the V0.5 of the steady-
state inactivation for total INa in Nf1+/- neurons.  At the voltage range of -50 mV 
to +10 mV (during this voltage range, sodium channels have the possibility to 
open), the depolarizing shift in V0.5 indicates that fewer sodium channels are 
inactivated, resulting in a greater number of sodium channels that are available 
to open, and thereby augmenting window currents.  The window current is 
represented by the area created by the overlap of the activation and inactivation 
functions of the sodium channel.  The opening of the non-inactivated sodium 
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channels (known as persistent INa) could augment window currents.  It is 
possible that the Nf1 mutation somehow increases the expression of more 
persistent INa, or shifts the inactivation of more sodium channels to a 
depolarized potential.   
Augmented INa could lead to higher overshoot of the AP.  However, in my 
experiments, the overshoot of the APs evoked from Nf1+/- neurons is not 
significantly different from wild-type neurons.  This lack of difference in the shape 
of APs may due to the electronic design of my amplifier (both Axon 200 B and 
EPC-7 amplifier), which can generate a voltage error in current-clamp mode that 
distorts the recorded signal (Magistretti et al., 1996).  Thus, in order to record 
APs with negligible distortions, a classical microelectrode amplifier is preferred in 
future current-clamp experiments.  
Interestingly, the morphology of total INa traces in mouse sensory neurons 
is different.  Two classes of neurons were identified based on the morphology of 
total INa: type I neurons were dominated by the fast inactivating TTX-S INa,  
whereas type II neurons exhibited mostly the slow inactivating TTX-R INa.  After 
treatment by TTX, the majority of INa evoked from type I neurons was diminished.  
In contrast, in type II neurons, there was little decrease in the peak currents 
observed after TTX.  The distribution of type I and type II neurons between 
genotypes is different.  There are more type II neurons in Nf1+/- sensory neurons 
compared to wild-type neurons.  In my study, eight out of ten wild-type sensory 
neurons were type I neurons, whereas in Nf1+/- neurons, only four of the ten 
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were type I neurons.  In Nf1+/- neurons, there is an increase in the percentage of 
type II neurons.  This could indicate that the expression of sodium channel 
transcripts may be different compared to wild-types.  Indeed, in mammalian 
sensory neurons, multiple sodium channel transcripts are detected: Nav1.1-1.4, 
Nav1.6-1.7 are TTX- S sodium channels, whereas Nav1.5, Nav1.8 and Nav 1.9 
are recognized as TTX-R sodium channels (Wood et al., 2004).  The enhanced 
percentage of type II neurons leads to the speculation that the subtypes 
encoding TTX-R sodium channels are upregulated in Nf1+/- neurons.  The 
upregulation of TTX-R sodium channel transcripts can be induced by multiple 
inflammatory mediators, such as NGF.  For example, Rudy et al., (1987) 
demonstrated that NGF increased the number of functional sodium channels and 
induced the expression of TTX-R sodium channels in PC12 cells.  In addition, 
Fjell et al., (1999b) showed that the deprivation of NGF in vivo suppressed the 
expression of Nav1.8, the transcript of a TTX-R sodium channel in small diameter 
sensory neurons.  Furthermore, delivery of NGF to the transected sciatic nerve 
up-regulated the mRNA of Nav 1.8 and augmented the TTX-R INa in small 
diameter sensory neurons (Dib-Hajj et al., 1998).  Based on the observation that 
more type II neurons in neurons isolated from Nf1+/- mouse, it is possible that 
the mRNA transcripts for TTX-R sodium channels in these Nf1+/- neurons were 
upregulated.  It is reasonable to speculate that the Ras-MEK-MAPK pathway, 
which could be activated either by decreased activity of neurofibromin or 
stimulation of NGF, upregulates the mRNA transcripts for TTX-R sodium 
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channels.  Therefore, the mRNA levels of multiple sodium channel subtypes in 
Nf1+/+ and Nf1+/- sensory neurons should be examined in future experiments.   
Interestingly, Breese et al., (2005) reported that the percentage of IB4-
positive mouse sensory neurons that were TRPV1-immunoreactive was elevated 
after CFA-induced inflammation.  The IB4-positive neurons typically have larger 
TTX-R INa (Stucky and Lewin, 1999).  In my study, the high percentage of type II, 
capsaicin-sensitive Nf1+/- neurons may suggest that the heterozygous mutation 
of the NF1 gene somehow increases the percentage of IB4-positive neurons that 
are TRPV1-immunoreactive.  Further experiments, like these to examine the 
colocalization of IB4 and TRPV1 on sensory neurons of both genotypes, should 
be performed in future investigations.   
The opening of sodium channels can lead to other functional changes of 
sensory neurons, such as the release of neurotransmitter from nerve terminals.  
Bouron and Reuter (1996) demonstrated that an elevated intracellular 
concentration of sodium ions entering the cell following AP firing caused an 
increase in glutamate release and accelerated the turnover rate of the vesicular 
pool in cultured rat hippocampal neurons.  In addition, a selective activator of 
voltage-gated sodium channels, brevetoxin-3, significantly augmented 
neurotransmitter release from the neuromuscular junction (Meunier et al., 1997).  
To further support the notion that augmented INa leads to the enhanced release 
of neurotransmitters, Hingtgen et al., (2006) reported that Nf1+/- neurons 
released more CGRP when stimulated by capsaicin and high potassium.  How 
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this augmented INa influences the release machinery in sensory neurons 
remains poorly understood.  It is possible that augmented INa produces longer 
depolarization of the membrane potential during the firing of an AP, and 
facilitates calcium ions entering the cell via voltage-gated calcium channels, 
thereby increasing the release of neurotransmitters.   
In summary, my data clearly suggest that neurofibromin can play a key 
role in modulating the excitability of small-diameter, capsaicin-sensitive sensory 
neurons by augmenting both TTX-R and TTX-S INa.  However, much evidence 
suggests that Ras modulates calcium currents and TRPV1 (Bron et al., 2003; 
Fitzgerald and Dolphin, 1997).  My data do not rule out the possibility that other 
channels, such as calcium channel and TRPV1 channels may also contribute to 
the augmented neuronal firing of Nf1+/- neurons.  A clearer understanding of the 
mechanisms underlying the enhanced neuronal excitability in sensory neurons 
with the Nf1 mutation, similar to the human disorder NF1, and how this 
sensitization may be modified in inflammation or injury could lead to better 
therapies for the painful conditions associated with NF1 or chronic painful 
conditions that arise from other ailments.   
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